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Summary 
Embryonic stem cells (ESCs) are characterized by their potential to self-renew 
indefinitely and by their ability to differentiate into all somatic cell types. This dual 
capacity makes ESCs a potential source for cell and tissue replacement therapies. 
However, before ESCs can safely and efficiently be used for clinical applications, 
intensive research on the mechanisms of pluripotency and ESC differentiation must be 
carried out. Chromatin and epigenetic regulatory mechanisms are well known to play key 
roles in ESC pluripotency. Remarkably, the chromatin of ESCs is particularly malleable 
and transcriptionally permissive. Such a property has been proposed to be crucial for the 
maintenance of a transcriptionally plastic state, which is required to enter in any lineage 
specification program during differentiation. ESCs exist in a variety of states in vitro, 
largely defined by the culture conditions, which reflect the natural development of the 
embryo from the blastocyst to post-implantation stages. When cultured in the presence of 
two small molecule inhibitors (ESCs+2i) closely resemble the developmental ground 
state in vivo whereas in the presence of serum and LIF (ESCs+serum), they are in a 
developmentally primed state. These two pluripotency states are defined by distinct gene 
expression and epigenetic signatures, which resemble cells of in vivo during pre- and 
post-implantation development, respectively. However, how chromatin structures and 3D 
genome organization is regulated during these different developmental states remains yet 
unclear. In this work, we aimed to identify the contribution of a particular chromatin 
remodeling complex called NoRC in maintaining ground state pluripotency. Although 
NoRC is highly expressed in both pluripotency states, only ESC+2i depend on NoRC for 
cell growth, differentiation, correct gene expression and H3K27me3 occupancy, whereas 
ESC+serum do not. Furthermore, we show that NoRC binds large and active regions 
within the A-compartment and limits far-cis chromatin contacts in order to maintain 
correct ground state 3D genome architecture. Strikingly, we identified two additional 
chromatin regulators, namely TOP2A and cohesin, which – in association with NoRC – 
also contribute to the integrity of ground state pluripotency. Particularly depletion of 
TOP2A or inhibition of TOP2 activities phenocopy the ground-state specific alterations 
observed upon TIP5 knockdown. These findings indicated that the ground-state 
chromatin structure is a fundamental player for correct gene expression and epigenetic 
states highlighting different degrees of genome dynamics during early phases of 
development. 
Zusammenfassung 
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Zusammenfassung 
Embryonale Stammzellen (ESCs) zeichnen sich durch ihr Selbsterneuerungspotential 
und ihre Fähigkeit aus, sich in alle somatischen Zelltypen zu differenzieren. Diese 
doppelte Kapazität macht ESC zu einer potenziellen Quelle für Zell- und 
Gewebeersatztherapien. Bevor jedoch ESCs sicher und effizient für klinische 
Anwendungen eingesetzt werden können, muss intensiv nach den Mechanismen der 
Pluripotenz und der ESC-Differenzierung geforscht werden. Chromatin und 
epigenetische Regulationsmechanismen spielen bekanntermaßen eine Schlüsselrolle 
bei der Pluripotenz der ESCs. Bemerkenswerterweise ist das Chromatin von ESCs 
besonders formbar und transkriptionell permissiv. Es wurde vorgeschlagen, dass eine 
solche Eigenschaft für die Aufrechterhaltung eines transkriptionell plastischen 
Zustands entscheidend ist, welcher für die Differenzierung in jedes 
Linienspezifikationsprogramm gebraucht wird. ESCs existieren in einer Vielzahl von 
Zuständen in vitro, die weitgehend durch die Kulturbedingungen definiert sind und 
die natürliche Entwicklung des Embryos von der Blastozyste bis zur Post-
Implantationsphase widerspiegeln. Werden sie in Gegenwart von zwei kleinen 
Molekülinhibitoren (ESCs+2i) gezüchtet, ähneln sie dem Entwicklungsgrundzustand 
in vivo, während sie in Anwesenheit von Serum und LIF (ESCs+serum) in einem 
entwicklungsgeprimten Zustand gehalten werden. Diese zwei Pluripotenzzustände 
sind durch unterschiedliche Genexpression und epigenetische Signaturen definiert, die 
Zellen der in vivo Prä- und Post-Implantationsentwicklung ähneln. Wie 
Chromatinstrukturen und die 3D-Genomorganisation während den verschiedenen 
Entwicklungsstadien reguliert werden, ist jedoch noch unklar. In dieser Arbeit wollten 
wir den Beitrag eines bestimmten Chromatin-Remodelling-Komplexes namens NoRC 
zur Aufrechterhaltung der Pluripotenz im Grundzustand analysieren. Obwohl NoRC 
in beiden Pluripotenzzuständen stark exprimiert wird, hängen nur ESCs+2i für 
Zellwachstum, Differenzierung, korrekte Genexpression und H3K27me3-Besetzung 
von NoRC ab, während ESCs+serum dies nicht tun. Darüber hinaus zeigen wir, dass 
NoRC grosse und aktive Regionen innerhalb des A-Kompartiments bindet und weite 
cis Chromatinkontakte begrenzt, um korrekte 3D-Genomarchitektur des 
Grundzustands zu erhalten. Bemerkenswerterweise identifizierten wir zwei 
zusätzliche Chromatinregulatoren, nämlich TOP2A und Cohesin, die zusammen mit 
NoRC auch zur Integrität der Pluripotenz im Grundzustand beitragen. Insbesondere 
Zusammenfassung 
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der Verlust von TOP2A oder seine Hemmung durch spezifische Inhibitoren zeigen 
die nach TIP5-Knockdown beobachteten Grundzustands-spezifischen Veränderungen. 
Diese Befunde zeigten, dass die Chromatinstruktur im Grundzustand ein 
fundamentaler Faktor für korrekte Genexpression und epigenetische Zustände ist, die 
unterschiedliche Grade der Genomdynamik in frühen Phasen der 
Embryonalentwicklung hervorheben. 
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Abbreviations 
2i 2 inhibitor 
5hmC 5-hydroxymethylcytosine 
5mC 5-methylcytosine 
ac acetylation 
ATP adenosine triphosphate 
bp  base pair 
CGI CpG island 
CHD chromodomain helicase DNA-binding  
ChIP chromatin immunoprecipitation 
CT chromosome territory 
CTCF CCCTC-binding factor 
DamID DNA adenine methyltransferase identification 
DNA desoxyribonucleic acid 
DNMT DNA methyltransferase 
EpiSCs epiblast stem cell 
ERK  extracellular signal-regulated kinase 
ESC embryonic stem cell 
GSK3  glycogen synthase kinase 3 
HAT histone acetyl transferase 
HDAC  histone de-acetylase 
HiC chromatin conformation capture sequencing 
HMT histone methyl transferase 
ICM inner cell mass 
IGS-rRNA intergenic spacer ribosomal RNA 
iPSCs induced pluripotent stem cells 
ISWI imitation switch  
SWI/SNF switch/ sucrose non-fermentable  
JAK Janus kinase 
kb kilo bases  
KO knock out 
LAD lamina-associated domain 
LIF  leukemia inhibitory factor 
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lncRNA long non coding RNA 
Mb mega bases  
me methylation 
MEK mitogen-activated protein kinase 1 
NAD nucleolus-associated domain 
NL nuclear lamina  
NOR nucleolus organizing region 
NoRC nuclelar remodeling complex 
nt nucleotides 
OCT_4 octamer-binding transcription factor 4  
OSN OCT4/SOX2/NANOG 
PGC primordial germ cell 
ph phosphorylation 
Pramel7 PRAME-like 7 
PRC Polycomb repressive complex 
pRNA promoter RNA 
PTM post-translational modification 
rDNA ribosomal DNA 
Rex1 Reduced Expression Protein 1 
RNAi  RNA interference 
RNP ribonucleoprotein 
rRNA ribosomal RNA 
siRNA small interfering RNA 
SMC structural maintenance of chromosomes 
SNF2H sucrose nonfermenting protein 2 homolog 
SOX2  SRY-Box 2 
STAT3  signal transducer and activator of transcription 3 
T Terminator element 
TAD topological-associated domain 
TDG thymine DNA glycosylase 
TET ten-eleven translocation 
TIP5 TTF1 interacting protein 5 
TKO triple knock out 
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TOP2A  topoisomerase 2a 
tRNA  transfer RNA 
TSS transcription start site 
TTF1 transcription termination factor 1 
ub ubiquitination 
UBF upstream binding factor 
UCE upstream control element 
UHRF1 ubiquitin like with PHD and ring finger domains 1 
ZGA zygotic genome activation 
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1. Introduction 
1.1 Embryonic stem cells (ESCs) 
Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of a 
blastocyst, an early pre-implantation stage of the developing embryo (in mouse, E3.5-
E4.5). Under optimal culturing conditions, these cells can be maintained in a 
pluripotent state that is characterized by the potential to self-renew indefinitely and by 
the ability to differentiate into all three germ layers endoderm, mesoderm and 
ectoderm (Martello and Smith, 2014). ESCs are of great interest as a model system 
for studying early developmental processes and for their potential therapeutic 
application in regenerative medicine (Weinberger et al., 2016). Considering the 
similarities of ESCs and cancer cells, extending the basic knowledge in stem cells 
might also lead to new therapeutic approaches for cancer therapies (Gaspar-Maia et 
al., 2011a).  
 
1.1.1 Origin of mouse ESCs  
In 1981 Evans and Martin independently succeeded for the first time in deriving 
pluripotent ESCs directly from the blastocyst of the developing mouse embryo. Co-
culturing these cells in a serum-containing medium with a feeder layer of mitotically 
inactivated fibroblasts allowed the maintenance of an undifferentiated state (Evans 
and Kaufman, 1981; Martin, 1981). Their pluripotent capacity was confirmed by two 
independent experimental readouts. Firstly, they generated teratocarcinomas that are 
composed of multiple tissue types from all three germ layers when grafted to adult 
mice. Secondly, these cells were capable of contributing to the germ line of chimeric 
animals which themselves were fertile and generated healthy offspring (Bradley et al., 
1984). Since ESCs were permissive to standard genetic manipulations and could be 
clonally expanded, ESCs could be used as a vehicle for introducing mutations into 
mice. In 1989, the first mouse knock out (KO) mouse was generated by gene targeting 
in ESCs (Thompson et al., 1989). Although in vitro culturing of ESCs was 
doubtlessly a break through in the field of stem cell research, the efficiency of ESC 
derivation and cultivation was very low. A large improvement was achieved by the 
addition of leukeamia inhibitory factor (LIF) to the culturing media. LIF was 
identified as a secreted factor from feeder cells that could effectively suppress 
1. Introduction 
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differentiation of ESCs (Smith et al., 1988; Williams et al., 1988). LIF signals to 
activate the JAK-STAT3 (Janus kinase-signal transducer and activator of transcription 
3) pathway, which controls the transcription of genes regulating self-renewal such as 
KLF4, GBX2 and C-MYC (Figure 1) (Martello and Smith, 2014). Thus, LIF could be 
used to replace feeders for both derivation and propagation of ESCs. However, LIF 
alone was not sufficient for self-renewal, since removal of serum from the medium 
led to a gradual loss in ESC pluripotency. This obstacle was overcome in 2003 by the 
discovery of bone morphogenic proteins (BMPs) as potent antagonists of neural 
specification in vertebrate embryos. Strikingly, BMP4 was found to be able to replace 
serum and – in combination with LIF – sustain ESC self-renewal in a serum- and 
feeder-free condition (Ying et al., 2003). Mechanistically, BMP4 signals via SMAD 
proteins to activate Inhibitor of Differentiation (ID) genes (Figure 1) (Malaguti et al., 
2013).  
 
Figure 1. Extrinsic Signaling Pathways reinforcing or antagonizing self-renewal. ESCs+serum depend on 
BMP4 and LIF signaling via SMAD and STAT3, respectively. In ESCs+2i ChIRON inhibits GSK3, which 
mimics canonical WNT signaling and results in activation of Esrrb expression. Inhibition of ERK signaling via 
PD interferes with FGF4 signaling to activate differentiation related genes. Taken from (Hackett and Surani, 
2014) 
 
1.1.2 Ground state, naïve and primed pluripotency 
The ability of maintaining ESCs in culture resulted in the definition of naïve 
pluripotency, which describes the property of cells giving rise to all embryonic 
lineages following blastocyst injection (Nichols and Smith, 2009). Although 
conventional ESCs cultured in serum+LIF (ESCs+serum) meet the rather descriptive 
criteria of naïve pluripotency, they have been shown to be heterogeneous and differ 
1. Introduction 
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substantially from the in vivo epiblast cells in the ICM. Particularly, the molecularly 
undefined serum component is known to contribute to a conflict in the pluripotency 
network. The interplay of pro- and anti-differentiation signaling pathways induce a 
metastable state leading to significant transcriptional, morphological and functional 
heterogeneity among these cells (Chambers et al., 2007; Hayashi et al., 2008; 
Toyooka et al., 2008). As a result, ESCs+serum exist in at least two distinct 
populations. One corresponding to the naïve pluripotent cells, while the other 
subpopulation resembles a developmentally more advanced state associated with 
enhanced expression of lineage-specific genes (Figure 2). The later population has 
further been shown to perform poorly in pluripotency assays (Hackett and Surani, 
2014). Interestingly, ESCs+serum were shown to be interchangeable between both 
subpopulations resulting in a dynamic and metastable state allowing cycling in and 
out of naïve pluripotency (Abranches et al., 2013). The problematic heterogeneity of 
ESCs+serum was overcome in 2008 by supplementing the ESC medium with two 
small molecule inhibitors referred to as “2i”. Blocking GSK3 and MEK/ERK 
activities by CHIR99021 and PD0325901, respectively resulted in the trapping of the 
ESCs in their naïve pluripotent state (ESCs+2i) (Figure 1) (Ying et al., 2008). Both 
GSK3 and MEK/ERK signaling are known to be antagonistic with self-renewal 
(Doble et al., 2007; Kunath et al., 2007; Sato et al., 2004). Mechanistically, EKR2, 
that is activated upon FGF4 signaling, phosphorylates the pluripotency protein KLF4 
leading to its proteasomal degradation (Yeo et al., 2014). Consequently, the 
pluripotency network is stabilized by the inhibition of MEK, the upstream activator of 
ERK1/2 (Figure 1) (Ying et al., 2008). The beneficial impact of GSK3 inhibition on 
self-renewal is mainly mediated by stabilization of β-catenin and therefore mimicking 
stimulation of the canonical WNT signaling pathway (Figure 1) (ten Berge et al., 
2011; Yi et al., 2011). In the absence of β-catenin the transcriptional repressor TCF3 
associates pluripotency genes and antagonizes with OCT4 and SOX2 activity. Upon 
stabilization, β-catenin translocates to the nucleus and interacts with TCF3 resulting 
in the disruption of TCF3-mediated repression (Faunes et al., 2013; Wray et al., 
2011). ESRRB has been shown to be among the most important factors upregulated in 
response to CHIR99021 treatment and thereby release from TCF3-mediated 
repression (Figure 1) (Martello et al., 2012). In summary, addition of these two 
inhibitors allows the derivation and propagation of ESCs in the absence of serum, 
which can therefore be maintained in a chemically well-defined medium allowing 
1. Introduction 
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more reproducible results. 2i-culturing conditions increases the ESC derivation 
efficiency and also allows ESC retrieval of a broader species spectrum. While 
ESCs+serum are successfully isolated from 129 and hybrid mouse strains only, 
ESCs+2i are derived from all mouse strains and even from other rodent species, such 
as from rat (Buehr et al., 2008; Kiyonari et al., 2010; Li et al., 2008; Nichols et al., 
2009). Molecular characterization of ESCs+2i revealed a highly homogenous 
population of cells that seem to be isolated from perturbation by differentiation 
inducers. Moreover, ESCs+2i exhibit reduced expression of lineage-related genes, a 
highly permissive epigenetic landscape and cluster closely with E4.5 epiblast cells at 
the single-cell transcriptome level. By contrast, ESCs+serum appear to resemble 
developmentally more advanced state of differentiation, as assessed by analyses of 
their transcriptome and epigenome (Boroviak et al., 2014; Marks et al., 2012). 
Although both ESCs+serum and ESCs+2i are functionally naïve pluripotent, ESCs+2i 
were additionally defined to be in a ground state that is defined as unrestricted naïve 
pluripotency established in vivo in the epiblast cells of the developing blastocyst 
(Figure 2). Ground state pluripotency of ESCs+2i is further supported by the fact that 
cells, that have left the naïve pluripotent state, usually die in the presence of 2i (Silva 
and Smith, 2008). Taken together, ESCs+2i are referred to as ground state pluripotent 
and are to date the best in vitro approximation of the epiblast cells from the 
developing embryo.  
Besides from the ICM, pluripotent stem cells can also be isolated from the post-
implantation epiblast cells at E5.5-8.0. The so-called epiblast stem cells (EpiSCs) are 
able to form tertacarcinomas and are capable of differentiating into all germ layers in 
vitro. However, upon injection into recipient mice they do not or only very 
inefficiently contribute to chimeric animals (Brons et al., 2007; Hayashi et al., 2011). 
This restricted or “primed” pluripotency is one of the main functional characteristics 
of EpiSCs representing an even more advanced developmental stage. Different than 
naïve ESCs, EpiSC require FGF2 and Activin A signaling for maintaining self-
renewal (Figure 2) (Brons et al., 2007). Transcriptionally, EpiSCs show reduced 
expression of many ancillary pluripotency factors (Festuccia et al., 2012). 
Furthermore, EpiSCs accumulate epigenetic barriers such as female X chromosome 
inactivation and promoter methylation of pluripotency genes. These molecular 
characteristics seem to be incompatible with the naïve state. Accordingly, EpiSCs are 
1. Introduction 
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distinct from ESCs+serum/ESCs+2i and functionally, they rather resemble the 
anterior primitive streak (Kojima et al., 2014).  
 
 
Figure 2. Spectrum of ground state and primed pluripotent stem cells. ESCs are isolated from the 
blastocyst, while EpiSCs derive from post-implantation epiblast. Depending on the derivation and culturing 
condition, these pluripotent stem cells reside in distinct pluripotency states, which are classified as naïve and 
primed. Furthermore, an unrestricted naïve state closely recapitulating the epiblast cells in the ICM is 
additionally defined as ground state. ESCs+2i and EpiSCs are classified as ground state and primed, 
respectively. ESCs+serum however, exist in a highly heterogeneous population of naïve and primed ESCs, 
which is reflected by high and low Rex1 expression. Taken and modified from (Hackett and Surani, 2014) 
Taken together, three main pluripotent states are distinguished among the cultured 
embryonic stem cells in vitro: (i) ground state (ii) naïve and (iii) primed pluripotency 
that are dependent on the ESC culturing conditions and on the developmental state of 
the embryo upon retrieval. Although these states are molecularly and functionally 
distinct, it is possible to interchange from to another and therefore model in vitro 
processes that occur during early embryonic development. An exact definition of 
ESCs+serum has been challenging due to their heterogeneity within the population. 
While one part is functionally naïve and highly expresses pluripotency factors, the 
other subpopulation performs poorly in pluripotency assays and seemed to be in a 
more primed state (Hackett and Surani, 2014). Molecular profiling of ESCs+serum 
revealed that these cells – in contrast to ESCs+2i – transcriptionally and 
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epigenetically resemble a more advanced post-implantation state of development. 
Even the most naïve ESCs+serum, as judged by high expression of Rex1, appear 
developmentally more advanced than ground state ESCs+2i and therefore represent a 
distinct molecular state of naïve pluripotency (Figure 2) (Marks et al., 2012). For the 
future of this work ESCs+serum will therefore be referred to as “primed”, while 
ESCs+2i have doubtlessly been shown to reside in ground state pluripotency.  
 
1.1.3 The pluripotency gene regulatory network 
Downstream of the extrinsic signals, a complex network of transcription factors 
activates self-renewal related genes and represses differentiation-associated pathways. 
This intrinsic genetic network is organized into three “core” and many “ancillary” 
pluripotency factors. Octamer-binding transcription factor 4 (OCT4 or POU5F1) is 
uniquely expressed in all ESCs and is absolutely essential for in vivo and in vitro 
pluripotency. It belongs to the Pic-Oct_Unc (POU) family of transcription factors and 
is exclusively expressed in ESCs and primordial germ cells (Rosner et al., 1990; 
Scholer et al., 1990). Similarly, SRY-box 2 (SOX2) is indispensable for the formation 
of the pluripotent epiblast. It is a member of the high mobility group (HMG) DNA 
binding proteins and among others a key regulator of OCT4 gene expression (Avilion 
et al., 2003). In contrast to OCT4, SOX2 is more broadly expressed in mouse. In 
addition to the pre- and postimplantation epiblast cells, SOX2 is present in 
trophectoderm and in the all neuroectodermal lineages. Interestingly, both depletion 
and overexpression OCT4 and SOX2 lead to ESC differentiation, highlighting that 
tight control of OCT4 and SOX2 expression is the foundation for the pluripotency 
gene regulatory network (Niwa et al., 2000). NANOG, a homeodomain-containing 
transcription factor, is considered as the third core pluripotency factor due to its 
crucial role in establishing the pluripotent state in the ICM and because of its ability 
to maintain pluripotency in the absence of LIF when overexpressed in ESCs 
(Chambers et al., 2007; Mitsui et al., 2003). However, ESCs are still capable to self-
renew upon its genetic depletion, implying that NANOG executes a different 
functional role from OCT4 and SOX2 (Carter et al., 2014; Schwarz et al., 2014). 
Genomic occupancy studies revealed that OCT4/SOX2/NANOG (OSN) bind 
overlapping regulatory elements, including their own promoters, and cooperatively 
regulate a network that self-maintains pluripotency. The OSN core serves as a 
1. Introduction 
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platform for recruitment and binding of additional factors such as co-activators, co-
repressors, regulatory RNAs or epigenetic factors (Young, 2011). In general, OSN 
often bind regions containing enhancer activity. Interestingly, gene ontology terms of 
these regulatory elements reveal enrichments in ‘self-renewal’ and ‘differentiation’, 
further highlighting a role of these core pluripotency factors in generating a bi-stable 
state (Young, 2011). Although OSN are expressed in both ground state and primed 
ESCs, their binding differs considerably. Upon transition of serum to 2i, OSN binding 
is rapidly reconfigured at enhancers increasing at elements with canonical Wnt 
transcription factor motifs and decreasing at targets of ERK signaling. Rewiring of 
these core pluripotency factors also correlates with transcriptional activity in ESCs+2i 
potentially stabilizing the ground state (Galonska et al., 2015b).  
Besides the three core pluripotency factors, ESCs express a repertoire of ancillary 
pluripotency regulators and co-factors, such as KLF2, ESRRB, KLF4, PRDM14, 
LASS4, TFCP211 and TBX3. Although individual ancillary factors are usually 
dispensable for ESC integrity, in combination they stabilize each other’s expression 
through several feedback loops reinforcing, fine-tuning and buffering the 
transcriptional pluripotency network (Dunn et al., 2014). While the core pluripotency 
factors are expressed in all ESCs, there are substantial differences in the dependency 
on ancillary factors in ground state and primed ESCs. In general, in ESCs+serum 
several of these proteins are heterogeneously expressed, reflecting their mixed 
population of naïve and primed cells. Interestingly, primed ESCs also rely on 
different subsets of ancillary factors, so-called “modules”, highlighting their context-
dependent roles (Hackett and Surani, 2014). For instance, the MYC module promotes 
rapid transition through the G1 phase of the cell cycle and inhibits differentiation in 
ESCs+serum (Chambers and Tomlinson, 2009). In ground state ESCs on the other 
hand, the MYC module is almost entirely silenced (Marks et al., 2012) and therefore 
dispensable for self-renewal. Also ESRRB, a critical component for supporting the 
pluripotency network in serum ESCs, is not required in ESCs+2i (Grabole et al., 
2013). In summary, OCT4, SOX2 and NANOG in concert with several ancillary 
factors control a cascade of pathways that are interconnected and control 
pluripotency, self-renewal and cell fate determination (Loh et al., 2006). 
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1.2 Chromatin and epigenetic modifications in ESCs 
Chromatin is the central regulatory unit of genetic material in eukaryotic cells. 147bp 
of DNA is wrapped around a histone octamer composed of two copies of each core 
histone proteins: H2A, H2B, H3 and H4 forming a nucleosome, the basic chromatin 
element. Linker DNA connects adjacent nucleosomes forming a so-called 10nm 
“beads-on-a-string” fiber (Olins and Olins, 1974). Histone 1 (H1) is not part of the 
core nucleosome but is capable of binding 20bp of linker DNA interconnecting 
nucleosomes to form higher order chromatin structures (Ramakrishnan, 1997). 
Importantly, histones are subjected to numerous post-translational modifications 
(PTMs) that influence the biophysical properties of the nucleosome (Kouzarides, 
2007). In combination with DNA methylation, these histone modifications form the 
basis of epigenetic inheritance regulating gene function (Figure 3).  
 
 
Figure 3. Scheme of chromatin structures. DNA is wrapped around histone octamers giving rise to the 
nucleosome. Chromatin can then further be organized in higher order structures. Epigenetic marks such as DNA 
methylation or histone PTMs may alter the transcriptional and compaction state of DNA without changing the 
underlying DNA sequence. Taken from (Marx, 2012) 
They cooperate with nucleosome remodeling complexes and factors regulating 
chromatin structure to define local and global chromatin dynamics enabling specific 
genomic regions to be expressed or silent. In general, chromatin can be functionally 
and structurally classified into “euchromatin” and “heterochromatin”. Euchromatin 
appears as structurally loose and accounts for most transcriptional activity within the 
cell. Heterochromatin by contrast, is lowly transcribed, forms highly compact 
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structures and is characterized by repressive histone modifications (Felsenfeld and 
Groudine, 2003).  
 
1.2.1 Chromatin organization of ESCs 
Through self-renewal, ESCs retain the potential to give rise to any cell type of the 
embryonic tissue. This ability requires a high grade of genome plasticity allowing the 
ESCs to enter any differentiation path for following lineage-specification. The 
chromatin of ESCs has several distinct features that allow preservation of the 
developmentally permissive state. In this regard, ESC chromatin is less condensed 
and is therefore classified to be in an “open” conformation. This observation is also 
reflected by an increased ratio between euchromatin and heterochromatin, which is 
significantly higher compared to differentiating cells (Bhattacharya et al., 2009; 
Meshorer and Misteli, 2006). Electron microscopy allowed detailed and high-
resolution visualization of chromatin structures. Indeed, chromatin in ESCs is evenly 
spread and largely devoid of heterochromatic regions. In differentiated cells by 
contrast, chromatin appeared more heterogeneous with distinct blocks of compaction, 
particularly at the nuclear periphery and around the nucleolus (Figure 4) (Efroni et 
al., 2008; Park et al., 2004; Savic et al., 2014). Importantly, this ESC-specific pattern 
of evenly spread chromatin organization has also been observed in the ICM epiblast 
cells of the developing embryo, excluding an artifact of long-term ESC culturing 
(Ahmed et al., 2010). Recently, super-resolution live cell imaging shed further light 
on the detailed chromatin dynamics in ESCs and differentiated cells. In line with an 
open state, the dispersed chromatin domains in ESCs are highly dynamic, especially 
in central nuclear positions. Upon early differentiation, this flexibility decreases in 
concert with an increase of compact and static DAPI-dense structures (Nozaki et al., 
2017). There is further evidence that support the concept of an open chromatin state in 
ESCs. Fluorescence recovery after photobleaching (FRAP) experiments have 
suggested that ESC chromatin contains several loosely bound architectural proteins 
such as linker histones and heterochromatin protein 1 (HP1). In differentiated cells 
however, this dynamic fraction was not detected (Meshorer et al., 2006). Recently, 
also considerable differences in chromatin organization between ground state and 
primed ESCs were observed. Ultra-high resolution microscopy by STORM 
investigating chromatin structures at the nucleosome level revealed that ESCs+2i 
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have a more open chromatin configuration when compared to ESCs+serum. So-called 
“nucleosome clutches” are significantly smaller in size and contain less nucleosomes 
per clutch in ESCs+2i. Taken together, pluripotent stem cells keep a largely open and 
dynamic chromatin conformation allowing the maintenance of a transcriptionally 
plastic state, which is essential for directing the different transcriptional programs 
during following lineage specification. Upon ESC differentiation, large-scale genome 
silencing takes place and ESC chromatin undergoes structural remodeling toward a 
highly condensed heterochromatic and transcriptionally repressed form (Bhattacharya 
et al., 2009; Meshorer and Misteli, 2006). 
 
 
Figure 4. Nuclear re-organization during differentiation. Electron microscopy images from ESC and NPC 
nuclei. The chromatin in ESCs is in a largely open conformation. Upon differentiation compact heterochromatin 
blocks form around the nucleolus and at the nuclear periphery. Nucleolus (Nu), Heterochromatin (Het). Taken 
from (Savic et al., 2014) 
1.2.2 Histone modifications   
Histones proteins contain a globular motif that allows protein dimerization and 
assembly of the octamers complex forming the basis of the nucleosome. Their N-
terminal domains however extend into an unstructured tail that protrude from the 
octamer and are able to form additional contacts with DNA and chromatin associated 
proteins. A striking feature of histones – particularly of their tail domains – is the 
large number and types of posttranslational modifications (PTMs) they are subjected 
to. Although many more histone PTMs have been reported, most research has focused 
on the small covalent modifications methylation (me), acetylation (ac) and 
phosphorylation (ph) (Kouzarides, 2007). Importantly, these epigenetic marks have a 
large impact on the biophysical properties of the nucleosome and on the surrounding 
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chromatin. This can occur directly through steric hindrance of histone-histone or 
histone-DNA interactions by the modification itself or via regulating the recruitment 
of effector proteins that specifically recognize the histone PTM (Taverna et al., 2007). 
The large number of different PTMs expands the regulatory properties of histones 
beyond that of a structural scaffold upon which the DNA is wrapped (Tee and 
Reinberg, 2014). Deciphering the co-called “histone code” has been a major research 
focus in the past years. Several histone PTMs have been characterized in relation to 
their association and impact on the regulation of gene expression (Strahl and Allis, 
2000). Thus, H3K4me1/3, H3K9ac, H3K14ac, H3K27ac H3K36me3, H4K20me are 
considered as “active” histone marks, since they are mainly associated with 
euchromatic regions containing actively transcribed genes. By contrast, H3K9me2/3, 
H3K27me2/3, H3K79me3, H2BK5me3 are defined as “repressive” histone 
modifications associated with transcriptionally silent regions of the genome 
(Kouzarides, 2007). All these PTMs are reversible and in a dynamic equilibrium 
mediated by their addition through “writer” and their removal via “eraser” enzymes. 
Their functional impact is usually mediated by so-called “reader” proteins, which 
specifically recognize PTM and trigger a biological output (Atlasi and Stunnenberg, 
2017). Further complexity in chromatin organization is mediated by the incorporation 
of histone variants that slightly differ in their amino acid sequence from the canonical 
histones. These replication-independent histones are linked to specific functions such 
as transcriptional activation (H3.3), kinetochore assembly (CENPA), DNA repair and 
recombination (γH2AX) or X chromosome inactivation (macroH2A) (Sarma and 
Reinberg, 2005). Taken together, histones and their PTMs provide a near endless 
combinatorial complexity that can function as a regulatory unit involved in all nuclear 
processes such as transcription, DNA replication, DNA damage response and nuclear 
architecture. For this reason the concept of “histone code” has been gradually 
replaced by the more suitable concept of “histone language” (Rothbart and Strahl, 
2014).  
 
1.2.2.1 Histone modifications and bivalent marks in ESCs 
As for the chromatin structure, the epigenome of ESCs is highly malleable and 
dynamic enabling these cells to undergo a wide range of lineage specifications. A 
global lack of constitutive heterochromatin in ESCs is reflected by reduced levels of 
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the repressive histone marks H3K9me2/3 and H3K27me3 when compared to 
differentiated cells (Hawkins et al., 2010; Meshorer et al., 2006). Conversely, high 
levels of several active histone modifications such as H3K4me3, H3K27ac and H4ac 
that contribute to keeping the chromatin open and accessible are linked to the mainly 
euchromatic state of the ESC genome (Azuara et al., 2006; Gaspar-Maia et al., 2011a; 
Liang and Zhang, 2013). Furthermore, the ES cell genome is transcriptionally 
hyperactive and transcribes normally silenced repetitive elements as well as coding 
and non-coding regions, resulting in increased levels of total RNA and mRNA (Efroni 
et al., 2008). Despite their transcriptional permissive state, ESCs must retain a certain 
grade of gene silencing to maintain pluripotency and genome stability. Particularly 
genes involved in differentiation processes need to be kept in a repressed state, 
without however silencing them irreversibly (Reik, 2007). Consequently, these genes 
are maintained in a transcriptionally poised state, characterized by the co-occurrence 
of H3K4me3 and H3K27me3 on their promoters. H3K4me3 is considered an “active” 
mark that is mainly detected at promoters of transcriptionally active genes. Its 
deposition is catalyzed by a subset of Trithorax group (trxG) proteins such as SET1, 
MLL1 and MLL2 (Shilatifard, 2012). Polycomb group proteins by contrast, form 
multi-subunit Polycomb repressive complexes (PRCs) 1 and 2. PRC1 catalyzes 
ubiquitination of H2A Lys 119 (H2A119ub) and is also directly involved in mediating 
chromatin compaction. PRC2 is composed of the core factors EZH2, EED and SUZ12 
and catalyzes H3K27me3. H3K27me3 is a central mark in the establishment of 
repressive chromatin and is mainly deposited at CpG-rich promoters and intergenic 
regions (Voigt et al., 2013; Zhao et al., 2007). The surprising discovery of both an 
active and a repressive histone PTM on the same promoter was first identified in 
mouse ESCs and was recently shown to occur on the same nucleosome and same 
allele by a co-ChIP approach (Weiner et al., 2016; Zhao et al., 2007). According to 
the current model, this “bivalent” epigenetic signature safeguards the ESCs from 
unscheduled perturbations in gene expression (Atlasi and Stunnenberg, 2017). In this 
regard, H3K4me3 is thought to facilitate recruitment RNA polymerase II and prevents 
permanent silencing, while H3K27me3 assures that gene expression is kept at low 
levels (Figure 5). Accordingly, most bivalent genes are marked by RNA Pol II 
occupies in its paused form phosphorylated at Serine 5 (S5p) on the C-terminal 
domain. Concurrently, Ser 2 (S2p)- phosphorylated RNA Pol II, a hallmark of 
productive mRNA elongation, is absent at these genes (Brookes et al., 2012). Upon 
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differentiation toward the neuronal lineage, several bivalent genes loose the 
H3K27me3 mark and became actively expressed. Genes that need to be entirely 
silenced by contrast, retain H3K27me3 coinciding with the complete removal of 
H3K4me3 (Figure 5) (Bernstein et al., 2005; Bernstein et al., 2006). These findings 
led to the intriguing model that bivalent domains maintain developmental genes in a 
silent state in ES cells while keeping them poised for subsequent activation upon 
differentiation (Voigt et al., 2013). A functional role for bivalent marks in ESCs was 
determined by the genetic depletion experiments of the core PRC2 components EED 
and SUZ12, which causes an entire loss of H3K27me3. These ESCs lacking 
H3K27me3 were only marginally impaired in their self-renewal potential but showed 
elevated expression of lineage-specific genes (Azuara et al., 2006; Pasini et al., 2007). 
In contrast to the mild effects on viability and self-renewal, all H3K27me3-deficient 
ESCs display a largely impaired differentiation potential (Leeb et al., 2010; Pasini et 
al., 2007). This phenotype is also recapitulated by a defect in EpiSCs viability and 
self-renewal in the absence of H3K27me3 and parallels the post-implantation lethality 
observed in PRC2 KO mice during gastrulation (Faust et al., 1995; Pasini et al., 
2004). Detailed investigations of promoter bivalency among the multiple pluripotency 
states revealed striking differences, largely due to altered levels or distribution of 
H3K27me3. H3K4me3 on the other hand, seems to be less dynamic and was shown to 
remain relatively stable in different ESC states and during human ESC differentiation 
(Hawkins et al., 2010; Marks et al., 2012). Promoter bivalency was originally reported 
in primed ESCs. Thus, most reports investigating its functional role were performed 
in ESCs+serum. In 2012 however, bivalency was examined in ESCs+2i that represent 
a more homogenous population and show a tighter control of lineage-associated gene 
expression (Marks et al., 2012). Surprisingly, these ground state ESCs had a reduced 
occupancy of H3K27me3 at developmental promoters and were consequently 
classified to have a reduced number of bivalent genes (Marks et al., 2012). 
Nevertheless, it should be mentioned that the average H3K27me3 still is enriched at 
promoters of these genes in ground state ESCs but were simply not assigned as 
bivalent because they fell below a arbitrary threshold previously used to define 
H3K27me3 peaks (Voigt et al., 2013). Consistent with these observations, low levels 
of promoter bivalency were found in pre-implantation embryos but sharply increased 
post-implantation. Taken together, bivalent domains keep developmental genes in a 
primed state that allows either their rapid activation or stable silencing upon 
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differentiation. This epigenetic feature also provides an elegant mechanism to explain 
the plasticity of the ESC genome (Voigt et al., 2013). Although bivalency was 
originally assumed to be stem cell-specific, this epigenetic feature has also been 
identified in terminally differentiated cells such as dopaminergic neurons, though at 
lower frequencies compared to ESCs (Ferrai et al., 2017). This suggests that 
bivalency might provide a general mechanism for dynamic responsiveness to signals 
such as environmental cues, also in somatic cells (Jadhav et al., 2016). Further 
genome-wide mapping studies of histone PTMs in ESCs have associated distinct 
histone marks with certain regulatory elements, such as H3K4me1 and H3K27ac with 
active enhancers or H3K4me3 and H3K27me3 with active and repressed promoters, 
respectively (Calo and Wysocka, 2013; Zhou et al., 2011). 
 
Figure 5.  The role of bivalent genes in ESCs and upon differentiation. Promoters of developmental genes are 
in a bivalent state in ESCs characterized by the presence of both H3K4me3 and H3K27me3. Together, these 
epigenetic marks lead to the recruitment of RNA Pol II in poised state. Upon differentiation, one of the two 
bivalent marks is usually lost leading to the permanent activation or silencing of the respective gene depending on 
gene function and cell type. Taken and modified from (Aloia et al., 2013) 
 
1.2.3 DNA methylation  
DNA methylation is among the best-studied epigenetic modification and it is 
conserved among most plant, animal and fungal models. Since it does not alter the 
Watson-Crick base-pairing, DNA methylation can be considered as a classical 
epigenetic modification. The DNA is typically methylated in the CpGs dinucleotide 
sequence context on carbon 5 of the cytosine base (5mC) (Figure 6). Methylation on 
both opposing DNA strands within the palindromic sequence allows successful 
maintenance of the epigenetic mark during DNA synthesis. Interestingly, its impact 
on transcription largely depends on the methylation position within the transcriptional 
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unit. Associated to promoters, DNA methylation blocks initiation and hence, acts as a 
transcriptional repressor. Within gene bodies however, 5mC correlates with active 
transcription and might even stimulate transcriptional elongation (Jones, 2012). 
Globally, most CpGs remain methylated at an average of approximately 60-80% in 
mammalian cells (Smith and Meissner, 2013). Highest enrichments of DNA 
methylation are observed at repetitive elements, satellite DNA, retrotransposons and 
in gene bodies (Ehrlich et al., 1982; Li and Zhang, 2014). Although globally depleted 
in the mammalian genome, CpG dinucleotides are found in clusters of so-called CpG 
islands (CGIs). CGIs are often associated with promoters of housekeeping and 
developmental regulator genes and are largely resistant to DNA methylation (Deaton 
and Bird, 2011). Thus, expression of these genes is typically regulated by 
transcription factors, while their repression can be mediated by various mechanisms 
such as H3K27me3 (Gal-Yam et al., 2006; Taberlay et al., 2011). Methylation at 
promoter-associated CGIs is rare but occurs at genes that are subjected to long-term 
and stable repression. Imprinted genes, promoters of genes exclusively expressed in 
germ cells and genes located on the inactive X chromosome represent such examples. 
In general there are two mechanisms by which DNA methylation my influence 
transcriptional silencing. The methyl marks can either directly or indirectly block 
transcription factor binding through steric interference or via recruitment of specific 
methyl-binding proteins, respectively (Tate and Bird, 1993). In the latter case, 
“reader” proteins that contain methyl-CpG binding domain (MBD) specifically 
recognize DNA methylation. These factors often recruit further effector proteins 
mediating transcriptional repression (Fatemi and Wade, 2006). For instance, the 
methyl-CpG binding protein 2 (MeCP2) binds methylated DNA sequences and 
recruits HDACs as well as H3K9me3-catalyzing enzymes in order to deposit 
repressive histone marks and induce transcriptional silencing (Fuks et al., 2003). 
Alternatively, DNA methylation was proposed to directly impair binding of NRF1 in 
mouse ESCs (Domcke et al., 2015).  
 
1.2.3.1 DNA methylation machinery 
Cytosine methylation is catalyzed the family of DNA methyltransferase (DNMT) 
enzymes, that include DNMT1, DNMT3A, DNMT3B and DNMT3L (Figure 6). 
DNMT1 recognizes hemimethylated DNA and is involved in maintaining the 
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methylated state after DNA replication. DNMT3A and DNMT3B associate with the 
enzymatically inactive DNMT3L and mediate de novo DNA methylation acting 
preferentially on unmethylated DNA (Yokochi and Robertson, 2002). DNMT3C, a 
novel rodent‐specific member of the de novo DNMT family, has recently been 
identified to mediate DNA methylation and silencing of retrotransposon elements 
during spermatogenesis. Consequently, animals depleted for DNMT3C were sterile, 
suggesting its specific role for male germ cell development (Barau et al., 2016). How 
de novo DNMTs are recruited to the genome in order to establish correct DNA 
methylation patterns is not entirely understood.  
At least to some extent, their genomic binding is guided by histone modifications. In 
this regard, H3K4me3 at promoters of active genes has been shown to prevent 
recruitment of de novo DNMTs in order to maintain a hypomethylated state of their 
CGIs (Otani et al., 2009). In addition, the PWWP domain of DNMT3B was shown to 
specifically recognize H3K36me3, a histone mark that is co-transcriptionally 
deposited by SETD2 at gene bodies of active genes. Accordingly, DNMT3B binding 
is enriched over transcribed regions and its depletion reduces 5mC levels over 
transcribed gene units (Baubec et al., 2015). A recent study further highlighted a 
preferential association of the isoform DNMT3A1 with H3K27me3-positive CGIs in 
ESCs and neuronal progenitors (NPCs). In line with a hypomethylated state of the 
CGIs, DNMT3A binding did not directly overlap with the H3K27me3 signal but was 
observed in regions adjacent to it (Manzo et al., 2017). In contrast to the de novo 
DNMTs, recruitment and regulation of the methylation maintenance machinery has 
been studied extensively. During mitosis, both daughter cells must re-establish correct 
methylation patterns ensuring the epigenetic inheritance. This mechanism is tightly 
regulated throughout replication to ensure exclusive targeting of DNMT1 to 
hemimethylated DNA in order to re-establish symmetrically methylated CpGs. While 
the DNMT1 transcript is constitutively expressed, DNMT1 protein levels fluctuate 
throughout the cell cycle in dividing cells, peaking at early S-phase when its activity 
is most required (Kishikawa et al., 2003). Via its interactions with proliferating cell 
nuclear antigen (PCNA) and E3 ubiquitin protein ligase UHRF1 (also known as 
NP95), DNMT1 is recruited to sites of DNA replication. UHRF1 specifically binds 
hemimethylated DNA through its SET-and RING-associated (SRA) domain correctly 
directing DNMT1 to the parental, methylated strand (Arita et al., 2008; Chuang et al., 
1997; Sharif et al., 2007). Genetic depletion of UHRF1 causes global DNA 
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hypomethylation and embryonic lethality, largely phenocopying the effects of 
DNMT1 ablation (Bostick et al., 2007). Furthermore, and in strong contrast to de 
novo DNMTs, DNMT1 is also structurally dependent on a hemimethylated substrate 
in order to prevent cryptic activity on unmethylated DNA (Song et al., 2011). Besides 
the core PCNA-UHRF1-DNMT1 interaction, several additional chromatin associated 
factors and histone modifications have been suggested to regulate DNMT1 
recruitment and stability. For instance, the histone acetyltransferase TIP60 and the 
methyltransferase SET7 modify specific DNMT1 residues and trigger its 
polyubiquitylation through UHRF1 resulting in DNMT1 targeting for proteasomal 
degradation (Du et al., 2010; Esteve et al., 2009). This DNMT1-destabilizing pathway 
is opposed during the peak of DNMT1 activity at early S-phase by histone 
deacetylase 1 (HDAC1) in complex with DNA-bound DNMT1 (Robertson et al., 
2000). Efficient DNMT1 targeting to heterochromatic DNA is assured by the specific 
binding of UHRF1 to H3K9me2 and H3K9me3, highlighting a connection between 
DNA methylation and repressive histone marks (Rothbart et al., 2012). Taken 
together, efficient DNA methylation maintenance is controlled at multiple levels to 
ensure that DNMT1 activity is stabilized only when in complex with hemimethylated 
DNA following DNA replication. This provides the necessary fidelity to recreate a 
precise and global methylation landscape (Smith and Meissner, 2013).  
 
1.2.3.2 DNA demethylation  
5mC is a highly stable but reversible epigenetic modification. DNA demethylation is 
achieved either by passive replication-dependent dilution or by an active and enzyme-
dependent removal of the methyl mark. In the case of passive dilution, successive 
rounds of DNA replication, in which DNMT1 fails to re-establish full methylation, 
results in daughter cells that have lost the epigenetic mark. Active 5mC removal by 
contrast, occurs in a stepwise chemical oxidation, which is catalyzed by the 
methylcytosine dioxygenase ten-eleven translocation (TET) proteins TET1, TET2 and 
TET3, and ultimately leads to removal of the modification (Figure 6) (Wu and 
Zhang, 2014). In this process 5mC is converted into 5-hydroxymethilcytosine 
(5hmC), which can be further oxidized to 5-formylcytosine (5fC) and finally into 5-
carboxylcytosine (5caC). Both 5fC and 5caC can be recognized and removed by 
thymine DNA glycosylase (TDG) in the context of the base excision repair (BER) 
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machinery ultimately restoring an unmethylated C:G base pair (Figure 6) (He et al., 
2011). Genome-wide binding analyses revealed prominent association of TET1 at 
CGIs of housekeeping and developmental gene promoters as well as at enhancer 
elements (Williams et al., 2011). Accordingly, 5hmC – the best-studied intermediate 
of the cytosine oxidation cascade – is mainly found at enhancers, and depletion of the 
three TET enzymes in mouse ESCs results in increased DNA methylation at 15–25% 
of all enhancers (Lu et al., 2014).  
 
 
Figure 6. The DNA methylation cycle. DNA methylation is mediated by DNMTs at carbon 5 of the cytosine 
base (5mC). DNA demethylation occurs in a stepwise chemical oxidation to 5hmC, 5fC and 5caC catalyzed by 
TET enzymes. In the context of the base excision repair, TDG is able to restore the cytosine to an unmethylated 
state. Taken and modified from (Huang and Rao, 2012) 
1.2.3.3 DNA methylation reprogramming in vivo 
Although average genome-wide DNA methylation is kept high and bulk 5mC patterns 
are static across most tissues, two major rounds of rapid demethylation take place 
during germ line and pre-implantation development. Shortly after fertilization, the 
hypermethylated paternal genome undergoes a rapid, almost complete loss of 
methylation (Smith and Meissner, 2013). Mechanistically, this demethylation of the 
sperm genome was initially explained by TET3-driven oxidation of 5mC to 5hmC. 
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Recent studies however showed that depletion of TET3 prevents 5hmC formation but 
does not affect the early demethylation of the paternal genome (Amouroux et al., 
2016). Thus, an alternative – and so far unknown – mechanism for DNA 
demethylation in the early mouse zygote was suggested (Amouroux et al., 2016). 
After this initial pulse, global methylation levels are continuously decreased reaching 
a minimum in the pre-implantation blastocyst stage. Different than the rapid 
demethylation, this second wave of demethylation is TET3-mediated 
hydroxymethylation dependent and is thought to counteract zygotic DNMT3A and 
DNMT1 activities (Amouroux et al., 2016). In contrast to the paternal genome, mater-
nal DNA methylation is lost during early embryonic development through passive 
replication-dependent dilution (Wu and Zhang, 2014). In general, this post-
fertilization demethylation is believed to be important for epigenetic reprogramming 
of the oocyte and sperm genome enabling them to enter the totipotent state (Burton 
and Torres-Padilla, 2014). Upon exit of pluripotency, levels of de novo DNMTs 
markedly increase leading to a sharp genome-wide re-methylation in the post-
implantation epiblast (Smith and Meissner, 2013). Interestingly, a second round of 
DNA demethylation takes place in post-implantation primordial germ cells (PGCs) 
and is closely linked to PGC reprogramming for induction of the pluripotency 
program (Atlasi and Stunnenberg, 2017).  
 
1.2.3.4 DNA methylation in ESCs 
DNA methylation reaches its lowest levels in pre-implantation embryos and PGCs. 
This global 5mC erasure is thought important to remove epigenetic barriers enabling 
the pluripotent state of these cells (Hackett and Surani, 2013). Despite deriving from 
the ICM and preserving a naïve pluripotent capacity, ESCs+serum accumulate high 
levels of global DNA methylation, which is usually associated with primed or 
lineage-restricted cells (Meissner et al., 2008). By contrast, ground state ESCs+2i 
have been shown to retain a largely hypomethylated genome with global 5mC levels 
three-fold lower relative to ESCs+serum (Ficz et al., 2013; Habibi et al., 2013). While 
levels and distribution of 5mC in ESCs+2i are largely comparable to the in vivo ICM 
epiblast cells, ESCs+serum resemble the hypermethylated state of primed post-
implantation cells. Strikingly, the most naïve, REX1-positive subpopulation within 
the heterogeneous ESCs+serum still retain high 5mC levels, underscoring that these 
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cells might be functionally naïve but not equivalent to ground state ESCs+2i (Ficz et 
al., 2013; Habibi et al., 2013). Interestingly, 5mC appears to be highly plastic in these 
ESCs, since transitions from serum to 2i culturing conditions and its reciprocal switch 
rapidly result in global DNA hypo- and hypermethylation, respectively (Habibi et al., 
2013; Shipony et al., 2014). Nevertheless, several loci such as genomic imprints and 
IAP elements remain resistant to demethylation, which is consistent with their escape 
from reprogramming during pre-implantation development (Habibi et al., 2013). 
Mechanistically, it has recently been proposed that impaired DNA methylation 
maintenance is primarily responsible for the genome-wide demethylation occurring in 
ground state ESCs (von Meyenn et al., 2016). Their results suggested that reduced 
levels of UHRF1 and H3K9me2 in ESCs+2i impair recruitment of DNMT1 resulting 
in replication-dependent dilution of DNA methylation (von Meyenn et al., 2016). 
Reduced expression of the de novo DNMT3A, DNMT3B and DNMT3L in ESCs+2i 
further stabilize the hypomethylated genome of ground state ESCs (Habibi et al., 
2013). Depletion of TET proteins by contrast, did not affect 2i-induced 
hypomethylation, implying that active demethylation is dispensable for this process 
(von Meyenn et al., 2016). An in vivo mechanism for maintaining the hypomethylated 
state in the ICM has recently been described (Graf et al., 2017). Pramel7 is highly 
expressed in the ICM and essential for pre-implantation development. Molecular 
characterization revealed that Pramel7 specifically targets UHRF1 for proteasomal 
degradation through ubiquitination via Cullin 2 (Graf et al., 2017). Strikingly, forced 
expression of Pramel7 in ESCs+serum causes a loss in global 5mC due to the 
impaired in DNA methylation maintenance pathway. As a result, Pramel7-
overexpressing ESCs+serum display a gene expression signature that clusters even 
closer to the pre-implantation epiblast cells than ESCs+2i (Graf et al., 2017). 
Furthermore, these cells are locked in a pluripotent state, since they are unable to 
undergo differentiation. However, DNA hypomethylation, induced by genetic 
depletion of UHRF1 or all DNMTs, did not recapitulate the ground state-specific gene 
expression signature observed in Pramel7-overexpressing ESCs (Ficz et al., 2013; 
Fouse et al., 2008; Graf et al., 2017; Sharif et al., 2016). This suggests that DNA 
hypomethylation alone is not sufficient to induce ground state pluripotency and that 
Pramel7 functions through additional, DNA methylation-independent mechanisms to 
promote the ground state (Graf et al., 2017). Taken together, DNA methylation shows 
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a dynamic pattern during early mammalian development that can largely be 
recapitulated in vitro in ESCs+2i or Pramel7-overexpressing ESCs and ESCs+serum.  
 
1.2.3.5 5mC dynamics in development and disease 
Catalytic active DNMTs are essential for correct human and mouse development. 
Genetic depletion of each subunit is lethal, though at different stages of development. 
While DNMT1 and DNMT3B KOs are embryonically lethal in both species, mice 
lacking DNMT3A are viable up to 4 weeks after birth (Li et al., 1992; Okano et al., 
1999). Although essential for cellular commitment, DNA methylation is not required 
for the establishment or maintenance of pluripotency. ESCs that lack any traces of 
DNA methylation mediated by genetic depletion of all three DNA methyltransferases, 
also referred to as triple knockout (TKO), remain viable and show no notable 
aneuploidy. Neither self-renewal nor the molecular signature of pluripotency is 
affected in these cells (Tsumura et al., 2006). ESCs that specifically lack individual 
DNMTs have also been reported. Loss of DNMT1 results in a rapid reduction of 5mC 
to a remaining global level of 20%. ESCs KO for both de novo DNMT3A and 
DNMT3B progressively lose nearly all DNA methylation over many cell division 
rounds, suggesting that DNMT1 alone is not sufficient for ensuring DNA methylation 
inheritance (Chen et al., 2003; Smith and Meissner, 2013). Similar to TKOs, 
molecular stem cell identity is not impaired; whereas differentiation is almost 
completely inhibited in these ES cell lines. Methylation-free ESCs do not upregulate 
germ-layer-associated markers and fail to silence pluripotency factors. Interestingly, 
in somatic cells, mutations affecting human DNMT genes have been linked to several 
diseases such as acute myeloid leukemia (AML) and immunodeficiency and 
centromere instability (Shah and Licht, 2011). As for the DNMT family, TET proteins 
are dispensable for self-renewal despite the complete erasure of 5hmC. TET KO 
ESCs show differentiation defects and are unable to contribute to chimeric embryos, 
suggesting essential roles of TET proteins for differentiation (Smith and Meissner, 
2013). Taken together, both DNA methylation and TET function are dispensable for 
self-renewal and ESC integrity but fulfill essential functions upon exit from 
pluripotency and are required for proper lineage specification.  
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1.2.4 Chromatin remodeling complexes in pluripotency 
Nucleosomes function as important structural building blocks for global packaging 
and organization of genetic information in the nucleus. At the same time they also 
represent a steric obstacle for any process that requires DNA access, such as gene 
transcription. By occupying key regulatory DNA elements, nucleosomes can prevent 
binding of transcription factors and therefore inhibit expression at the level of 
transcription initiation. Thus, DNA regions close to transcription start sites of actively 
expressed genes are usually depleted of nucleosomes (Petesch and Lis, 2012). 
However, spontaneous remodeling of the nucleosome is usually counteracted by its 
biophysical properties. 14 histone-DNA contacts that are normally present in the 
nucleosome lead to substantial positional stability and provide an energetic barrier for 
remodeling. ATP-dependent chromatin remodeling complexes use the energy from 
ATP hydrolysis for translocation, eviction or exchange (also referred to as 
repositioning, ejection and editing) of nucleosomes along the DNA template (Clapier 
et al., 2017). Chromatin remodeling enzymes are often part of large macromolecular 
complexes. Usually, a single ATP-hydrolyzing factor provides the energy for 
remodeling, while several additional factors of the complex modulate the ATPase 
activity and provide specificity to genome-wide binding. Thus, combinatorial 
assembly of the individual factors provides the required diversity in chromatin 
remodeling activities to ensure correct gene expression patterns in a cell- and tissue-
specific manner (Ho and Crabtree, 2010). By precisely controlling nucleosome 
positioning and mobility, these complexes are able to promote the transcription of a 
set of genes, while simultaneously inhibiting inappropriate expression of another set 
supporting cell-specific identities. Accordingly, varying subunit compositions have 
been identified in different cell types and tissues during development (Hota and 
Bruneau, 2016). All ATP-dependent chromatin remodeling complexes contain an 
ATPase subunit belonging to the SNF2 family of DNA helicases. Based on the 
similarities and differences in their catalytic ATPases domains, chromatin remodeling 
complexes are further categorized into four subfamilies: imitation switch (ISWI), 
chromodomain helicase DNA-binding (CHD), switch/ sucrose non-fermentable 
(SWI/SNF) and INO80 (Figure 7). At least one member of each chromatin 
remodeling complex subfamily is essential for mouse embryogenesis, highlighting 
their central role in mammalian development (Chen and Dent, 2014; Gaspar-Maia et 
al., 2011a).  
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Figure 7. The composition of chromatin remodeling complexes. The subunit composition of some mammalian 
chromatinremodeling complexes is shown: (A) BAF complex, (B) ISWI complexes, (C) NuRD complex 
composed of CHD proteins and (D) INO80/SWR complexes. Taken and modified from (Hota and Bruneau, 
2016) 
1.2.4.1 Roles of SWI/SNF family members in ESCs and during development 
The SWI/SNF contains two major complexes: BAF (BRG/BRM-associated factor) 
and PBAF (polybromo BAF). BAF members consist of at least 15 different subunits 
and form large, up to 1.5 MDa complexes, that vary in their composition between 
different cell types and tissues (Figure 7) (Lessard and Crabtree, 2010). BRG1 (or 
SMARC4), its central component containing the ATPase activity, is essential for 
mammalian development. It was shown to have crucial roles during zygotic genome 
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activation (ZGA) regulating global H3K4me2. Accordingly, BRG1 KO mice die 
during pre-implantation development (Bultman et al., 2000). Similar to the in vivo 
development, BRG1 has been shown to be essential in ESCs (Kidder et al., 2009). 
Interestingly, ESCs have a particular subunit composition that was termed as esBAF, 
which contains BRG1, BAF155 and BAF60A but lacks BRM, BAF170 and BAF60C 
(Ho et al., 2009). ESCs depleted for several esBAF components show aberrant self-
renewal and an impaired differentiation potential (Hota and Bruneau, 2016; Kidder et 
al., 2009). Mechanistically, esBAF was shown to function on several levels for 
maintaining ESC pluripotency by modulating LIF/STAT3 signaling and PRC-
mediated repression (Ho et al., 2011). BRG1 binds to promoters of key pluripotency 
genes and activates their expression. At the same time, esBAF also binds promoters of 
PRC components and their target genes preventing premature expression of lineage-
associated genes (Ho et al., 2009; Kidder et al., 2009). In summary, esBAF is required 
for early mammalian development and maintenance of the pluripotency 
transcriptional network in ESCs. However, its function is not restricted to pre-
implantation development. BAF chromatin remodeling complexes are also necessary 
for the development of several further organs and cell types, such as brain, skin, heart, 
muscle or immune cells (Hota and Bruneau, 2016). Interestingly, in these post-
implantation developmental processes, BAF complexes repress expression of core 
pluripotency factors, implying that its function is highly context- and cell type-
specific (Hota and Bruneau, 2016).  
 
1.2.4.2 Roles of ISWI complexes in ESCs and during development  
Compared to BAF complexes, ISWI are usually smaller in size. Typically, they are 
composed of 2-4 accessory subunits that form a complex with one of the two ATPase 
components SNF2H (SMARCA5) or SNF2L (SMARCA1) (Figure 7) (Lazzaro and 
Picketts, 2001). While SNF2L expression is restricted to the brain and post-natal 
reproductive tissues, SNF2H is ubiquitously expressed and essential for early 
embryonic development (Lazzaro and Picketts, 2001; Stopka and Skoultchi, 2003). In 
the fertilized zygote, SNF2H co-localizes with BRG1 and regulates the initial wave of 
transcription via its recruitment by transcription intermediary factor 1α (TIF1α) 
(Torres-Padilla and Zernicka-Goetz, 2006). Thus, its genetic depletion in mice leads 
to lethality during the pre-implantation development caused by a failure in 
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proliferation of both trophectoderm and ICM (Stopka and Skoultchi, 2003). After 
implantation, both SNF2H and SNF2L-containing complexes regulate ectoderm-
derived lineages. SNF2H is implicated in promoting proliferation of neural 
progenitors (Alvarez-Saavedra et al., 2014). Thus, conditional SNF2H mutants 
display impaired proliferation of granule neuron progenitors and Purkinje cells 
leading to post-natal neural maturation defects. Mechanistically, SNF2H acts on the 
C-terminal tail of H2A blocking H1 linker histone loading on chromatin and therefore 
maintaining the chromatin in a more open conformation (Alvarez-Saavedra et al., 
2014). SNF2L by contrast, represses proliferation of neuronal progenitor cells and 
thereby regulates proper brain size (Yip et al., 2012). Thus, SNF2H and SNF2L form 
distinct ISWI chromatin remodeling complexes that appear to have antagonistic roles 
during early brain development. In addition, they also appear to differ in their modes 
of action. While SNF2H promotes an open and permissive chromatin structure, 
SNF2L complexes generate a more closed and restricted chromatin configuration. In 
general, ISWI complexes containing SNF2H seem to have crucial roles during early 
embryonic development and in progenitor cells, whereas SNF2L-containing 
complexes are required during differentiation and maturation (Hota and Bruneau, 
2016).  
One particular ISWI chromatin remodeling complex that was recently shown to fulfill 
essential roles upon exit of pluripotency is the nucleolar remodeling complex (NoRC) 
(Leone et al., 2017; Savic et al., 2014). NoRC is composed of two subunits, the ATP-
dependent chromatin remodeler SNF2H/SMARCA5 and TIP5, a >200 kDa protein 
that shares sequence homology with the largest subunits of other members of 
SNF2H/ISWI-containing remodeling complexes (Erdel and Rippe, 2011; Strohner et 
al., 2001). Interestingly, NoRC undergoes a switch-of-function upon differentiation. 
While abundantly present in the nucleoplasm of ESCs, NoRC is specifically recruited 
to ribosomal RNA genes located in nucleoli only upon exit of pluripotency (Leone et 
al., 2017; Savic et al., 2014). Once associated with rRNA genes, NoRC mediates their 
transcriptional silencing via recruitment of DNMTs and histone modifying complexes 
(Guetg et al., 2012; Santoro et al., 2002). Importantly, this specific tethering 
mechanism requires a processing step of a long non-coding RNA, which only occurs 
upon differentiation but not in ESCs (Leone et al., 2017; Savic et al., 2014). Artificial 
recruitment of NoRC to the rRNA genes could therefore be achieved by solely 
introducing the processed form of the long non-coding RNA (lncRNA) termed pRNA 
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(Leone et al., 2017; Savic et al., 2014). Strikingly, this resulted not only in the 
formation of repressive marks at the rDNA locus but also led to a global spreading of 
compact heterochromatic structures throughout the nucleus, concomitant with a loss 
of pluripotency (Savic et al., 2014). Taken together, NoRC serves as an excellent 
mechanistic example how the site-specific activity of a particular chromatin 
remodeling complex needs to be kept under tight control for maintaining ESC 
integrity.  
 
1.2.4.3 Roles of CHD family members in ESCs and during development 
In total, nine different chromodomain helicase DNA-binding proteins have been 
identified (CHD1-9). They largely act alone or – in the case of CHD3 and CHD4 – 
form a complex termed Nucleosome Remodeling Deacetylase (NuRD) (Figure 7). 
CHD proteins fulfill diverse roles during early and post-implantation embryonic 
development, as well as in terminally differentiated cell lineages (Hota and Bruneau, 
2016). During ZGA, CHD1 regulates the expression of several transcription factors 
such as OCT4, NANOG or CDX2 that is essential for coordinated ICM and 
trophectoderm differentiation. Thus, its depletion causes post-implantation lethality 
(Suzuki et al., 2015). Also CHD4 was shown to have redundant roles during pre-
implantation differentiation by restricting the expression of inappropriate genes 
(O'Shaughnessy-Kirwan et al., 2015). In ESCs, CHD1 regulates both mRNA and 
rRNA transcription by directly interacting with RNA polymerases I and II (Guzman-
Ayala et al., 2015). CHD1 binds open regions of the ESC genome and maintains its 
euchromatin structure. Accordingly, its depletion leads to defects in self-renewal and 
pluripotency by inducing the accumulation of compact heterochromatic blocks 
(Gaspar-Maia et al., 2009). The NuRD complex, which is composed of either CHD3 
or CHD4 and several associated factors including HDAC1 and HDAC2, has been 
under major investigation in ESCs. Although largely dispensable in ESCs, NuRD is 
required for proper ESC differentiation. At the molecular level, CHD4-containg 
NuRD complexes associate with C-terminal binding protein 2 (CTBP2) to deacetylate 
H3K27 and recruit PRC2 for inducing H3K27me3-mediated repression upon 
differentiation (Kim et al., 2015). Taken together, CHD1 and NuRD complexes seem 
to have essential roles during pre-implantation development and ESC pluripotency. In 
addition, NuRD was also found important for later development of synapse formation, 
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where it represses several developmental genes by its deacetylation activity on H3 
lysine 9, 14 and 27 (Yamada et al., 2014).  
 
1.2.4.4 Roles of INO80/SWR complexes in ESCs and during development 
INO80 and SWR complexes represent the fourth subfamily of ATP-dependent 
chromatin remodelers (Figure 7). They are characterized by a conserved insertion in 
their ATPase/helicase domain that mediates their interaction with the two helicases 
RVB1 and RVB2. In mammalian cells three different, multi-subunit complexes are 
distinguished: The INO80 complex and two SWR-related complexes SRCAP and 
P400/TIP60 (Hota and Bruneau, 2016). The INO80 complex binds to promoters of 
ESC master transcription factor genes and promotes their transcription by recruiting 
the mediator complex and RNA pol II. Thus, INO80 is crucial for ESC self-renewal 
and pluripotency (Wang et al., 2014). Besides INO80, an RNAi screen also identified 
the SWR-related P400/TIP60 complex to be essential for ESC pluripotency (Fazzio et 
al., 2008). In addition to directly promote transcription, both INO80 and SWR 
complexes are also able to mediate the exchange and deposition of the histone variant 
H2A.Z. This histone editing activity occurs at active and poised promoters in ESCs 
and is required for proper ESC differentiation (Subramanian et al., 2013). In 
summary, all four groups of ATP-dependent chromatin remodelers mediate crucial 
functions during early mammalian development. These roles are mediated by both 
ATP-dependent remodeling of nucleosomes and in an ATP-independent manner by 
their interaction with auxiliary effector proteins such as transcription factors or 
histone modifying enzymes.  
 
1.3 3D genome organization 
Folding of DNA into chromatin and its spatial organization is essential for all 
biological processes occurring within the nucleus such as transcription, replication, 
repair and recombination. Regulation of transcription for instance, does not only 
occur through promoter-proximal regions but can also be modulated by distal 
regulatory elements. These enhancers are often far apart in linear DNA sequence – up 
to 1Mb in the case of the Shh gene (Lettice et al., 2003) – but can physically associate 
with their respective target promoters by looping of the chromatin. In a larger scale, 
spatially isolated genomic regions, such as lamina-associated domains (LADs) or 
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topological-associated domains (TADs), have been described to form local sub-
compartments that can be permissive or repressive for gene transcription. Thus, the 
3D genome architecture is highly regulated in mammalian cells allowing gene 
regulatory networks in a cell- and tissue-specific manner (Bonev and Cavalli, 2016). 
The first report of spatial chromosome organization goes back go 1885 and was 
proposed by Rabl and Boveri (Boveri, 1909; Rabl, 1885). According to their model, 
chromosomes exist in discrete chromosome territories (CT) in interphase nuclei 
(Boveri, 1909; Rabl, 1885). Strikingly, this territorial model of chromosomal 
organization has been generally accepted nowadays. Thus, each chromosome resides 
in a separate region in the nucleus and becomes randomly re-shuffled after each cell 
division, since no preferential nuclear positioning was attributed to the individual 
chromosomes (Cremer and Cremer, 2010). Accordingly, the large majority of all 3D 
chromatin contacts occur within the same chromosome (Cremer and Cremer, 2010). 
This model was further supported by mathematical polymer modeling of DNA 
dynamics and kinetics within the nucleus (Dekker and Mirny, 2016). According to 
their calculations, loci located on different chromosomes are insufficiently close in 
space in order to re-establish a reproducible and stable physical interaction within the 
time frame of one cell cycle (Dekker and Mirny, 2016). Only very recently, technical 
advances allowed detailed investigation of intra-chromosomal organization in 
mammalian cells genome-wide. Indeed, these experiments doubtlessly confirmed that 
the vast majority of DNA contacts occur within chromosomes, while stable 
interactions between chromosomes are extremely rare (Lieberman-Aiden et al., 2009). 
In general, chromosome conformation capture techniques (3C, 4C, 5C and HiC) rely 
on proximity ligation of closely associated DNA regions in 3D. Coupled to high 
throughput sequencing, HiC results generate maps showing the contact frequencies of 
physical interactions of two DNA loci. Usually, results of these population-based 
techniques are further investigated by fluorescence in situ hybridization (FISH), 
which allows analysis of DNA loci positioning in individual cells within a population. 
Although the resolution of fluorescence microscopy has greatly improved, FISH 
comes at the cost of genome-wide analyses by focusing on a restricted amount of loci 
at a time (Dixon et al., 2016).  
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1.3.1 Hierarchical organization of chromatin 
Together these new approaches shed light on a highly complex and multi-layer 
organization pattern of chromosomes within mammalian cells (Figure 8). At the basis 
lie nucleosome-nucleosome interactions that form a 10nm “beads-on-a-string” fiber 
(Olins and Olins, 1974; Ricci et al., 2015). Nucleosomes cluster into heterogeneous 
groups of so-called “clutches” that are cell-type dependent and vary in size (Ricci et 
al., 2015). As a next level of organization, chromatin can form loops bringing two 
distant DNA elements in close proximity. As one of the key features of vertebrate 
genomes, cis-regulatory elements can thereby act on their target promoters over large 
distances of linear DNA. These interactions were further proposed to form active 
chromatin hubs promoting transcription by high local concentrations of transcription 
factors and RNA polymerase II (Dixon et al., 2016). However, long-range chromatin 
contacts are not limited to enhancer-promoter contacts but can also occur between 
promoters and its respective transcribed region. These “gene-loops” are thought to 
reinforce the directionality of RNA synthesis from the promoter and promote the re-
start of a transcription cycle after its termination (Bonev et al., 2017; Tan-Wong et al., 
2012). As one of the most exciting discoveries of recent HiC analyses was the 
identification of topologically associated domains (TADs) (Dixon et al., 2012). At the 
level of several hundred kilo bases (kb), chromosomes are segregated into spatially 
isolated regions. This partitioning into TADs correlates with linear genomic features 
such as histone modifications, coordinated gene expression patterns and replication 
timing (Dixon et al., 2012). Surprisingly, TADs were shown to be largely cell-type 
invariant and even conserved among several species (Dixon et al., 2012; Rao et al., 
2014). Thus, TADs are considered as the basic unit of chromosome folding and are 
suggested to be an important secondary structure in chromosome organization (Dixon 
et al., 2016). Further chromatin compartmentalization can be observed at a megabase-
scale. Large-range interactions between individual TADs occur across entire 
chromosomes. This largely bimodal interaction pattern led to the definition of A and 
B compartments, based on their preferential interaction with each other (A 
compartments interact with other A domains and vice versa) (Lieberman-Aiden et al., 
2009). Independent of 3C-based technologies, further studies investigated in defining 
genomic regions that are spatially isolated within the nucleus. Lamina-associated 
domains (LADs) are composed of heterochromatin and late-replicating domains that 
preferentially locate to the nuclear periphery and add an additional layer of chromatin 
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organization inside the nucleus (Peric-Hupkes et al., 2010). Taken together, these 
observations led to the conclusion that chromosome structures are formed in a highly 
organized and hierarchical manner (Figure 8).  
 
Figure 8. Hierarchical organization of chromatin structures. a. Examples for chromatin loop formation. A loop 
structure is characterized by the point-shaped peak in local contact frequencies of HiC maps. b. TADs form 
triangles in HiC maps and are often enriched for loop structures at their boarders. c. Genome partitioning into A/B 
compartments are highlighted by the checkerboard pattern in low resolution HiC-maps. d. Chromosomes 
themselves are isolated genomic elements that form chromosome territories consisting each of a single 
chromosome. Taken from (Bonev et al., 2017) 
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1.3.2 Chromatin loops 
As introduced earlier, chromatin loops bring two distant genomic loci into close 
spatial proximity (Figure 8). This mechanism is mostly acknowledged to bridge 
enhancers to their respective promoter targets allowing their timely activation and 
expression. Thus, chromatin looping is a dynamic and cell-type specific process 
(Bonev and Cavalli, 2016). One well-described example occurs at the locus control 
region of the β-globin cluster. Via long-range chromatin interactions, it contacts its 
target genes exclusively in erythroid cells leading to their active expression. Cells 
from different lineages however, do not form this loop and hence, do not express β-
globin genes (Palstra et al., 2003). In order to address which factors are involved in 
mediating long-distant DNA contacts, a recent study identified CTCF, cohesin, YY1 
and ZNF143 enriched at anchors of strong chromatin interaction points (Rao et al., 
2014). Indeed, it is now believed that CTCF and cohesin are the main players for the 
formation of chromatin loops. CCCTC-binding factor (CTCF) binds to the non-
palindromic consensus sequence CCGCGNGGNGGCAG, which is mediated by its 
11 zinc finger motifs (Ong and Corces, 2014). CTCF was initially identified as an 
insulator to heterochromatin spreading (Kellum and Schedl, 1991) and is now 
accepted as one of the main architectural proteins mediating intrachromosomal 
interactions (Ong and Corces, 2014). Cohesin on the other hand is a ring-shaped 
complex composed of SMC1, SMC3 and RAD21. Through its structure it can 
encircle two chromatin fibers and has thereby been shown to hold the two sister 
chromatids together after DNA replication until the onset of anaphase. Its role as 
architectural protein forming chromosome loops has only recently been investigated 
(Ong and Corces, 2014). In ESCs, cohesin associates with the Mediator complex and 
localizes to active enhancers and is further believed to mediate enhancer-promoter 
interactions (Kagey et al., 2010). Accordingly, its short-term depletion leads to 
immediate loss in nearly all loop structures detected by HiC experiments, 
underscoring its essential role in promoting and stabilizing these 3D structures (Rao et 
al., 2017). Mechanistically, a model of “loop extrusion” has been proposed to form 
these long-range contacts mediated by cohesin and CTCF. Although cohesin 
occupancy is detected at CTCF bound sites in steady-state conditions by ChIPseq, its 
loading on chromatin is thought to occur elsewhere (Kagey et al., 2010; Zuin et al., 
2014). Upon loading, cohesin then travels along chromosome arms by actively 
pushing DNA through its ring-shaped domain. Consequently, a loop structure will 
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form and continuously increase in size until the cohesin complex reaches two CTCF-
bound boarder elements on each side. This, in turn, traps the cohesin complex and 
leads to its stable association at these sites, ultimately forming the loop anchor 
(Figure 9) (de Wit et al., 2015; Guo et al., 2015; Nora et al., 2017; Sanborn et al., 
2015). Interestingly, the orientation of CTCF binding seems to be crucial for this 
trapping mechanism, since stable loops are only formed between convergently 
oriented CTCF sites (Rao et al., 2014).  
 
 
Figure 9. Loop extrusion model. Cohesin loading occurs in a sequence independent mechanism, preferentially at 
sites of active transcription. By pushing the chromatin through its loop, cohesin travels along the chromosome arms 
forming a loop structure. At convergently oriented CTCF sites cohesin is trapped resulting in a stable chromatin 
loop. Taken and modified from (Schwarzer et al., 2017) 
Dynamic loading and unloading of cohesin on and from chromatin are essential for 
this process, since depletion of both loading and unloading factors largely impacted 
global 3D chromatin structures (Busslinger et al., 2017; Haarhuis et al., 2017; 
Schwarzer et al., 2017). These studies further highlighted that cohesin association 
counteracts compartmentalization into A/B compartments. Stabilizing cohesin on 
chromatin by depleting its releasing factor WAPL led to a global increase of loop 
structures. This effect seemed to counteracted global genome partitioning into A and 
B compartments, since these chromosome-wide structures were largely reduced in 
WAPL KO cells (Haarhuis et al., 2017). Genetic depletion of cohesin loading by 
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contrast resulted in an increased A/B compartmentalization, suggesting that local and 
global genome organization mechanisms seem to counteract each other to some extent 
(Schwarzer et al., 2017). Thus, it has been proposed that cohesin turnover might 
provide the flexibility necessary for nuclear compartmentalization (Haarhuis et al., 
2017). In line with this hypothesis, siRNA-mediated knockdown of cohesin indeed 
resulted in an increase in chromatin dynamics, as determined by high-resolution live 
cell imaging (Nozaki et al., 2017). 
Although CTCF and cohesin have doubtlessly been shown essential for chromatin 
looping, they are not the only proteins that are implicated in long-range chromosomal 
contacts. For instance, the Mediator complex and yin yang 1 (YY1), which interact 
with cohesin and CTCF, respectively, have been proposed to mediate 
intrachromosomal contacts in interphase cells (Jonathan A. Beagan, 2017; Kagey et 
al., 2010). Furthermore, PRC-repressed genes were shown to form ultra-long contacts 
forming highly dense and compact clusters of repressive chromatin. Strikingly, these 
contacts were dependent on PRC components, indicating that these epigenetic factors 
can directly influence the 3D architecture (Boettiger et al., 2016; Joshi et al., 2015; 
Schoenfelder et al., 2015a).  
 
1.3.3 Topological associated domains  
One level above chromatin loops, 3D chromatin structures extend into topological 
associated domains (TADs). TADs were originally identified by HiC experiments, in 
which TADs manifest as contiguous square domains along the diagonal of contact 
frequency maps. This pattern indicates that regions within the same TAD interact with 
each other more frequently than with regions of adjacent TADs (Figure 8) (Bonev 
and Cavalli, 2016). This implies two basic features of TAD organization: “self-
association” within TAD domains and “insulation” between neighboring TADs. 
These two properties are the basis for the various computational algorithms that have 
been used for TAD identification. In general, insulation scores of at least 2-fold in 
interaction frequencies are used as threshold for TAD definition (Dekker and Mirny, 
2016). It must therefore be taken into consideration that TADs arise through 
arbitrarily chosen thresholds from HiC results and are not linked to a specific 
biological function for their definition. Thus, their calling may alter depending on the 
depth, quality and resolution of HiC sequencings. Accordingly, TADs were initially 
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described at a median size of 880kb, whereas subsequent analysis of higher resolution 
HiC data suggested a smaller median domain size of 185kb (Bonev and Cavalli, 
2016). A further degree of inconsistency may be explained by differences in the 
computational algorithms used to identify them (Dixon et al., 2016). However, the 
confusion in varying TAD annotations is mainly caused by the fact that TADs – 
similar to the global 3D chromatin structures – are hierarchical in their organization 
(Phillips-Cremins et al., 2013). Large TADs can therefore be further divided into 
smaller domains referred to as sub-TADs. Although TADs and subTADs show many 
similarities in their structures and insulation degrees, there are some substantial 
differences among them. Most importantly and in contrast to TADs, subTADs seem 
to differ between different cell lineages (Phillips-Cremins et al., 2013). In this regard 
it was proposed that TADs might represent a larger and more invariant level of 
chromatin organization within which cell-type-specific structures can form to play 
roles in lineage-specific genome regulation (Dixon et al., 2016).  
It is now accepted that the property of insulation is the most determinant for TAD 
structures. TAD boarders function as boundary elements preventing the ability of an 
enhancer to activate genes located in different TADs (Figure 10) (Hnisz et al., 
2016a). In mammals, many of these insulated anchor regions possess strong 
chromatin loop structures leading to the alternative term of “loop-domain” (Rao et al., 
2014). Irrespective of its nomenclature, this observation suggests a strong relationship 
between chromatin loops and the spatial organization into TADs. Indeed, anchor sites 
are highly enriched for cohesin and CTCF occupancy. In order to elucidate their 
causative roles in TAD formation, several recent studies investigated the effect of 
cohesin and CTCF depletion on TAD structures (Nora et al., 2017; Rao et al., 2017; 
Schwarzer et al., 2017). Strikingly, loss of either one of these two factors leads to 
complete loss in TAD structures, underscoring their essential roles in TAD formation 
(Nora et al., 2017; Rao et al., 2017; Schwarzer et al., 2017). Attempts to predict TADs 
however, has been challenging so far, since only few CTCF-bound sites form stable 
loops that function as insulating regions. Accordingly, only 15% of all mammalian 
CTCF-binding sites are located within a boundary, suggesting that CTCF binding 
alone may be insufficient for the establishment of boundaries.  
Further correlation studies revealed a significant overlap of TAD structures with other 
genomic features such as histone modifications, coordinated gene expression and 
DNA replication timing (Dixon et al., 2012). Nevertheless, TAD organization is not a 
1. Introduction 
 44 
consequence of chromatin marks, since – at least for the Xist locus – TADs remained 
unchanged in the G9a and EED KO ESCs that lack H3K9me2 and H3K27me3, 
respectively (Nora et al., 2012). Conversely, TADs did not seem to be determinant for 
epigenetic landscapes, since neither CTCF nor cohesin depletion largely affected 
histone modifications genome-wide (Nora et al., 2017; Schwarzer et al., 2017). These 
results are to some extent contradictory to studies, in which deletion of single 
boundary elements clearly led to spreading of active chromatin structures into the 
neighboring TAD (Narendra et al., 2015). Taken together, these findings suggest that 
TADs do not regulate global chromatin patterns. However, CTCF-occupied 
boundaries may restrict spreading of active or repressed chromatin in a local and 
context-dependent manner. 
 
 
Figure 10. TAD function in gene regulation. Genes within the same TAD are often expressed in a 
co-regulated manner, presumingly driven by a single enhancer element. TAD boundaries blocks the 
contact of an enhancer located in one TAD with target genes of another TAD. In a few cases TAD 
boundaries may also function as insulators for spreading of repressive chromatin into active domains 
and vice versa. TAD boarders can also function as a physical barrier to antisense transcripts. Taken and 
modified from (Dixon et al., 2016) 
 
As functionally isolated units of the genome, gene expression was shown to occur in a 
co-regulated manner within TADs (Figure 10) (Dixon et al., 2016). Thus, it has been 
observed that genes within the same TADs are coordinately expressed across different 
cell types and tissues. This may be particularly important for gene clusters of 
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functionally related genes, such as for olfactory receptors, which have often been 
found to reside within the same TAD (Dixon et al., 2016). TAD boundaries on the 
other hand, seem to fulfill an important insulation function to prevent spreading of 
gene expression activities (Figure 10). Deletion of a TAD boundary on the X 
chromosome in ESCs for instance, led to increased expression of several genes 
located on the other side of the boundary (Nora et al., 2012). Strikingly, TAD 
boarders were even shown to act as physical barriers preventing the linear tracking of 
molecules along the chromosome. This phenomenon was described by the 
observation that non-coding transcripts from divergent transcription abruptly ended at 
TAD boundaries (Figure 10) (Austenaa et al., 2015). The most impressive work on 
elucidating the biological function of TAD boundaries was performed by Mundlos 
and colleagues (Lupianez et al., 2015). Their investigations revealed that several 
diseases displaying limb malformation were linked with mutations in a TAD 
boundary. Consequent rewiring of enhancer-promoter contacts over the lost boundary 
caused deregulated expression of genes involved in limb bud development. Strikingly, 
this disease phenotype could be highly recapitulated by introducing deletions, 
inversions or duplications into the DNA sequence of the respective TAD boundary in 
mice (Lupianez et al., 2015). There have been further studies, which linked disease 
phenotypes with disruption of TAD structures. Particularly cancer cells have been 
proposed to undergo “enhancer hijacking”. During this process enhancer contacts are 
rewired and act on new – potentially proto-oncogene - targets, which can be caused 
by elimination of TAD boundaries (Hnisz et al., 2016b; Northcott et al., 2014).  
 
1.3.4 Megabase-scaled compartmentalization 
Results from HiC experiments revealed an invaluable insight into large-scale spatial 
organization of chromatin within the nucleus of mammalian cells. They highlighted 
the segmentation of the linear chromosomes into TADs, which have been shown to be 
cell type invariant. A further discovery from HiC results was the preferential 
association of individual TADs with each other over variable genomic distances 
giving rise to two types of compartments, called A and B (Figure 11) (Dixon et al., 
2016). This megabase-scaled compartmentalization is visible as a checkerboard 
pattern of contact frequencies between genomic intervals over the entire chromosome 
(Schwarzer et al., 2017). While A-compartments highly correlate gene expression and 
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active histone marks, B-compartments largely represent silent regions of the genome. 
In contrast to TADs, compartmentalization into A and B are cell-type specific. Thus, 
TADs themselves are conserved but their preferential association with other TADs 
can switch through attraction and/or repulsion mechanisms depending on their 
transcriptional activities. This switching was observed to occur extensively during 
ESC differentiation or reprogramming of somatic cells to induced pluripotent stem 
cells (iPSCs) (Bonev et al., 2017; Stadhouders et al., 2018). The mechanism 
responsible for the formation of A/B compartmentalization remains elusive. However, 
a recent study highlighted that TADs themselves are not required for A/B 
compartmentalization (Schwarzer et al., 2017). In fact, deletion of TAD structures by 
preventing cohesin loading resulted in a more nuanced and finer segregation of the 
genome into A/B compartments. Importantly, this new compartmentalization directly 
corresponded to gene expression activities and chromatin modifications of the 
respective loci (Schwarzer et al., 2017). This observation suggests that chromatin has 
an intrinsic tendency to self-associate into A/B compartments based on the local 
epigenetic landscape and transcriptional activity. Furthermore, this megabase-scale of 
genome organization is – to some extent – opposed by the segregation of the 
chromatin into TADs, which brings loci of contrasting states together into the same 
hub (Schwarzer et al., 2017).  
 
1.3.4.1 Nucleolar-associated domains (NADs) 
Independent of proximity ligation experiments, many studies have aimed to determine 
the genomic composition of sub-nuclear compartments, such as the nucleolus and the 
nuclear lamina (Figure 11). Electorn microscopy experiments have shown that 
nucleolar-associated domains (NADs) contain highly compact heterochromatic 
structures (Efroni et al., 2008; Park et al., 2004; Savic et al., 2014). However, their 
identification and characterization has been challenging, since specific targeting of the 
membrane-less compartment has not been successful so far. To date, attempts to 
identify NADs have been performed by purification and sequencing of nucleoli 
(Nemeth et al., 2010; van Koningsbruggen et al., 2010). Although both studies 
identified mainly inactive regions from all chromosomes associated to nucleoli, their 
results revealed variable outcomes. While one study observed enriched tRNA genes at 
NADs (Nemeth et al., 2010), the other report suggested a significant overlap of NADs 
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with previously published LADs (van Koningsbruggen et al., 2010). Most likely, 
these discrepancies derive from variations of the sonication-based purification 
procedure, making a precise definition of NADs impossible. Thus, their 
comprehensive characterization among different cell types and tissues remains to be 
determined.  
 
 
Figure 11. Global genome compartmentalization. Large-scale genome segregation can be observed into A and 
B compartmentalization of self-associating active and repressed genomic regions, respectively. Further genome 
organization can be observed by preferential association of mostly heterochromatic regions to the nuclear lamina 
(LADs) and to the nucleolus (NADs). Taken from (Gasser, 2016) 
1.3.4.2 Lamina-associated domains (LADs) 
Identification and characterization of lamina-associated domains (LADs) was 
achieved in 2008 using a method called DNA adenine methyltransferase (dam) 
identification (DamID). Fusion of the bacterial dam protein to LAMIN B1 mediates 
site-specific GATC methylation of DNA loci located at the nuclear periphery thereby 
allowing the identification LADs (Guelen et al., 2008). This and following studies 
revealed comprehensive maps of LADs in different cell types and species (van 
Steensel and Belmont, 2017). Mouse and human cells contain 1000 to 1500 LADs, 
which are between 10kb and 10Mb in size and present on all chromosomes. They 
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cover approximately 40% of the genome and are generally gene-poor associated with 
low levels of gene expression. Typically rich in A/T-rich sequences, LADs are also 
enriched for the repressive histone marks H3K9me2 and H3K9me3 (van Steensel and 
Belmont, 2017). However, the exact mechanism of anchoring of LADs to the nuclear 
lamina (NL) in mammalian cells is not fully understood. Results from single-cell 
DamID experiment revealed that LAD regions contact the NL over continuous 
stretches, suggesting multivalent interactions that do not include a specific DNA 
consensus sequence (Kind et al., 2013). At least in part, this interaction is mediated by 
H3K9me2 and H3K9me3. Deletion or inhibition of the H3K9 methyltransferases 
G9A, SUV39H1 and SUV39H2 weakened the NL-LAD interaction and its triple KO 
was sufficient to peel the HBB locus completely away from the NL (Bian et al., 2013; 
van Steensel and Belmont, 2017). Reciprocal experiments elucidating the role of 
lamin proteins in mediating NL-LAD interactions revealed surprising results. 
Deletion of all lamins had no effect on genome-wide contacts with the NL in mouse 
ESCs, suggesting redundant roles of LAMIN A/C and LAMIN B receptor in 
generating a scaffold to which LADs are anchored (Amendola and van Steensel, 
2015). Experiments investigating gene positioning in single cells revealed that only 
30% of LADs contact the lamina at a given time point. Thus, LADs are not constantly 
associated with the lamina but show some dynamics and seem to randomly attach or 
detach at every cell cycle (Kind et al., 2013). Although the NL has been accepted as a 
silent compartment of the genome, investigating its causal role in gene repression has 
resulted in variable outcomes. Insertion of reporter genes into LADs or their artificial 
tethering to the NL was reported to lead to a two- to six-fold reduction in expression 
(Akhtar et al., 2013; Reddy et al., 2008). Other studies by contrast, did not observe 
any effects on expression or transcriptional activation of their reporters upon NL-
localization (Finlan et al., 2008; Kumaran and Spector, 2008). Together, these results 
suggest that proximity to the NL can cause reduction in gene expression, but only of a 
subset of genes (van Steensel and Belmont, 2017). Besides generating a map of 
LADs, DamID experiments also revealed a large proportion of the genome that is 
preferentially positioned away from the NL. These so-called inter-LADs or ICDs are 
located in the nuclear interior and account for most transcriptional activity of the 
genome. Furthermore, they contain high gene densities and are enriched for active 
histone marks, such as H3K4me1, H3K4me3 and H3K27ac (van Steensel and 
Belmont, 2017). Correlation studies with HiC experiments revealed a near identical 
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overlap between inter-LADs/LADs with A/B compartmentalization. While LADs 
largely correspond to the B compartment, the A compartment overlaps with inter-
LADs (Kind et al., 2015). This implies that LADs tend to interact with each other and 
are spatially separated from active compartments of the genome. Strikingly, there is 
also a cross talk between LADs and NADs. DamID-mediated labeling of LADs 
showed that after mitosis NL-associated domains redistributed to both the NL and the 
nucleolus. This observation indicates that LADs are variably positioned at either the 
NL or in close association with the nucleolus (Kind et al., 2013).  
 
1.3.5 3D chromatin organization in ESCs and during development 
Higher-order chromatin structures in 3D are well known to play essential roles in 
gene expression regulation. How these structures emerge during development could 
only very recently be addressed due to technical challenges of low starting material. 
Three recent studies investigated the organization of the genome during early 
embryonic development in mice and drosophila using low-cell HiC experiments (Du 
et al., 2017; Hug et al., 2017; Ke et al., 2017). Interestingly, the genome of mature 
oocytes at the metaphase II stage completely lacks TADs and exists in a largely 
unstructured conformation (Ke et al., 2017). In sperm by contrast, extra-long-range 
interactions (>4Mb) and even inter-chromosomal interactions occur frequently, which 
is in agreement with a highly compacted sperm genome (Ke et al., 2017). Upon 
fertilization, large-scale chromatin re-organization of the paternal genome takes place 
resulting in a largely diminished higher-order structure after fertilization (Du et al., 
2017). Subsequent re-establishment of chromatin organization is a slow process and 
extents throughout the entire pre-implantation development (Du et al., 2017). 
Importantly, all three studies in parallel reported that this re-organization of the 3D 
architecture could occur in the absence of transcription, ruling out a major role of the 
zygotic genome activation for TAD formation (Du et al., 2017; Hug et al., 2017; Ke et 
al., 2017). By contrast, treatment with aphidicolin abolished TAD formation, 
attributing an essential role of DNA replication for TAD establishment (Ke et al., 
2017). Taken together, these findings highlight that compartmentalization of the 
genome after fertilization is a slow process, which is not transcription- but replication-
dependent. These studies further highlight that pluripotent epiblast stem cells in the 
ICM have already completely re-established TAD structures. Accordingly, cultured 
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ESCs show clear genome partitioning into TADs and A/B compartments (Dixon et 
al., 2012). A next large-scale re-organization of the genome occurs upon exit of 
pluripotency and during following lineage-specification. Upon differentiation, the 
open structure of ESC chromatin is remodeled associated with the formation of 
compact heterochromatic blocks and reduced chromatin dynamics (Bhattacharya et 
al., 2009; Meshorer and Misteli, 2006; Nozaki et al., 2017). Interestingly, the 
nucleolus seems to fulfill essential roles during this process serving as an ignition 
point for global heterochromatin formation and spreading during very early 
differentiation processes (Savic et al., 2014). Regarding sequence-resolved analyses, 
DamID and ultra-high resolution HiC have been performed on ESCs and ESC-derived 
neuronal lineages (Bonev et al., 2017; Peric-Hupkes et al., 2010). As expected, TADs 
themselves largely remain constant during differentiation to neuronal cells, whereas 
association between TADs alters globally. Contacts between active TADs become 
less pronounced, while inactive TADs interact more strongly. Furthermore, dynamic 
interactions between neural transcription factors appear in concert with a cell-type 
specific establishment of enhancer-promoter contacts (Bonev et al., 2017). 
Interestingly, also LADs undergo large repositioning across the genome (Peric-
Hupkes et al., 2010). While increase in NL-contacts was generally associated with 
gene silencing, gene re-positioning to the nuclear interior correlated with their 
activation (Peric-Hupkes et al., 2010; van Steensel and Belmont, 2017). Globally, 
around half of all LADs were found to vary in different cell types leading to the 
discrimination between constant LADs (cLADs) and facultative LADs (fLADs) 
(Meuleman et al., 2013; Peric-Hupkes et al., 2010).  
 
1.4 The nucleolus 
The nucleolus is the largest nuclear sub-compartment of mammalian cells in which 
ribosomal RNA (rRNA) transcription, rRNA maturation and ribosome biogenesis 
take place. The membrane-less nucleolus is formed by clustered rRNA gene repeats 
located at nucleolar organizer regions (NORs), which are positioned at centromeric 
regions of five chromosomes in mouse cells (Dundr et al., 2000). The nucleolus can 
be further divided into several structural and functional subdomains. Transcription of 
rRNA genes catalyzed by RNA polymerase I (Pol I) occurs in fibrillar centers (FCs), 
while the subsequent modification and processing of the nascent pre-rRNA, as well as 
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its assembly in pre-ribosomal particles takes place in dense fibrillar components 
(DFCs). The third nucleolar domain, called granular component (GC), accounts for 
later rRNA processing steps and maturation of ribosomes (Scheer and Hock, 1999). 
Importantly, nucleolar structures are dynamically regulated in space and time. During 
mouse development, nucleolus formation occurs at the late 2-cell stage correlating 
with activation of Pol I transcription (Engel et al., 1977). In general, it is believed that 
formation and maintenance of nucleolar integrity is dependent on active transcription 
or rRNA genes. Accordingly, inhibition of Pol I transcription leads to rearrangement 
of nulceolar components followed by complete nucleolar disintegration (Nemeth and 
Grummt, 2018). Globally, nucleoli are in terms of transcription the most active 
domains of the mammalian genome, accounting for 35% of total transcription in 
proliferating cells (Moss et al., 2007). Thus, it is relatively surprising that the active 
nucleolus also serves as a hub for local heterochromatin localization (Nemeth and 
Langst, 2011). Loss of silencing correlates with rDNA instability, nucleolar 
disintegration and cellular senescence, suggesting essential roles of heterochromatin 
in nucleolar function and stability (Nemeth and Grummt, 2018). Conversely, the 
nucleolus participates in global heterochromatin organization within the nucleus. In 
differentiating cells, the it plays a pioneering role in shaping global heterochromatin 
formation and spreading (Savic et al., 2014). Furthermore, it was shown to be 
important for anchoring the inactive X chromosome to perinuclear compartments in 
female cells (Yang et al., 2015). In summary, the nucleolus is a transcriptionally 
highly active sub-compartment of the nucleus, which mainly accounts for ribosome 
biogenesis but also plays important roles in functional organization of the genome.   
 
1.4.1 Ribosomal RNA (rRNA) genes 
rRNA genes are organized in tandem repeat arrays, which – in mouse – are located on 
chromosomes 12, 15, 16, 18 and 19 (Dev et al., 1977). Each of these arrays can act as 
an independent NOR (Bell et al., 1992). In total, mice contain approximately 400 
rRNA gene copies, each of around 45kb in size (Grozdanov et al., 2003). A single 
gene unit consists of a 13-14kb sequence encoding the pre-rRNA, which is separated 
by the long intergenic spacer (IGS) element of around 30kb. Regulatory elements, 
such as the core promoter element (CPE), upstream control element (UCE), spacer 
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promoter, enhancer repeats and the transcription terminator elements are located in 
the IGS (Figure 12) (Grob et al., 2011).  
 
 
Figure 12. Structure of rRNA genes. RNA Pol I-mediated transcription is initiated at the spacer promoter giving 
rise to IGS-rRNA and at the core promoter driven by the core promoter element (CPE) for transcription of 45S 
pre-rRNA (indicated by black arrows). Red boxes mark the twelve terminator elements (T-1 to T10). Cyan boxes 
indicate varying numbers of repetitive enhancer repeats. The upstream control element (UCE) contains a CpG at 
position -133, which is critical for rDNA silencing. 
The mouse rRNA gene promoter consists of the CPE directly adjacent to the TSS and 
the UCE located 100bp upstream. The Upstream binding factor (UBF) specifically 
binds the CPE and UCE and is an important factor in promoting rDNA transcription. 
Together with the TATA binding protein (TBP) centered TIF-IB complex, UBF 
forms the pre-initiation complex required for recruitment of RNA Pol I (Moss et al., 
2007). Strikingly, this complex remains associated to NORs during mitosis, 
bookmarking these loci for immediate re-activation in G1 (Leung et al., 2004). Active 
rDNA transcription generates the 45S pre-rRNA, which is further modified and 
processed into 28S, 18S and 5.8S rRNAs. These mature rRNA transcripts are 
subsequently packaged with ribosomal proteins forming the large and small subunits 
of ribosomes (Santoro, 2005). 2kb upstream of the core promoter resides the spacer 
promoter (Kuhn and Grummt, 1987). This alternative rDNA promoter displays 
several sequence homologies with the core promoter and is therefore also highly 
enriched for RNA Pol I occupancy (Santoro et al., 2010). Transcription from the 
spacer promoter gives rise to the 2kb lncRNA IGS-rRNA. In somatic cells IGS-rRNA 
is rapidly processed giving rise to a more stable 200nt lncRNA called promoter RNA 
(pRNA), which corresponds to the sequence to the core promoter element and is 
involved in rRNA gene silencing (Mayer et al., 2006; Santoro et al., 2010). The rDNA 
enhancer repeats are located between both the core and upstream promoter and are 
therefore also part of the IGS-rRNA. Various numbers in enhancer repeats (6, 9, 10, 
11, 12 and 22) have been reported, of which a subclass containing 9 repeats is 
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particularly important for regulating the epigenetic state of rDNA (Santoro et al., 
2010). Twelve copies of terminator elements (T-1-T10) represent additional cis 
regulatory sequences in the rDNA locus. T0-T10 are located downstream of rRNA 
genes and are implicated in termination of rRNA transcription (Grummt et al., 1985). 
Two additional terminator elements are found upstream of the core promoter (T0) and 
spacer promoter (T-1), respectively. All Ts are specifically recognized and bound by 
transcription termination factor 1 (TTF1), which is implicated in promoting rDNA 
transcription and its termination (McStay and Grummt, 2008). However, bound to T0 
at the core promoter, TTF1 can also mediate to the recruitment of a repressor complex 
leading to the permanent silencing of the respective rRNA gene unit (Nemeth et al., 
2004).  
 
1.4.2 Chromatin and epigenetic regulation of rRNA genes 
Despite the large demand for rRNA in mammalian cells, not all rRNA gene copies are 
actively transcribed. Visualization of rDNA genes by Miller spreads in S. cerevisiae 
revealed two types of rRNA genes: One class was actively transcribed by RNA Pol I, 
giving rise to the typical “Christmas tree” structures, while the other subclass did not 
show any indication of RNA synthesis (Miller and Beatty, 1969). Although Miller 
spreading techniques cannot be used for mammalian cells, the co-existence of active 
and silent rRNA genes within the same cell has been confirmed in higher eukaryotes 
(Santoro, 2011). Epigenetic characterizations revealed that genes harboring 
processive rRNA transcription are enriched for active histone marks such as 
H3K4me2 and H4ac (Santoro and Grummt, 2005; Santoro et al., 2002). Silent rRNA 
genes by contrast, are associated with heterochromatin protein 1 (HP1) and the silent 
marks H3K9me2, H3K27me3 and H4K20me3 (Santoro and Grummt, 2001, 2005; 
Santoro et al., 2002). Interestingly, most of these histone modifications were shown to 
peak at the spacer promoter without any detectable enrichment at the main promoter 
(Zentner et al., 2014). However, these findings must be treated with caution due to the 
low mappability of the rDNA locus (Zentner et al., 2014). In addition to the repressive 
histone marks, silent rDNA loci are also highly enriched for DNA methylation. 
Particularly one CpG at position -133 located within the UCE is directly involved in 
silencing rRNA transcription. When methylated, this CpG prevents the binding of 
UBF to rDNA chromatin and thereby impairs formation of the initiation complex 
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leading to transactional repression (Santoro and Grummt, 2001). Another important 
contribution to rRNA gene transcription comes from ATP-dependent chromatin 
remodeling complexes that regulate the exact nucleosome positioning. In mouse cells, 
a particular nucleosome at the core promoter element exists in two distinct positions, 
directly corresponding to the transcriptional state of the respective locus (Li et al., 
2006). In active rRNA genes, this nucleosome occupies the sequence region from -
157 to the TSS. In silent genes however, it extends over the TSS covering the region 
from -132 to +22. Situated in this “off” position, the -133 CpG becomes exposed at 
the 5’ boundary of the nucleosome and can be targeted by DNMTs for DNA 
methylation, thereby stabilizing the silent state (Santoro and Grummt, 2001; Santoro 
et al., 2002). Specific recruitment of nucleosome remodeling complexes to the 
respective gene loci is mediated by TTF1 bound to the T0 element (Langst et al., 
1998; Langst et al., 1997). Importantly, the chromatin state of active and silent rRNA 
genes is stably propagated throughout the cell cycle ensuring epigenetic inheritance. 
These regulatory mechanisms controlling rDNA expression are not rRNA gene-
specific but seem to act on a larger scale affecting entire rRNA gene clusters. Thus, 
active and silent NORs can be distinguished in higher eukaryotes (Pikaard, 2000; 
Schlesinger et al., 2009). While the exact mechanism mediating inheritance of active 
rRNA genes is not fully understood, many studies have highlighted the crucial role of 
the nucleolar remodeling complex (NoRC) in silencing rDNA chromatin in mammals 
(Santoro et al., 2002).  
 
1.4.3 Nucleolar remodeling complex NoRC 
NoRC was originally discovered by a yeast two-hybrid system screening for TTF1-
interacting proteins. These analyses identified TTF1-interacting protein 5 (TIP5), 
which – in association with SNF2H – forms the ATP-dependent chromatin 
remodeling complex NoRC and binds to rRNA genes (Strohner et al., 2001). Further 
investigations revealed that NoRC is the key player in establishing and maintaining 
the heterochromatic state of silent rRNA genes (Li et al., 2006; Santoro et al., 2002; 
Strohner et al., 2001; Zhou et al., 2002). SNF2H is a member of the ISWI subfamily 
and serves as the catalytic subunit for several other chromatin remodeling complexes 
as well (Hota and Bruneau, 2016; Strohner et al., 2001). TIP5 on the other hand is a 
large, > 200kDa protein that is not known to occur in any other complex than NoRC 
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(Bochar et al., 2000; Bozhenok et al., 2002; Ito et al., 1999; LeRoy et al., 2000). TIP5 
belongs to the protein family of bromodomain adjacent zinc finger (BAZ) proteins 
and has therefore also been alternatively named as Baz2a (Jones et al., 2000). While 
SNF2H is responsible the nucleosome remodeling activity, TIP5 provides the 
specificity for rDNA binding and serves as a binding platform for further factors 
required for transcriptional silencing. Thus, several TIP5 domains have been assigned 
crucial roles for mediating these functions. For instance, the C-terminal bromodomain 
allows binding of acetylated histones – H4K16ac in the case of rDNA – and is 
necessary to mediate HDAC1 recruitment. The PHD domain is required for the 
interaction with SNF2H, histone methyltrasnferases (HATs) and DNMTs (Zhou and 
Grummt, 2005; Zhou et al., 2002). The TIP5/ARBD/MBD (TAM) domain of TIP5 is 
of particular importance, since it binds stem loop structures of the lncRNA pRNA 
mediating itns rDNA-specific recruitment (Mayer et al., 2006). Immediately after 
replication of the silent rDNA in late S-phase, TIP5 is recruited to the rRNA promoter 
via its interaction with pRNA and T0-bound TTF1 (Mayer et al., 2008; Savic et al., 
2014). Through the recruitment of further factors, such as HDAC1, SETDB1, PARP1 
and DNMTs, TIP5 represses rRNA transcription maintaining the silent state of rDNA 
chromatin (Figure 13) (Guetg et al., 2012; Li et al., 2006; Santoro and Grummt, 
2005; Santoro et al., 2002; Zhou et al., 2002; Zhou et al., 2009).  
 
 
Figure 13. Schematic representation of active and silent rRNA genes. Transcriptionally active 
rRNA genes are occupied by UBF and RNA Pol I and are asociated by active histone marks (labeled 
in blue).  Characterized by an open chromatin conformation, these rDNA repeats give rise to the 45S 
pre-rRNA. Chromatin of silent rDNA by contrast, is highly compact and marked by DNA 
methylation (red label) and silent histone PTMs (orange label). The silencing complex NoRC is 
recruited via the lncRNA pRNA associated to TIP5. Subsequent recruitment of histone 
methyltransferases (HMTs), HDACs and DNMTs mediate the rDNA silencing.  
 
45S pre-rRNA 
H3K4me3 AcH4  AcH3 H3K9me2/3 H4K20me3  meCpG 
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In addition to the recruitment of effector proteins, NoRC is also responsible for 
sliding of the rDNA promoter nucleosome into the “off” position covering the region 
-132 to +22 (Santoro, 2011). The following CpG methylation at position -133 and 
consequential displacement of UBF is required for efficient rRNA gene silencing, 
since its repression is blocked by treatment with 5-azacytidine (Santoro and Grummt, 
2001). Taken together, NoRC has been identified as the main component responsible 
for rRNA gene silencing. Mechanistically, NoRC coordinates several enzymatic 
processes including ATP-dependent nucleosome remodeling, histone deacetylation, 
DNA and histone methylation to establish a closed chromatin structure and block 
rRNA transcription.  
 
1.4.4 Long non-coding RNA pRNA 
RNA Pol I-mediated transcription of the upstream promoter gives rise to the IGS-
rRNA, which maps to the 2kb spacer region between both promoters and further 
contains sequences from the main promoter. IGS-rRNA transcription is highly cell 
cycle-regulated occurring only during early S-phase from a subset of active, 
hypomethylated rRNA genes that harbor nine enhancer repeats (Santoro et al., 2010). 
In mid-late S-phase, IGS-rRNA is processed to a shorter version that matches the 
rDNA promoter sequence and is therefore called promoter RNA (pRNA) (Santoro et 
al., 2010). The exact mechanism of IGS-rRNA processing is not fully understood but 
was shown to require the RNA helicase DHX9 (Leone et al., 2017). Interestingly, 
production of the  ~200nt lncRNA pRNA coincides with NoRC recruitment to newly 
replicated, silent rRNA genes (Guetg et al., 2012; Li et al., 2006). A central pRNA 
sequence motif folds into a conserved stem loop structure that is specifically 
recognized by the TIP5-TAM domain. Binding to pRNA induces a conformational 
change of TIP5, which facilitates its interaction with other factors involved in rDNA 
silencing (Mayer et al., 2008). In support with this hypothesis pRNA is required for 
the interaction of TIP5 with TTF1 and PARP1, whereas its depletion via LNA causes 
defects in heterochromatin formation at rRNA genes (Guetg et al., 2012; Mayer et al., 
2006; Savic et al., 2014). Further work elucidating the mechanism of NoRC 
recruitment revealed that single mutations in the pRNA loop structure but not in its 5’ 
regions abolished the interaction of TIP5 with TTF1 and its association with rDNA 
(Mayer et al., 2008; Savic et al., 2014). Conversely, TIP5 TAM domain-mutants that 
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are impaired in pRNA binding fail to associate with chromatin and do not establish 
rDNA heterochromatin (Mayer et al., 2006). In summary, these studies suggest a 
mechanism by which rRNA genes are silenced via lncRNA-mediated recruitment of 
the chromatin remodeling complex NoRC.  
Recent studies highlighted that pRNA-guided rDNA silencing does not only occur in 
a spatiotemporal-regulated manner throughout the cell cycle but is also tightly 
controlled during development. In line with their global lack in constitutive 
heterochromatin, compact chromatin structures at the nucleolus are absent in ESCs. 
Accordingly, all rRNA genes are active and devoid of heterochromatic marks (Savic 
et al., 2014). As ESCs exit pluripotency, TIP5 rapidly localizes to nucleoli and 
progressively establishes heterochromatin at rRNA genes during early differentiation 
processes (Savic et al., 2014). Strikingly, the impairment in rDNA silencing in ESCs 
cannot be explained by diminished NoRC expression, since TIP5 is even 
overexpressed in ESCs. By contrast, an absence of pRNA was shown to be the 
driving force for maintaining euchromatic rRNA genes in ESCs. Although ESCs 
actively express IGS-rRNA, it is not further processed into its mature form, resulting 
in a defect in NoRC recruitment to rDNA. In agreement with this observation, 
transfection of mature pRNA is sufficient for directing TIP5 to rDNA followed by 
heterochromatin formation at these loci in ESCs (Savic et al., 2014). Moreover, it was 
shown that TIP5 is able to bind IGS-rRNA but thereby inhibits its interaction with 
TTF1. Accordingly, immunofluorescence experiments in ESCs revealed that TIP5 is 
even excluded from nucleoli under basal conditions, whereas transfection of pRNA 
rapidly leads to its exclusive nucleolar localization (Leone et al., 2017; Savic et al., 
2014). Strikingly, pRNA administration causes chromatin compaction not only at the 
rDNA but leads to global heterochromatin formation also at non-nucleolar regions, 
such as major and minor satellite repeats. This re-organization of the genome is 
accompanied by a global increase in the repressive H3K9me2 levels and by a loss in 
the pluripotent potential (Savić et al., 2014). Thus, the nucleolus functions – in 
addition to its known role in ribosome production – as a seeding point for global 
heterochromatin formation leading to re-structuring of the genome in differentiating 
cells. Furthermore, these observations imply that NoRC undergoes a crucial switch-
of-function from ESCs to differentiated cells. While its role in silencing rRNA genes 
in differentiating and somatic cells has been extensively investigated, the high 
expression of TIP5 in ESCs suggests a non-nucleolar function in pluripotency.  
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2. Aims 
Recent results of our laboratory suggested an important role for the nucleolar 
remodeling complex (NoRC) in ESCs (Savic et al., 2014). NoRC consist of two 
subunits, the ATPase SNF2H/SMARCA5 and TIP5 and has previously been 
identified as the key determinant for the establishment of epigenetic silencing at 
ribosomal rRNA genes in somatic cells (Li et al., 2006; Santoro et al., 2002; Strohner 
et al., 2001; Zhou et al., 2002). In embryonic stem cells (ESCs) however, all rRNA 
genes are actively transcribed and therefore devoid of heterochromatic blocks (Savic 
et al., 2014). Nevertheless TIP5 – the main component of NoRC – is highly expressed 
in ESCs, but does not associate with rDNA and, hence, does not regulate rRNA gene 
transcription. Upon differentiation, TIP5 is rapidly recruited to rDNA by a lncRNA-
mediated mechanism and progressively establishes permanent silencing of a subset of 
rRNA genes (Savic et al., 2014). Thus, these results suggest that NoRC rapidly 
switches its function during the transition of ESCs into lineage-committed cells. 
Remarkably, ESCs depleted of TIP5 grow slower and have an impaired ability to 
differentiate, highlighting an essential role of NoRC in pluripotency that is not related 
to the regulation of rRNA genes (Savic et al., 2014). The aim of this project was to 
mechanistically elucidate the role of NoRC in ESCs. Given the two ESCs models in 
serum and 2i, we further aimed to determine whether NoRC undergoes an additional 
switch-of-function from ground state to primed pluripotency. Understanding how the 
pluripotent state of ESCs is maintained has the potential to help future clinical 
applications of regenerative medicine. Moreover, given the recognized similarity of 
ESCs and cancer cells, increased knowledge of ESC biology might also lead to new 
approaches for cancer therapies. The recent link established in our lab concerning the 
role of TIP5 in ESCs and prostate cancer cells has the potential to directly improve 
therapeutic and prognostic strategies in cancer and regenerative medicine. 
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Abstract 
3D genome architecture is important for gene regulatory circuits. Yet, its contribution to early 
developmental states remains unclear. Here we show that ground state and developmentally 
primed pluripotent embryonic stem cells (ESCs) differ in their dependency on a set of 
chromatin regulators. One of these factors is the chromatin remodeling complex NoRC, 
composed of TIP5 and SNF2H. Although NoRC is highly expressed in both pluripotency 
states, only ground state ESCs depend on NoRC for correct gene expression, control of 
global H3K27me3 occupancy, growth and differentiation. NoRC binds large and active 
regions within the A-compartment, interacts with topoisomerase 2A (TOP2A) and cohesin, 
and limits far-cis chromatin contacts in order to maintain ground state 3D genome 
architecture. NoRC acts together with TOP2A as depletion or activity inhibition of TOP2A 
phenocopies the changes in gene expression and H3K27me3 occupancy observed upon 
TIP5 knockdown in ground state ESCs without any influence in ESC+serum. These findings 
highlighted different degrees of genome dynamics between the early phases of development 
through the action of chromatin remodelers and the relief of chromatin torsional stress. 
 
Introduction 
Embryonic stem cells (ESCs) are derived from pre-implantation epiblasts of the late 
blastocyst and have the potential to produce all tissues when injected into host embryos 
(Boroviak et al., 2014; Nichols and Smith, 2009). These properties make ESCs an invaluable 
system to elucidate regulatory mechanisms during early mammalian development. Compared 
to differentiated cells, ESCs display a less condensed and more euchromatic conformation. 
This structure is particularly malleable and transcriptionally permissive and reflects the plastic 
state of pluripotent cells that must retain the ability to enter into any lineage specification (de 
Wit et al., 2013; Gaspar-Maia et al., 2011b; Gorkin et al., 2014). The positive correlation 
between epigenetic repressed structures and more advanced developmental stages is also 
apparent between ground state and developmentally primed pluripotent ESCs (Ficz et al., 
2013; Habibi et al., 2013; Marks et al., 2012). ESCs exist in a variety of states in vitro, largely 
defined by the culture conditions, which reflect the natural development of the embryo from 
the blastocyst to post-implantation stages (Hackett and Surani, 2014). ESCs can be 
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propagated in medium containing fetal calf serum and leukaemia inhibitory factor (LIF) 
(ESC+serum) or in serum-free 2i medium (ESC+2i) that contains LIF plus two small-molecule 
kinase inhibitors for MEK/ERK (PD0325901) and GSK3 (CHIR99021) (Ying et al., 2008). Both 
ESC+2i and ESC+serum are pluripotent. However, ESC+2i closely resemble the 
developmental ground state in vivo whereas ESC+serum are developmentally primed 
(Boroviak et al., 2014). Accordingly, ESC+2i have a higher efficiency in chimera formation 
compared to ESC+serum (Alexandrova et al., 2016). Moreover, ESC+2i and ESC+serum 
display distinct transcriptional profiles, epigenetic landscapes and chromatin structures. In 
comparison to ESC+serum, ESC+2i show decreased expression of lineage priming genes 
(Marks et al., 2012). Furthermore, the epigenetic and chromatin organization of ESC+2i is in a 
less repressed state. ESC+2i have hypomethylated DNA similar to pre-implantation embryos, 
whereas ESC+serum genome is hypermethylated, reminiscent of post-implantation embryos 
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Marks et al., 2012). Similarly, there is 
a reduced prevalence of the repressive H3K27me3 mark at Polycomb target promoters in 
ESC+2i (Joshi et al., 2015; Marks et al., 2012). Finally, quantitative super-resolution 
nanoscopy coupled with computer simulations revealed that ESC+2i harbor a more open 
chromatin configuration when compared to ESC+serum (Ricci et al., 2015).  
The 3D genome organization has been thought to be functionally important for correct 
execution of gene expression programs. The crucial roles in chromatin organization of 
architectural proteins, notably cohesin and the transcriptional insulator CTCF, have been 
extensively studied (Dixon et al., 2012; Guo et al., 2015; Merkenschlager and Nora, 2016; 
Rao et al., 2017; Schwarzer et al., 2017). Cohesin and CTCF co-localize at topology-
associated domain (TAD) boundaries (Dixon et al., 2012; Rao et al., 2014). Data supported a 
role of CTCF as boundary element whereas cohesin is thought to be loaded at sites of active 
transcription and travels along the chromosome arms by a loop extrusion mechanism until 
reaching convergently oriented CTCF sites (de Wit et al., 2015; Guo et al., 2015; Nora et al., 
2017; Sanborn et al., 2015). Recent studies have also suggested crucial roles of Polycomb 
repressive complexes 1 and 2 (PRC1, PRC2) in the establishment of long-range intra- and 
interchromosomal interactions in ESCs (Joshi et al., 2015; Schoenfelder et al., 2015b). 
Importantly, these long-range interactions were detected only in ESC+serum and not in 
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ESC+2i, suggesting that PRC-mediated epigenetic repressive signature is a determinant of 
3D genome organization during early development. However, how the 3D organization of 
chromatin is regulated and how it contributes to ground state and developmental primed 
ESCs remains unclear. 
Chromatin remodeling complexes use the energy of ATP hydrolysis to move, destabilize, 
eject, or restructure nucleosomes (Clapier and Cairns, 2009). Although their role on local 
chromatin changes has been intensively investigated, the possibility whether they can shape 
3D genome architecture remains to be elucidated. The nucleolar remodelling complex NoRC 
is a chromatin remodeling complexes, which consists of two subunits, the ATPase 
SMARCA5/SNF2H and TIP5, a >200 kDa protein that shares sequence homology with the 
largest subunits of SNF2H/ISWI-containing remodeling complexes (Ralf Strohner, 2001; 
Santoro et al., 2002). In differentiated cells, TIP5 is mainly localized in nucleoli, associates 
with ribosomal RNA (rRNA) genes and establishes their epigenetic silencing (Guetg et al., 
2010; Mayer et al., 2006; Santoro et al., 2002). In contrast, in ESCs the ability of NoRC to 
silence rRNA gene transcription is prevented through long non-coding RNA (lncRNA)-
mediated mechanisms that result in the impairment of TIP5 recruitment to rRNA genes 
(Leone et al., 2017; Savić et al., 2014). As a consequence, all rRNA genes in ESCs are active 
and display euchromatic features, including the lack of DNA methylation (Savić et al., 2014; 
Schlesinger et al., 2009).  
The ability of NoRC to act as a repressor of rRNA gene transcription only upon exit of 
pluripotency suggests a switch of function during development. In this work, we explored the 
role of NoRC in ground state and primed pluripotency states and found an unexpected non-
nucleolar function of NoRC in ESCs. We showed that NoRC is a regulator of chromatin 
architecture of ground state pluripotent ESCs and contributes to local chromatin compaction 
by limiting far-cis contacts. NoRC associates with large and active regions of the genome and 
interacts with DNA topoisomerase 2A (TOP2A) and cohesin. Our results further indicate that 
NoRC is required to regulate the expression of developmental genes and to control global 
H3K27me3 occupancies. Furthermore, the data underscored fundamental differences in the 
chromatin organization between ground state and primed ESCs. While ESC+2i depend on 
NoRC for maintenance of correct gene expression and H3K27me3 signature, proliferation 
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and differentiation capacities, ESC+serum do not. The results indicated that the open 
structure of ground state chromatin strongly depends on chromatin remodelers and on the 
relief of chromatin torsional stress in order to reinforce active and repressed genome 
partitioning through chromatin compaction. In contrast, the more repressed and closed 
chromatin of ESC+serum is less dependent on factors that additionally limit chromatin 
dynamics and flexibility. These findings highlight how such closely and developmentally 
related ESC types display different requirements for the organization of genome architecture, 
shedding light on crucial chromatin dynamics taking place during early mammalian 
development. 
 
Results 
Ground state and primed pluripotent ESCs differ in the requirement of NoRC activity 
for cell proliferation and differentiation capacity  
Our initial analysis suggested that in ESCs NoRC function was not related to rRNA 
transcriptional control and was distinct between between ground state and primed ESCs. 
First, TIP5 - the main NoRC component - is more highly expressed in ESC+2i than in 
differentiated cells (Fig. 1A). Second, although not bound to rRNA genes, TIP5 is still tightly 
associated with chromatin in ESC+2i (Fig. 1B). Third, proliferation of ESC+2i decreased upon 
TIP5 depletion by siRNA (Fig. 1D,E). Similar results were obtained with a different siRNA and 
in another ESC line (Supplementary Figure 1A,B). Fourth, and consistent with previous 
results (Savić et al., 2014), after induction of monolayer differentiation upon withdrawal of LIF, 
ESC+2i treated with siRNA-Tip5 underwent cell death while control cells displayed 
morphological structures typical of differentiated cells and were negative for alkaline 
phosphatase staining (Fig. 1F,G). All these results indicated that ground state ESCs depend 
on TIP5 expression for proliferation and differentiation capacity and highlighted an 
unexpected non-nucleolar function of NoRC. Next we asked whether proliferation and 
differentiation capacities of primed ESC+serum were also dependent on NoRC. Surprisingly, 
although TIP5 expression levels and knockdown efficiency in ESC+2i and ESC+serum were 
similar (Fig. 1C,D), depletion of TIP5 in ESC+serum did not cause any evident defect in 
proliferation or differentiation (Fig. 1E-G). Taken together these results highlighted a 
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substantial difference in the requirement of NoRC for cell proliferation and differentiation 
capacities between ground state and primed pluripotent ESCs.  
 
In ESC+2i NoRC regulates genes with a bivalent chromatin signature  
Previous data demonstrated that ground state and primed pluripotent ESCs display significant 
differences in their transcriptional profiles and epigenetic landscapes (Ficz et al., 2013; Habibi 
et al., 2013; Marks et al., 2012). The unexpected finding that only ESC+2i rely on NoRC for 
cell proliferation and their differentiation capacity suggests that NoRC contributes to the 
molecular differences between these two pluripotency states. To understand these distinct 
phenotypes in more detail we performed transcriptome analyses of ESC+2i and ESC+serum 
treated with siRNA-Tip5 or siRNA-control (Fig. 2A, Supplementary Table 1). We found that 
depletion of TIP5 induces higher differential gene expression in ESC+2i than in ESC+serum. 
Upon TIP5 depletion in ESC+2i, 1934 genes showed transcriptional changes (log2 fold 
change = 0.58; P<0.05; 1236 upregulated and 698 downregulated). In contrast, in 
ESC+serum the number of genes affected by TIP5 knockdown was lower (351 upregulated 
and 207 downregulated) and only a minority of them were upregulated (65) or downregulated 
(56) by TIP5 knockdown in both ESC states (Supplementary Figure 2A). More than half of 
genes (1052) regulated by TIP5 in ESC+2i were also differentially expressed between 
ESC+2i and ESC+serum (Supplementary Figure 2B).  The top 10 gene ontology (GO) 
terms for genes regulated by TIP5 in ESC+2i revealed a high enrichment in pathways linked 
to developmental processes (Fig. 2B, Supplementary Table 2). This was not the case for 
genes regulated by TIP5 in ESC+serum, which are mostly implicated in biological processes 
linked to cell signalling and cell adhesion. To determine which epigenetic signature 
characterizes TIP5-regulated genes in ESC+2i, we performed ChIPseq analysis in ESC+2i for 
the repressive H3K27me3 and the active H3K4me3 histone modifications (Fig. 2C,D). 
Although H3K27me3 levels at gene promoters in ESC+2i are generally lower than in 
ESC+serum (Fig. 2D) (Marks et al., 2012), we found that promoters of TIP5-regulated genes 
were enriched for the repressive histone mark H3K27me3 and contained the active H3K4me3 
modification. This epigenetic signature characterizes bivalent domains, which are considered 
to poise expression of developmental genes, allowing timely activation while maintaining 
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repression in the absence of differentiation signals (Voigt et al., 2013). Compared to random 
genes, H3K27me3 levels at TIP5-regulated genes transcription start site (TSS) in ESC+2i 
were higher whereas H3K4me3 were lower (Fig. 2C). Moreover, in ESC+2i these promoters 
had high enrichment of Ezh2, Suz12 and Ring1B, components of Polycomb complexes 1 and 
2 (PRC1, PRC2) (Supplementary Figure 2C). Expression levels of TIP5-regulated genes 
were low in both ESC+2i and ESC+serum (Fig. 2E), a result that is consistent with the lower 
occupancy of the active mark H3K36me3 across their gene body and RNA Polymerase II at 
their TSS compared to random genes (Fig. 2C, Supplementary Figure 2C). Validation by 
qRT-PCR supported a role of TIP5 in the regulation of these genes in ESC+2i but not in 
ESC+serum without affecting pluripotency genes Rex1 and Nanog (Fig. 2F). Similar results 
were obtained using a different siRNA-Tip5 sequence and another ESC line (Supplementary 
Figure 2D,E). Taken together, these results indicate that only ground state ESCs depend on 
TIP5, the component of NoRC, to regulate expression of bivalent-marked genes implicated in 
developmental processes. By contrast, developmentally primed ESCs seemed to be 
unaffected by changes in TIP5 expression levels. 
 
NoRC regulates H3K27me3 occupancy in ground state ESC 
Previous studies have shown that ESC+serum are epigenetically more restricted and 
developmentally primed compared to ground state ESC+2i, which in turn are characterized by 
reduced genome wide DNA methylation and H3K27me3 at Polycomb target promoters (Ficz 
et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Marks et al., 2012). To determine whether 
NoRC has a specific function in the regulation of ground state epigenetic signature, we 
analysed occupancy of active histone marks H3K4me3 and H3K27ac and the repressive 
H3K27me3 modification upon TIP5 knockdown. Western blot analyses indicated that total 
levels of these histone modifications were not altered in the absence of TIP5 (Fig. 3A, 
Supplementary Figure 3A). Surprisingly, ChIPseq analysis revealed a global re-distribution 
of H3K27me3 in ESC+2i but not in ESC+serum upon TIP5 depletion (Fig. 3B, Fig. 4B, 
Supplementary Figure 3B). In contrast, no changes were detected for H3K4me3 and 
H3K27ac at TSSs upon TIP5 knockdown (Fig. 3B, Supplementary Figure 3B). For genes 
with high levels of H3K27me3 (first quartile, Q1) in ESC+2i, TIP5 depletion resulted in a 
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decrease of H3K27me3, while genes with relatively low H3K27me3 levels (quartiles 2-4, Q2-
4) displayed an increase of this repressive mark. ChIP-qPCR experiments validated the 
decrease of H3K27me3 at TSS of selected genes with high H3K27me3 content and showed 
that this effect was specific for ESC+2i (Fig. 3C). A similar result was obtained with a different 
siRNA-Tip5 sequence (Supplementary Figure 3C). Importantly, redistribution of H3K27me3 
was not only restricted to TSS but was also detected at a subset of regions in ESC+2i where 
CTCF sites mark transitions in H3K27me3 enrichment (Fig. 3D, E). Upon TIP5 depletion, 
H3K27me3 redistributed over CTCF sites, decreasing at high H3K27me3 regions and 
increasing at adjacent low H3K27me3 regions. In contrast, H3K27me3 transitions marked by 
CTCF sites in ESC+serum were not affected upon TIP5 knockdown. We validated these 
results with independent H3K27me3 ChIP-qPCR experiments and another siRNA-Tip5 (Fig. 
3E, Supplementary Figure 3B). In summary, these results highlight a difference in chromatin 
organization between ground state and developmental primed ESCs, implying that only 
ESC+2i require NoRC to reinforce H3K27me3 boundaries.  
To determine whether the specific requirement of NoRC in ground state is related to the 
hypomethylated genome and low H3K27me3 occupancy at PRC targets that characterizes 
ESC+2i, we analysed the role of TIP5 in controlling gene expression and H3K27me3 
deposition in DNA methyltransferases triple knockout ESCs (DNMT1, 3B and 3A KO, TKO-
ESC) and ESCs knockout for core components of PRC1 and PRC2 complexes (Ring1b-/- 
ESC and Eed-/- ESC). TIP5 knockdown in TKO-ESCs cultured in serum did not affect cell 
proliferation, expression of TIP5-regulated genes and H3K27me3 promoter occupancy, 
indicating that the specific function of TIP5 in ESC+2i does not depend on a low DNA 
methylation content (Supplementary Figures 3D-F). Analyses of Eed-/- and Ring1b-/- ESCs 
cultured in 2i showed that TIP5 depletion still affects cell proliferation and gene expression 
(Supplementary Figures 3G-I). These results are also in agreement with previous studies 
showing that global expression of bivalent genes is not altered in the absence of H3K27me3 
in ESC+2i (Galonska et al., 2015a). Thus, although TIP5 is required for a correct distribution 
of H3K27me3 in ESC+2i, alterations in H3K27me3 alone are not sufficient to explain TIP5 
impact on cell proliferation and transcriptional changes. Taken together these results suggest 
that alterations in gene expression and H3K27me3 are two independent readouts of NoRC 
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dependent changes of specific ground state chromatin conformation. 
 
TIP5 associates with large and active genomic regions of ground state ESCs 
The results described above suggested that the chromatin architecture of ground state ESCs 
requires NoRC to maintain correct gene expression and H3K27me3 levels. Since TIP5 is 
bound to chromatin (Fig. 1B), we analysed and compared TIP5 genomic occupancy in 
ESC+2i and ESC+serum. We established an ESC line containing a FLAG-HA (F/H) tag at the 
N-terminus of the endogenous TIP5 through CRISPR/Cas9 technology (Fig. 4A). Previous 
studies showed that the fusion of the F/H peptide at the N-terminus of TIP5 does not affect its 
activity (Guetg et al., 2012; Mayer et al., 2006). The obtained ESC lines (F/H-TIP5-ESC) 
contain F/H insertion at both TIP5 alleles and express TIP5 at levels similar to wild-type (wt) 
cells (Supplementary Fig. 4A-C). We performed ChIPseq analysis with anti-FLAG or anti-HA 
immunoprecipitation and assessed the specificity of TIP5-ChIP by comparing FLAG- or HA-
ChIP of F/H-TIP5-ESCs and wt-ESCs (Fig. 4). Surprisingly, the genomic binding pattern of 
TIP5 in both ESC+2i and ESC+serum did not appear as a distinct peak-like profile, but was 
rather enriched over large domains that extended up to several hundred kb (Fig. 4B). 
Although TIP5 genomic distribution was similar in ESC+serum and ESC+2i, TIP5 binding was 
higher in ESC+2i (Fig. Fig. 4B-D; Supplementary Fig. 4D). We validated the levels of TIP5 
binding at selected genomic regions of ESC+2i and ESC+serum by classical ChIP-qPCR 
experiments (Figure 4D). The ChIP results were also consistent with previous data showing a 
lack of TIP5 association with rRNA genes in both ESC+2i and ESC+serum (Savić et al., 
2014).  
In contrast to differentiated cells where TIP5 associates with repressive epigenetic signatures 
(i.e. DNA methylation and K3K9me2/3) (Santoro et al., 2002), we found that TIP5 occupies 
active regions of the genome (marked by H3K4me1 and H3K27ac) and poorly correlates with 
H3K27me3 and H3K9me3 regions in ESC+2i (Figure 4E). Accordingly, TIP5-bound regions 
were found in internal chromatin domains (ICDs) and were excluded from the repressed 
lamina-associated domains (LADs) (Peric-Hupkes et al., 2010) (Supplementary Fig. 4E). 
Importantly, TIP5-regulated genes in ESC+2i did not show a preferential association with 
TIP5 (Supplementary Fig. 4F), an expected result given the high H3K27m3 levels at these 
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genes (Fig. 2C). Analysis at TSS of all TIP5-bound genes revealed that they were enriched 
for the active H3K4me3 and H3K27ac marks and depleted in H3K27me3 (Fig. 4F). Moreover, 
in ESC+2i but not in ESC+serum H3K27me3 at TIP5-bound genes – usually low at promoters 
of these genes –increased upon knockdown of TIP5 whereas H3K4me3 levels were not 
affected (Fig. 4G). These results suggest that NoRC does not directly regulate gene 
expression or H3K27me3 occupancy, since neither TIP5-regulated genes nor regions with 
high H3K27me3 were specifically bound by TIP5. Instead, NoRC appears to function as a 
structural factor presumably shaping active chromatin domains of ground state pluripotent 
cells.  
 
TIP5 interacts with TOP2A and cohesin to regulate gene expression and H3K27me3 
occupancy in ESC+2i 
In order to understand how TIP5 shapes and specifically regulates chromatin of ESC+2i, we 
analysed which proteins interact with TIP5. Due to its tight association with chromatin, we 
aimed to purify TIP5 and its direct interaction partners in their native environment by 
establishing a protocol that allows immunoprecipitation from purified chromatin (Chromatin-IP, 
Fig. 5A). F/H-TIP5 and wt-ESC nuclei were incubated with the reversible protein-protein 
specific crosslinker dithiobis(succinimidyl propionate) (DSP) and chromatin was isolated by 
centrifugation of nuclear extracts. After digestion with MNase, solubilisation of 
mononucleosomes was achieved with 1% SDS, which does not affect protein-protein 
interactions stabilized by DSP crosslinking. The identification of TIP5-interacting proteins on 
chromatin was determined by comparing anti-FLAG immunoprecipitates from F/H-TIP5 and 
wt-ESC chromatin followed by mass spectrometry (Fig. 5B, Supplementary Table 3). 
Analysis from three independent experiments revealed 24 proteins consistently interacting 
with TIP5 in ESC+2i. As expected, the strongest interacting partner of TIP5 was SNF2h (Fig. 
5B), indicating that the function of TIP5 in ESCs is directed via the NoRC complex. Moreover, 
we detected all known and previously validated TIP5-interactors such as DNMT1, PARP1 and 
DHX9 (Guetg et al., 2012; Leone et al., 2017; Ralf Strohner, 2001; Santoro et al., 2002). 
Interestingly, among the top TIP5-interacting proteins we found Topoisomerase 2A (TOP2A) 
and structural maintenance of chromosomes protein 3 (SMC3), which is part of the cohesin 
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complex (Fig. 5B,C). Furthermore, two out of three chromatin IP experiments detected the 
interaction of TIP5 with another cohesin component, SMC1 (Supplementary Table 3). Both 
TOP2A and cohesin are well known regulators of chromatin architecture. Topoisomerases 
exert the key function in relieving torsional stress of DNA (Nitiss, 2009). In ESCs, TOP2A is 
the most highly expressed type II isoenzyme that catalyzes the transient passage of two DNA 
duplexes and its inactivation is embryonically lethal (Akimitsu et al., 2003; Tiwari et al., 2012). 
Cohesin proteins are key architectural components of the genome that anchor long-range 
interactions allowing the formation of sub-megabase domains (TADs) (Schwarzer et al., 
2017).  
To determine whether TOP2A and cohesin mediate TIP5 function in ESC+2i, we analysed 
and compared gene expression in ESC+2i and ESC+serum upon knockdown of TOP2A and 
SMC3 or after treatment with ICRF-193, a potent TOP2 inhibitor (Pommier et al., 2010). 
Knockdown of TOP2A and SMC3 or catalytic inhibition of type 2 topoisomerases in ESC+2i 
induced transcriptional changes at candidate genes that are highly similar to those observed 
upon TIP5 knockdown (Fig. 6A-C). Moreover, the lack of apparent additive activation or 
repression of TIP5-regulated genes upon combined depletion suggests that TIP5 regulates 
gene expression in ESC+2i with TOP2A or SMC3 via shared pathways. Importantly, depletion 
of TOP2A or treatment with ICRF-193 in ESC+serum did not affect gene expression at any of 
the analyzed TIP5-regulated genes. SMC3 knockdown in ESC+serum, however, could still 
induce activation of few genes as found in ESC+2i (Sema6, Lef1 and Efnb2). Therefore, as 
for NoRC, ESC+2i require TOP2A and SMC3 for correct gene expression, further highlighting 
substantial differences in the chromatin architecture of ground state and primed pluripotent 
cells.   
To determine whether TOP2A or SCM3 regulate H3K27me3 occupancy, we performed ChIP 
analyses in ESC+2i and ESC+serum. Similarly to TIP5 knockdown, upon TOP2A depletion 
ESC+2i but not ESC+serum decreased H3K27me3 levels at both TIP5-regulated genes and 
regions where CTCF sites marked transitions in H3K27me3 enrichment (Fig. 6D, E). In 
contrast to TIP5 and TOP2A, SMC3 knockdown in ESC+2i did not cause evident changes in 
H3K27me3 occupancy at any of the analyzed regions (Fig. 6F). This result is consistent with 
a recent study showing that H3K27me3 is unaffected by cohesin (Rao et al., 2017). To 
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determine how TOP2A and SMC3 act together with NoRC, we analyzed whether they are 
required for the association of TIP5 with chromatin. We performed TIP5 ChIP analyses in 
ESC+2i and found that TOP2A or SMC3 depletion as well as inhibition of topoisomerase 
activity decreased the association of TIP5 with TIP5-bound sequences (Fig. 6G-I). Taken 
together these findings indicate that NoRC – together with TOP2A and cohesin –regulates 
gene expression specifically in ESC+2i. Furthermore, the data suggest that the release of 
chromatin torsional stress mediated by TOP2A is particularly required in ground state ESC to 
maintain correct H3K27me3 occupancy.  
 
NoRC is required for 3D genome architecture of ground state ESCs  
The results described so far point to a role of NoRC in chromatin organization of ground state 
ESCs. To determine whether NoRC affects chromatin architecture in ESC+2i, we generated 
DNA-DNA contact maps in control and TIP5 depleted cells using chromosome conformation 
capture (HiC) analysis (Bonev and Cavalli, 2016). We generated roughly 200 million valid 
read pairs from ESC+2i treated with siRNA-control (95 million) and siRNA-Tip5 (105 million). 
As expected, TIP5 associates with the A compartment of ESC+2i (Fig. 7A). Globally, we did 
not detect any changes in the organization of the genome into A/B compartments upon TIP5 
depletion (Supplementary Fig. 5A). However, we observed a genome wide increase in far-
cis contacts (>10Mb) in ESCs lacking TIP5 (Fig. 7B, Supplementary Fig. 5B), suggesting a 
role of NoRC in regulating global genome architecture. These results indicate that NoRC 
limits long-range chromatin contacts by mediating local chromatin compaction, an action that 
recent work has suggested to be important to reinforce active and repressed genome 
partitioning (Haarhuis et al., 2017; Schwarzer et al., 2017). The defect in chromatin 
organization was also evident at the H3K27me3 domains HoxA and HoxB loci (Fig. 7C-D). In 
ESCs, the HoxA gene cluster shows strong internal interactions, forming a small 
subcompartment that separates two larger TADs (Fig. 7C, left panel). In the absence of TIP5 
the contacts within this subTAD became weak and the entire cluster fused with two 
neighboring TAD structures. Concomitant with the loss of interactions within the HoxA locus, 
new contacts were also visible in the adjacent TADs. Interestingly, upon TIP5 knockdown in 
ESC+2i, HoxA1 and HoxA7 were upregulated whereas Evx1 was downregulated (Fig. 2F, 
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Supplementary Table 1), supporting a structural role of NoRC in preventing the separation 
of HoxA locus into two compartments. Similar structural changes were also observed at the 
HoxB locus, with the loss of loop anchor points and fusion with the adjacent compartment 
(Fig. 7D, right panel). Further visual inspection of Hi-C maps revealed that ESCs depleted of 
TIP5 displayed several structural alterations, such as loss and gain of loop anchor contacts 
(Supplementary Fig. 5C-D). In summary, we propose an active role of NoRC in controlling 
global chromatin architecture, which is particularly important for maintaining correct gene 
expression signatures and epigenetic landscapes in ground state ESC+2i. 
 
Discussion 
In this study we show that ground state and primed ESCs display substantial differences in 
their chromatin organization due to their differential dependency on the chromatin remodeling 
complex NoRC. Upon TIP5 depletion - the main component of NoRC - ground state ESCs 
proliferated slower and displayed highly impaired differentiation. Furthermore, we 
demonstrated that NoRC is required for maintenance of correct gene expression signatures 
and H3K27me3 occupancy in ESC+2i. Importantly, this strong dependency on NoRC was 
ground state-specific, since TIP5 depletion in ESC+serum did not result in any apparent 
defects. Strikingly, we could recapitulate these ground state-specific phenotypes by depleting 
or inactivating the chromatin regulators TOP2A and SMC3, which we found associated with 
TIP5 on chromatin.  
3D genome architecture has been proposed to be highly important for gene regulatory 
circuits. Recent work revealed that, relative to ESC+serum, ESC+2i have a less condensed 
chromatin structure and lack long-range genomic interactions (Joshi et al., 2015; Ricci et al., 
2015). Moreover, in comparison to ESC+serum, ESC+2i contain more CTCF-occupied sites 
and loop structures (Beagan et al., 2017), suggesting that the 3D chromatin organization 
plays a particularly important role in ground state ESCs. Our results indicated that NoRC is 
involved in regulating genome architecture in ground state ESCs. We identified TOP2A and 
cohesin as strong TIP5 interacting partners on chromatin and showed alterations in far-cis 
genome contact frequencies upon TIP5 knockdown in ESC+2i. Interestingly, we did not 
detect CTCF as an interacting partner of TIP5, suggesting that cohesin might associate with 
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NoRC while traveling along the chromosome arms rather than at the stable anchor points co-
occupied by CTCF. Accordingly, we did not detect any TIP5 enrichment at CTCF/cohesin 
peaks (data not shown). Our HiC analysis revealed global changes in far-cis contacts 
(>10Mb) but does not provide the required resolution for elucidating changes in local 
chromatin structures. However, a recent study highlighted that abolishing cohesin loading 
resulted in a highly similar increase in these far-cis chromatin contacts (Haarhuis et al., 2017). 
Since cohesin is known to limit local chromatin dynamics (Nozaki et al., 2017), it has been 
suggested that local chromatin compaction globally limits long-range chromatin contacts and 
therefore reinforces active and repressed genome partitioning (Haarhuis et al., 2017; 
Schwarzer et al., 2017). Strikingly, the reciprocal experiment of restricting cohesin removal 
from chromatin revealed the inverse outcome resulting in a reduction of far-cis chromatin 
contacts, further supporting this hypothesis (Haarhuis et al., 2017). Thus, our results suggest 
that NoRC contributes to local chromatin compaction and thereby limits far-cis contacts in 
ground state ESCs. Chromatin of ESC+serum by contrast, generally contains more 
condensed chromatin structures at the level of nucleosomes (Ricci et al., 2015). 
Consequently, primed ESCs might be less dependent on factors that additionally limit 
chromatin dynamics and flexibility, explaining why ESC+serum are less dependent on NoRC 
than ground state ESC+2i. Considering that expression of TIP5 and its genomic occupancy 
were similar between ESC+2i and ESC+serum, the results imply that NoRC function might be 
determined by the state of its substrate (i.e. chromatin), rather than NoRC itself. How NoRC 
mechanistically controls local chromatin dynamics remains elusive and will be an aim of our 
future investigations.  
The ground state-specific role of TIP5 could be recapitulated by depleting or chemically 
inactivating TOP2A in ESC+2i and ESC+serum. Besides controlling the expression of TIP5-
regulated genes, TOP2A was also required for correct H3K27me3 occupancy in ESC+2i 
without any detectable influence in ESC+serum. While cohesin and its contribution to 3D 
genome organization into TADs has been extensively studied in recent years (Rao et al., 
2017; Schwarzer et al., 2017), the role of topoisomerases in regulating chromatin structures 
and genome architecture in mammalian cells remained under-investigated. Previous analyses 
of TOP2A in ESC+serum revealed an association with active regions that correlate poorly 
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with H3K27me3 (Dykhuizen et al., 2013; Thakurela et al., 2013), a binding profile that is 
similar to TIP5 genome occupancy found in our analyses. Unfortunately, due to the 
discontinuation of validated high-grade ChIP TOP2a antibodies (Naughton et al., 2013; 
Thakurela et al., 2013) we have been unable to measure TOP2A genome occupancy in 
ESC+2i. Computational modeling studies proposed an active role of topoisomerases and 
supercoiling in shaping the 3D genome structures (Benedetti et al., 2014a; Benedetti et al., 
2014b). Accordingly, recent data indicated that transcription-induced supercoiling might act as 
the driving force of chromatin loop extrusion during the formation of TADs in interphase 
chromosomes (Racko et al., 2017). Moreover, TOP2B was found to associate with CTCF at 
TAD borders and was suggested to resolve torsional stress leading to the stable association 
of cohesin at TAD boundaries (Uuskula-Reimand et al., 2016). Of note is that inhibition of 
TOP2 activities or depletion of TOP2A or SMC3 resulted in similar changes in gene 
expression (upregulation or downregulation) as observed upon TIP5 KD in ESC+2i. These 
results point to a role of NoRC that, particularly in cooperation with TOP2A, might have a 
major function in shaping 3D genome architecture instead of directly acting as activator or 
repressor on gene expression.  
The role of NoRC in genome architecture is further strengthened by the fact that TIP5 binds 
to large and active chromatin regions (type A compartment) and that its occupancy does not 
correlate with TIP5-regulated genes. We would like to further emphasize that the changes in 
gene expression and H3K27me3 do not seem to be directly coupled. Although differentially 
expressed genes were enriched in H3K27me3, TIP5 depletion in Eed and Ring1b KO in 
ESC+2i highly recapitulated gene expression changes observed in TIP5-depleted wt ESC+2i. 
Instead it seems that changes in gene expression and H3K27me3 content are two 
independent read outs of altered chromatin structures triggered by TIP5 depletion. 
Remarkably, genes affected by TIP5 knockdown are also often differentially expressed in 
ESC+2i and ESC+serum, suggesting that transcription of these genes – so far for unknown 
reasons – are in general more sensitive to changes in chromatin structures in ESCs.  
The switch of NoRC function between ground state and primed ESCs suggests that NoRC 
action is highly dependent on the developmental and chromatin state of the cells. A change of 
NoRC function was also previously reported during the transition from pluripotency toward 
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differentiation and between normal and cancer cells. In somatic and healthy cells, TIP5 is 
exclusively localized within the nucleolus, the compartment where rRNA genes reside, and 
represses their transcription (Guetg et al., 2012; Santoro et al., 2002). By contrast, in both 
ground state and primed ESCs, the binding of TIP5 to rRNA genes and its nucleolar 
localization are impaired (this work and (Leone et al., 2017; Savic et al., 2014)). Similarly to 
ESCs, in metastatic prostate cancer (PCa) cells TIP5 is abundantly present in the 
nucleoplasm and regulates genes involved in developmental processes and frequently 
repressed in metastatic PCa (Gu et al., 2015b). Considering that cancer cells often acquire 
stem cell-like features, it is likely that NoRC uses similar mechanisms to regulate ESCs and 
cancer cells, a working hypothesis that is currently under investigation in our lab. 
Our study showed the different responses triggered by loss of chromatin regulators between 
such closely related cell types (ground state and primed ESCs). These results suggest that 
the global shaping of chromatin is a fundamental player for gene regulation and chromatin 
states and highlight different degrees of genome plasticity during the early phases of 
development. 
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Materials and Method 
Cell culture 
One hundred and twenty-nine mouse embryonic stem cells (E14 line) were cultured in either 
2i media composed of DMEM-F12 and Neurobasal medium (1:1, Life Technologies), 
supplemented with 1× N2/B27 (Life Technologies), 1× penicillin/streptomycin/l-glutamine (Life 
Technologies), 50 µM β-mercaptoethanol (Life Technologies), recombinant leukemia 
inhibitory factor, LIF (Polygene, 1,000 U/ml) and MEK and GSK3β inhibitors, 2i (Sigma 
CHIR99021 and PD0325901, 3 and 1 µM, respectively) or in serum medium containing 
DMEM (Life Technologies), 15% FCS, 1× MEM NEAA, 100 µM β-mercaptoethanol, 1× 
penicillin/streptomycin (Life Technologies). ESCs were seeded at a density of 50,000 
cells/cm2 in culture dishes (Corning® CellBIND® surface) coated with 0.1% gelatin without 
feeder layer. Propagation of cells was carried out every 2 days using enzymatic cell 
dissociation.  
ESCs were differentiated by culturing for 48–72h in complete medium: DMEM, 10% FCS, 1 
mM sodium pyruvate (Sigma), 1× NEAA (Life Technologies), 1× penicillin/streptomycin/l-
glutamine, 100 µM β-mercaptoethanol on 0.1% gelatin-coated culture dishes. 
Differentiation toward neural progenitor cells (NPCs) was obtained according to previously 
established protocol (Bibel et al., 2004). In brief, differentiation employed a suspension-based 
embryoid bodies formation (Bacteriological Petri Dishes, Bio-one with vents, Greiner®) in 
neural differentiation media (DMEM, 10% FCS, 1× MEM NEAA, 1× penicillin/streptomycin/l-
glutamine, 100 µM β-mercaptoethanol). During the 8-day differentiation procedure, media 
were exchanged every 2 days. In the last 4 days of differentiation, the media were 
supplemented with 2µM retinoic acid (RA) to generate neuronal precursors. DNMT-TKO 
ESCs were kindly provided by M. Okano (Tsumura et al., 2006). Eed-KO and Ring1b-KO 
ESC+2i were a gift from C. Ciaudo (ETH, Zurich). 
 
Transfections 
ESCs were transfected with the indicated siRNAs (50 nM siRNA) using Lipofectamine® 
RNAiMAX (Life Technologies) in Opti-MEM® GlutaMAX™ (Life Technologies) reduced-serum 
medium. ESCs were seeded 2h prior to siRNA transfection and collected 3 days post 
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transfection if not stated differently. For analysis of differentiation potential of TIP5-depleted 
ESCs, transfected cells were re-seeded at equal cell numbers into complete differentiation 
medium 48h post transfection. Survival of differentiated cells was assessed 72h later. 
Efficiencies of siRNA-mediated depletions were monitored by qRT–PCR 3 days post-
transfection. 
 
Alkaline phosphatase (AP) staining 
Cells were fixed in 4% paraformaldehyde for 10 min, washed with AP buffer (100 mM Tris-Cl 
pH 9.5, 100 mM NaCl, 50 mM MgCl2), and then incubated for 5–10 min in BCIP®/NBT liquid 
substrate system (Sigma). The reaction was blocked with 10 mM Tris and 1 mM EDTA for 10 
min. 
 
ICRF-193 treatment 
ESCs were seeded 24h prior to treatment. ICRF-193 was added directly to the medium to 
final concentration of 500nM, as it has previously been reported for ESCs (Thakurela et al., 
2013). Cells were harvested for respective experiments after 24h of inhibitor treatment.  
 
RNA extraction, reverse transcription, and quantitative PCR (RT–qPCR) 
RNA was purified with TRIzol reagent (Life Technologies). 1µg total RNA was primed with 
random hexamers and reverse-transcribed into cDNA using MultiScribe™ Reverse 
Transcriptase (Life Technologies). Amplification of samples without reverse transcriptase 
assured absence of genomic or plasmid DNA (data not shown). The relative transcription 
levels were determined by normalization to Rps12 or beta-Actin mRNA levels, as indicated. 
qRT–PCR was performed with KAPA SYBR® FAST (Sigma) on a Rotor-Gene Q (Qiagen). 
Primer sequences are listed in Supplementary Table 4. 
 
Chromatin fractionation 
ESCs were collected by trypsinization, washed once with PBS and counted. ES cell pellets 
were resuspended at a concentration of 10mio cells/ml in chromatin fractionation buffer 
(10mM Hepes pH 7.6, 150mM NaCl, 3mM MgCl2, 0.5% Triton X-100, 1mM DTT freshly 
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supplemented with cOmplete™ Protease Inhibitor Cocktail (Roche)) and incubated for 30 
minutes at room temperature rotating. Precipitated chromatin was fractionated by 
centrifugation. Total and chromatin fractionated samples were further processed by MNase 
(S7 Micrococcal nuclease, Roche) digest for ensuring sufficient genomic DNA fragmentation. 
All samples were incubated in 1x Laemmli buffer (10% glycerol, 10mM Tris pH 6.8, 2% SDS, 
0.1mg/ml bromphenolblue, 2% β-mercaptoethanol) at 95°C for 5 minutes and were further 
analyzed by Western Blotting.  
 
Generation of FLAG/HA-TIP5 ES cell line by CRISPR/Cas9 
CRISPR/Cas9 cloning and targeting strategy was performed as previously described (Ran et 
al., 2013). sgRNA guide sequence (GTCGTTTGCCTCCATTTCTGT) was chosen to target 
the TIP5 locus on exon 3 three base pairs upstream of the ATG start codon and was cloned 
into pSpCas9(BB)-2A-GFP (PX458, Addgene). This plasmid was co-transfected with the HDR 
repair template plasmid containing the FLAG/HA inclusion flanked by 1kb homology arms into 
wild type ESCs at a molar ratio of 1:3. After two days, positively transfected cells were 
selected for GFP expression and were then further cultured for additional three days. 
Subsequently, ESCs were seeded for single cell clone isolation. Derived clones were 
genotyped by PCR using two different primer pairs. One PCR aimed to identify site-specific 
FLAG-HA inclusion, while the other PCR allowed distinguishing between inclusions in one or 
both alleles (as illustrated in Supplementary Fig.S4). The integrity of the FLAG-HA inclusion 
was verified by cloning the exon 3 sequences into CloneJET PCR cloning kit (Thermo 
Scientific) and by Sanger sequencing (Microsynth).  
 
Chromatin immunoprecipitation and mass spectrometric analyses 
Approximately 108 ESCs were collected by scraping followed by washing with PBS. Nuclei 
were isolated by re-suspending the cells in two consecutive rounds in hypotonic buffer (10mM 
Hepes pH 7.6, 1.5mM MgCl2, 10mM KCl, 2mM Na3VO4 freshly supplemented with cOmplete™ 
Protease Inhibitor Cocktail (Roche)). The suspension was passed through a douncer 
homogenizer with a loose pestle 10-20 times and the purity of nuclei was checked under a 
microscope. The chromatin was then isolated and crosslinked by resuspending the nuclei in 
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the chromatin fractionation/crosslinking buffer (10mM Hepes pH 7.6, 3mM MgCl2, 150mM 
NaCl, 0.5% Triton X-100, 0.5mM dithiobis[succinimidylpropionate] (DSP, Thermo Scientific),  
2mM Na3VO4 supplemented with cOmplete™ Protease Inhibitor Cocktail (Roche)) and rotation 
at room temperature for 30min. The crosslinking was stopped by the addition of 25mM Tris 
HCl pH 7.5. The chromatin was then isolated by centrifugation and washed twice in MNase 
digestion buffer (0.3M Sucrose, 50mM Tris pH 7.5, 30mM KCl, 7.5mM NaCl, 4mM MgCl2, 
1mM CaCl2, 0.125% NP-40, 0.25% NaDeoxycholate, 2mM Na3VO4 supplemented with 
cOmplete™ Protease Inhibitor Cocktail (Roche)). Digestion of chromatin into 
mononucleosomes was assured by digestion with 100U MNase (Roche) in MNase digestion 
buffer at 37°C for 1h. SDS was then added to a final concentration of 1% followed by a 3x 
30sec sonication steps with a bioruptor sonicator (Diagenode). Insoluble precipitates were 
removed by centrifugation and soluble crosslinked chromatin extracts were diluted 10x in IP 
buffer (0.3M Sucrose, 50mM Tris pH 7.5, 30mM KCl, 300mM NaCl, 4mM MgCl2, 1mM CaCl2, 
0.125% NP-40, 0.25% NaDeoxycholate, 2mM Na3VO4 supplemented with cOmplete™ 
Protease Inhibitor Cocktail (Roche)) and 30µl ANTI-FLAG M2 Affinity Gel (Sigma) were 
added to the extracts. Binding of FLAG/HA-TIP5 was performed by incubation over night at 
4°C while rotating. The beads were subsequently washed five times in wash buffer (20mM 
Tris pH 7.5, 20% glycerol, 100mM KCl, 300mM NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.125% 
NP40, 0.25% NaDeoxycholate, 2mM Na3VO4 supplemented with cOmplete™ Protease 
Inhibitor Cocktail (Roche)). Purified complexes were then eluted with 2mM FLAG peptide 
(Sigma) in TBS buffer (50mM Tris-HCl pH 8.0, 150mM NaCl). Eluted proteins were 
precipitated with the addition of 0.25x volume of 100% trichloric acid (Sigma). Protein pellets 
were washed five times with cold Acetone (Merck) and submitted for subsequent mass 
spectrometric analyses by the Functional Genomics Center Zurich (FGCZ). The dry pellets 
were dissolved in 45 µl buffer (10 mM Tris + 2 mM CaCl2, pH 8.2) and 5 µl of trypsin (100 
ng/µl in 10 mM HCl) for digestion, which was carried out in a microwave instrument (Discover 
System, CEM) for 30 min at 5 W and 60 °C. Samples were dried in a SpeedVac (Savant). For 
LC-MS/MS analysis the samples were dissolved in 0.1% formic acid (Romil)) and an aliquot 
ranging from 5 to 25% was analyzed on a nanoAcquity UPLC (Waters Inc.) connected to a Q 
Exactive mass spectrometer (Thermo Scientific) equipped with a Digital PicoView source 
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(New Objective). Peptides were trapped on a Symmetry C18 trap column (5 µm, 180 µm x 20 
mm, Waters Inc.) and separated on a BEH300 C18 column (1.7 µm, 75 µm x 150 m, Waters 
Inc.) at a flow rate of 250 nl/min using a gradient from 1% solvent B (0.1% formic acid in 
acetonitrile, Romil)/99% solvent A (0.1% formic acid in water, Romil) to 40% solvent B/60% 
solvent A within 90 min. Mass spectrometer settings were: Data dependent analysis. 
Precursor scan range 350 – 1500 m/z, resolution 70’000, maximum injection time 100 ms, 
threshold 3e6. Fragment ion scan range 200 – 2000 m/z, Resolution 35’000, maximum 
injection time 120 ms, threshold 1e5. Proteins were identified using the Mascot search engine 
(Matrix Science, version 2.4.1). Mascot was set up to search the SwissProt database 
assuming the digestion enzyme trypsin. Mascot was searched with a fragment ion mass 
tolerance of 0.030 Da and a parent ion tolerance of 10.0 PPM. Oxidation of methionine was 
specified in Mascot as a variable modification. Scaffold (Proteome Software Inc.) was used to 
validate MS/MS based peptide and protein identifications. Peptide identifications were 
accepted if they achieved a false discovery rate (FDR) of less than 0.1% by the Scaffold 
Local FDR algorithm. Protein identifications were accepted if they achieved an FDR of less 
than 1.0% and contained at least 2 identified peptides.  
 
Chromatin immunoprecipitation (ChIP) 
ChIP analysis was performed as previously described (Leone et al., 2017). Briefly, 1% 
formaldehyde was added to cultured cells to cross-link proteins to DNA. For histone ChIPs, 
isolated nuclei were then lysed and sonicated using a Bioruptor ultrasonic cell disruptor 
(Diagenode) to shear genomic DNA to an average fragment size of 200 bp. 20 µg of 
chromatin was diluted to a total volume of 500 µl with ChIP buffer (16.7 mM Tris–HCl, pH 8.1, 
167 mM NaCl, 1.2 mM EDTA, 0.01% SDS, 1.1% Triton X-100) and pre-cleared with 10 µl 
packed Sepharose beads for 2 h at 4°C. Pre-cleared chromatin was incubated overnight with 
the indicated antibodies. The next day, Dynabeads protein-A (or -G, Millipore) were added 
and incubated for 4 h at 4°C. After washing, bound chromatin was eluted with the elution 
buffer (1% SDS, 100 mM NaHCO3). Upon proteinase K digestion (50°C for 3 h) and reversion 
of cross-linking (65°C, overnight), DNA was purified with phenol/chloroform, ethanol 
precipitated and quantified by qPCR using the primers listed in Supplementary Table 4. 
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For TIP5 ChIPs, we noticed that sonication of formaldehyde-crosslinked chromatin induced 
degradation of TIP5 (data not shown). Therefore, to increase the efficiency of TIP5 ChIPseq, 
we fragmented crosslinked chromatin into mono-nucleosomes through digestion with MNase. 
Briefly, isolated and crosslinked nuclei were MNase digested in 400µl MNase digestion buffer 
(0.3M Sucrose, 50mM Tris pH 7.5, 30mM KCl, 7.5mM NaCl, 4mM MgCl2, 1mM CaCl2, 
0.125% NP-40, 0.25% NaDeoxycholate, 2mM Na3VO4 supplemented with cOmplete™ 
Protease Inhibitor Cocktail (Roche)) with 100U MNase (Roche) at 37°C for 1h. The digestion 
was then stopped with 5mM EDTA and the digested chromatin was solubilized in 1% SDS 
and three pulses of 30sec sonication using a Bioruptor ultrasonic cell disruptor (Diagenode). 
200µg of pre-cleared chromatin was immunopurified with incubation of 30µl of Anti-FLAG M2 
Affinity Gel (Sigma) or 30µl Anti-HA magnetic beads (Pierce) over night. The samples were 
subsequently washed, eluted and the DNA was purified as for histone ChIPs. ChIP-qPCR 
measurements were performed with KAPA SYBR® FAST (Sigma) on a Rotor-Gene Q 
(Qiagen) always comparing enrichments over input samples. Primer sequences are listed in 
Supplementary Table 4.  
For ChIPseq analyses, the quantity and quality of the isolated DNA was determined with a 
Qubit® (1.0) Fluorometer (Life Technologies, California, USA) and a Bioanalyzer 2100 
(Agilent, Waldbronn, Germany). The Nugen Ovation Ultra Low Library Systems (Nugen, 
Inc, California, USA) was used in the following steps. Briefly, ChIP samples (1 ng) was end-
repaired and polyadenylated before the ligation of Illumina compatible adapters. The adapters 
contain the index for multiplexing. The quality and quantity of the enriched libraries were 
validated using Qubit® (1.0) Fluorometer and the Bioanalyzer 2100 (Agilent, Waldbronn, 
Germany). The libraries were normalized to 10nM in Tris-Cl 10 mM, pH8.5 with 0.1% 
Tween 20. The TruSeq SR Cluster Kit v4-cBot-HS (Illumina, Inc, California, USA) was used 
for cluster generation using 8 pM of pooled normalized libraries on the cBOT. Sequencing 
was performed on the Illumina HiSeq 2500 single end 126 bp using the TruSeq SBS Kit v4-
HS (Illumina, Inc, California, USA). 
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ChIPseq data analysis 
Own and published ChIPseq reads were aligned to the mouse mm10 reference genome 
using Bowtie2 (version 2.2.5; (Langmead and Salzberg, 2012)). Read counts were computed 
and normalized using “bamCoverage” from deepTools (version 2.0.1; (Ramirez et al., 2014)) 
using a bin size of 50bp. deepTools was also further used to generate all heat maps, profiles 
and pearson correlation plots. TIP5 bound regions were defined using SICER (version 1.1; 
(Zang et al., 2009)) by comparing the FLAG ChIPs of tagged vs non-tagged TIP5 ESCs in 2i 
and serum using the following arguments: W=1000 G=3000 FDR=0.00001. These analyses 
revealed 8824 and 7221 TIP5-bound regions in 2i and serum ESCs, respectively. Highly 
similar results were obtained by defining TIP5 bound regions comparing the FLAG ChIPs to 
the input samples, excluding strong biases of the FLAG antibody.  
CTCF ChIPseq data sets in 2i and serum ESCs were taken from (Jonathan A. Beagan, 
2017). CTCF peaks were defined using MACS2 (version 2.1.0; (Zhang et al., 2008)) 
comparing the CTCF ChIPseq to its respective input sample with a qValue cutoff of 0.0001. 
Using these parameters 56218 and 47245 CTCF peaks were defined in 2i and serum ESCs, 
respectively. The ratio of mean H3K27me3 read counts 2.5kb upstream and downstream of 
each CTCF peak were calculated and served as “insulation scores”. H3K27me3-insulated 
CTCF peaks were defined with an insulation score of >2 or <0.5. Regions with an overall 
average of less than 0.3 normalized read counts were excluded. This filtering resulted in 7547 
CTCF peaks (13.4% of all CTCF peaks) and 8448 peaks (17.9% of all CTCF peaks) that 
were H3K27me3-insulated in 2i and serum ESCs, respectively. The accuracy of these 
calculations was confirmed by plotting published H3K27me3 ChIPseq data sets from wild 
type 2i and serum ESCs (Marks et al., 2012) over these H3K27me3-insulating CTCF peaks 
revealing highly similar results (data not shown). Pearson correlation plots were generated 
using deepTools (version 2.0.1). After removal of blacklist regions, chromosome 19 was 
partitioned into 1kb windows and correlation plots were computed with indicated data sets. 
H3K36me3 (GSM590119), H3K9me3 (GSM850407) (Marks et al., 2012) and H3K4me1 
(GSM1856424) (Joshi et al., 2015) were taken from published ChIPseq data sets of ESCs in 
2i. For data analysis over transcribed regions, genomic coordinates from all refseq transcripts 
were retrieved from Ensembl biomart. After removal of blacklist regions, normalized ChIPseq 
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data sets were plotted either over +/- 5kb from the TSS or over the entire transcribed region 
by scaling the gene length to 20kb (+5kb from TES and -5kb from the TSS). For 
distinguishing H3K27me3-high and H3K27me3-low promoters, mean read counts +/- 5kb 
from each TSS were computed. The first quartile was termed as H3K27me3-high, while 
quartiles 2-4 were defined as H3K27me3-low. TIP5-bound genes were defined by an overlap 
of a TIP5-bound region with the transcribed regions of the respective gene using bedtools 
(version 2.24.0; (Quinlan and Hall, 2010)). Conversion of mm9 and mm10 data sets was 
performed using Crossmap (version 0.2.4; (Zhao et al., 2014)). Integrative Genome Viewer 
(IGV, version 2.3.92) (Robinson et al., 2011) was used to visualize and extract representative 
ChIPseq tracks. 
 
RNAseq and data analysis 
Total RNA from three independent siRNA-mediated TIP5 knockdown experiments was 
purified with TRIzol reagent (Life Technologies) as stated above. In order to remove DNA 
contaminants, the samples were treated with 1U DNaseI (Thermo Scientific) for 1h at 37°C 
and the RNA samples were re-purified using TRIzol. The quality of the isolated RNA was 
determined with a Qubit® (1.0) Fluorometer (Life Technologies, California, USA) and a 
Bioanalyzer 2100 (Agilent, Waldbronn, Germany). Only those samples with a 260 nm/280 nm 
ratio between 1.8–2.1 and a 28S/18S ratio within 1.5–2 were further processed. The TruSeq 
RNA Sample Prep Kit v2 (Illumina, Inc, California, USA) was used in the succeeding steps. 
Briefly, total RNA samples (100-1000 ng) were poly A enriched and then reverse-transcribed 
into double-stranded cDNA. The cDNA samples was fragmented, end-repaired and 
polyadenylated before ligation of TruSeq adapters containing the index for multiplexing 
Fragments containing TruSeq adapters on both ends were selectively enriched with PCR. 
The quality and quantity of the enriched libraries were validated using Qubit® (1.0) 
Fluorometer and the Caliper GX LabChip® GX (Caliper Life Sciences, Inc., USA). The 
product is a smear with an average fragment size of approximately 260 bp. The libraries 
were normalized to 10nM in Tris-Cl 10 mM, pH8.5 with 0.1% Tween 20. The TruSeq SR 
Cluster Kit HS4000 (Illumina, Inc, California, USA) was used for cluster generation using 10 
pM of pooled normalized libraries on the cBOT. Sequencing was performed on the Illumina 
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HiSeq 4000 single end 100 bp using the TruSeq SBS Kit HS4000 (Illumina, Inc, California, 
USA). Reads were aligned to the reference genome (ensembl version 82) with Subread 
(i.e. subjunc, version 1.4.6-p4; (Liao et al., 2013)) allowing up to 16 alignments per read 
(options: –trim5 10 –trim3 15 -n 20 -m 5 -B 16 -H –allJunctions). Count tables were generated 
with Rcount (Schmid and Grossniklaus, 2015) with an allocation distance of 100 bp for 
calculating the weights of the reads with multiple alignments, considering the strand 
information, and a minimal number of 5 hits. Variation in gene expression was analyzed with 
a general linear model in R with the package edgeR (version 3.12.0; (Robinson and Oshlack, 
2010)) according to a crossed factorial design with two explanatory factors (i) siRNA against 
Tip5 and a mock sequence and (ii) ESCs grown in 2i or serum. Genes differentially 
expressed between specific conditions were identified with linear contrasts using trended 
dispersion estimates and Benjamini-Hochberg multiple testing corrections. Genes with a P-
value below 0.05 and a minimal fold change of 1.5 were considered to be differentially 
expressed. These thresholds have previously been used characterizing chromatin remodeler 
functions (de Dieuleveult et al., 2016). Gene ontology analysis was performed with David 
Bionformatics Resource 6.8 (Huang et al., 2009). 
 
HiC and data analysis 
HiC experiments were performed in triplicates of ESC+2i treated with siRNA-control or 
siRNA-TIP5. Five million cells were pelleted and resuspended in PBS-10%FCS. PBS-
10%FCS-4% formaldehyde was added to a final concentration of 2% formaldehyde (v/v). 
Samples were incubated at room temperature for 10 minutes with mixing. Ice-cold glycine 
solution was added to a final concentration of 0.2M and immediately centrifuged for 5 minutes 
at 300xg at 4°C. Cells were washed in 1 ml of ice-cold PBS. Pellet was flash-frozen in liquid 
nitrogen. Pellet was taken up and washed in 1 ml ice cold lysis buffer1, resupended again in 1 
ml of ice cold lysis buffer and incubated for 30 minutes at 4°C.  Sample was pelleted and 
washed in 0.5 ml 1.2x DpnII buffer, resuspended in 0.5 ml of DpnII buffer again and moved to 
a thermomixer at 37°C and 300 rpm. SDS was then carefully added to a concentration of 
0.3%, slowly suspended with a pipet and incubated for an hour. Triton X-100 was added to a 
concentration of 2.6% and sample was incubated for another hour. To digest the sample, 200 
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units of DpnII enzyme were added for a 4 hour incubation in a thermomixer at 37°C and 900 
rpm; another 200 units of DpnII were added for overnight incubation. From here on, we 
adopted the protocol described in (Rao et al., 2014) with some adjustments Cells were 
incubated for 20 minutes at 65°C to heat inactivate DpnII, pelleted and 300 µl of fill-in 
mastermix was added (218 µl of MilliQ, 30 µl of 10x NEB buffer 2, 15 µl of 10mM dCTP, 15 µl 
of 10mM dGTP, 15 µl of 10mM dTTP, 37.5 µl of 0.4mM biotin-14-dATP (Life Technologies, 
19524-016), 10 µl of 5U/µl DNA Polymerase I, Large (Klenow) Fragment (NEB, M0210)). 
Sample was mixed by pipetting and incubated for 60 minutes at 37°C shaking at 300 rpm and 
placed at 4°C afterwards. 900 µl of ligation mix was added (120 µl 10x ligase buffer, 50 units 
of T4 ligase (Roche) and 770 µl MilliQ) and mixed by inverting and incubated overnight at 
16°C. Sample was pelleted for 5 minutes at 1000 x g and taken up in 500 µl 10 mM Tris. 
Protein was degraded by adding 50 µl of 20mg/ml proteinase K (NEB, P8102), 50 µl of 10% 
SDS and incubated at 55°C for 30 minutes. 57 µl of 5M of sodium chloride was then added 
and the sample was incubated at 68°C overnight or for at least 1.5 hours. Samples were 
cooled to room temperature and DNA was purified using NucleoMag P-Beads and taken up in 
5mM Tris pH7.5. Samples were sheared to a size of 300-500 bp using a Covaris S2 focused-
ultrasonicator. From here on, the protocol described in (Rao et al., 2014) was adopted. 
FastQ files were mapped to the mouse genome (mm10) using bwa-mem (Li and Durbin, 
2010) and filtered and deduplicated using HiCUP v0.5.10 (Wingett et al., 2015). 
Chromosomal interaction matrices were generated using Juicer (Durand et al., 2016) at 500 
Kb resolution and normalized by Knight and Ruiz’s matrix balancing algorithm. Biological 
replicates were first processed independently and inspected for clustering between TIP5 
depletion and control conditions by PCA. Next, replicates per condition were pooled to create 
merged contact maps that were used in the downstream analyses. 
To visualize the impact of Tip5 knockdown in chromosomal architecture, we plotted the 
median contact frequency from each genomic region at increasing genomic 
distance. ENCODE Data Analysis Consortium Blacklisted Regions (Hoffman et al., 2013) 
were excluded from the analysis. 
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Public Datasets Used in This Study 
Public datasets used in this study are listed in Table 4. 
 
Accession numbers 
All raw data generated in this study using high throughput sequencing are accessible through 
NCBI’s GEO (accession number GSE112222). 
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Figure legends 
Figure 1 
TIP5 is required for proliferation and differentiation of ESC+2i 
A. TIP5 expression is higher in ESC+2i than in differentiated cells (neural progenitors, NPC). 
Left panel. TIP5 mRNA levels were measured by qRT-PCR and normalized to Rps12 mRNA 
and to ESC+2i. Average values of three independent experiments. Error bars represent s.d. 
Right panel. Western blot showing TIP5 protein levels in ESC+2i and NPC. Tubulin is shown 
as a protein loading control. 
B. TIP5 associates with chromatin of ESC and NPC. Chromatin-bound (Chrom.) and soluble 
(Sol.) fractions of equivalent cell number of ESC+2i and NPCs were analyzed by western blot 
for TIP5 levels. Tot., total protein. Tubulin and histones are shown as loading and 
fractionation control. 
C. TIP5 is expressed at similar levels in both ESC+2i and ESC+serum. Left panel. TIP5 
mRNA levels were measured by qRT-PCR and normalized to Rps12 mRNA and to ESC+2i. 
Average values of three independent experiments. Error bars represent s.d.. Right panel. 
Western blot showing TIP5 protein levels in ESC+2i and ESC+serum. SNF2H is shown as a 
protein loading control. 
D. siRNA-knockdown efficiency of TIP5 shown by qRT-PCR and western blot. TIP5 mRNA 
levels were measured by qRT-PCR and normalized to Rps12 mRNA and to each ESC line. 
Average values of three independent experiments. Error bars represent s.d. Right panel. 
Western blot showing TIP5 protein levels. Tubulin is shown as a protein loading control. 
E. TIP5 knockdown affects proliferation of ESC+2i but not of ESC+serum. Data represent 
relative cell numbers after 3 days of siRNA treatment and were normalized to ESC 
transfected with siRNA-Control. Average values of three independent experiments. Error bars 
represent s.d. Statistical significance (P-values) for the experiments was calculated using the 
paired two-tailed t-test (** < 0.01; ns, non-significant). 
F. TIP5 is required for the differentiation of ESC+2i but not of ESC+serum. Representative 
images of alkaline phosphatase staining of ESC and cells after 3 days of differentiation.  
G. Quantification of differentiated cells. Values represent relative number of differentiated 
cells from three independent experiments relative to control cells. 
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Figure 2 
TIP5 regulates expression of bivalent genes in ESC+2i 
A. Volcano plot showing fold change (log2 values) in transcript level of ESC+2i and 
ESC+serum upon TIP5 knockdown. Gene expression values of three replicates were 
averaged and selected for 1.5 fold changes and P <0.05.  
B. Top 10 biological process gene ontology terms as determined using DAVID for genes 
regulated by TIP5 in ESC+2i and ESC+serum.  
C. Left panel. Heat map profiles of H3K4me3 and H3K27me3 at ±5 kb from the TSS of genes 
differentially regulated by TIP5 in ESC+2i and random genes. Differentially regulated genes 
are shown as upregulated or downregulated in ESC+2i upon TIP5 knockdown. Data were 
ranked by H3K27me3 levels. Right panel. Average density profiles of H3K4me3, H3K27me3 
and H3K36me3 at genes upregulated or downregulated in ESC+2i upon TIP5 knockdown 
and random genes. Transcription start site (TSS), transcription end site (TES). 
D. Example of transcription levels and H3K4me3 and H3K27me3 occupancy at a bivalent 
gene upregulated (Efnb2) and downregulated (Rasip1) upon TIP5 knockdown in ESC+2i but 
not in ESC+serum. 
E. Genes regulated by TIP5 in ESC+2i are expressed at low level. Transcription levels are 
expressed as normalized RPKM. Box plot with median bar, first-third quartile box and 5th–
95th percentile whiskers. (*** <0.001, two-tailed t-test.) 
F. Validation by qRT-PCR of genes regulated by TIP5 in ESC+2i but not in ESC+serum. 
Nanog, Rex1 and Actin B (ActB) are shown as genes not regulated by TIP5. mRNA levels 
were normalized to Rps12 mRNA and to ESCs transfected with siRNA-Control. Average 
values of three independent experiments. Error bars represent s.d.  
 
Figure 3 
TIP5 regulates H3K27me3 occupancy in ESC+2i 
A. Western blot showing total levels of H3K27me3, H3K27ac and H3K4me3 in ESC+2i 
transfected with siRNA-control and siRNA-Tip5. Histone H3 is shown as a protein loading 
control. 
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B. Average density plot of ChIPseq read counts of H3K4me3, H3K27ac and H3K27me3 at -/+ 
5 kb from the TSS of refseq genes in ESCs treated with siRNA-control or siRNA-Tip5. Q1: 
first quartile corresponding to sequences with high H3K27me3 content. Q2-4: quartiles 2-4 
corresponding to sequences with low H3K27me3 content. 
C. ChIP-qPCR of H3K27me3 in ESC+2i and ESC+serum treated with siRNA-control or 
siRNA-Tip5. Data were measured by qPCR and normalized to input and to Tshz1 value in 
control cells. Control represents an intergenic sequence that does not contain H3K27me3. 
Average values of three independent experiments. Error bars represent s.d. 
D. Average density and heatmap profile of H3K27me3 transition state regions marked by 
CTCF sites in ESC+2i or ESC+serum transfected with siRNA-control or siRNA-Tip5. Data 
were ranked by H3K27me3 content in the corresponding siRNA-control ESCs. Cluster 1 
represents high to low H327me3 transition whereas Cluster 2 shows low to high H3K27me3 
levels. 
E. H3K27me3 ChIP-qPCR in ESC+2i (top panel) or ESC+serum (bottom panel) transfected 
with siRNA-control or siRNA-Tip5. Values show H3K27me3 occupancy at four sequences 
(#1-#4) with elevated H3K27me3 at CTCF boundary (H3K27me3hi/CTCF). Data were 
measured by qPCR and normalized to input and to sequence #1 value in control cells. 
Average values of three independent experiments. Error bars represent s.d. 
 
Figure 4 
TIP5 associates with large and active chromatin domains in ESC+2i and ESC+serum 
A. Western blot showing equal TIP5 levels in wt-ESC and F/H-TIP5 ESC line containing 
FLAG-HA sequences at the N-terminus of both Tip5 alleles. Whole cell lysates from 
equivalent amounts of cells were analysed. SNF2H and Tubulin are shown as protein loading 
controls. 
B. Representative images showing the association of TIP5 at regions enriched in H3K27ac 
and low in H3K27me3. The grey rectangles highlighted some of TIP5 associated regions. The 
data also show the decrease of H3K27me3 levels in ESC+2i upon TIP5 knockdown at 
regions not bound by TIP5. 
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C. Boxplot showing the mean of normalized TIP5 occupancies in ESC+2i and ESC+serum at 
TIP5-bound regions. Statistical significance (P-values) for the experiments was calculated 
using the unpaired two-tailed t-test (**** < 0.0001). 
D. Anti-FLAG ChIP of wt-ESCs and F/H-TIP5-ESCs cultured in 2i or serum. Data were 
measured by qPCR and normalized to input and a control region that is not bound by TIP5. 
Average values of three independent experiments. Error bars represent s.d. 
E. Pearson correlation heat map for the indicated ChIPseqs. TIP5 ChIPseqs were performed 
with FLAG antibodies in F/H-TIP5-ESCs cultured in 2i or serum and with HA antibodies in 
F/H-TIP5-ESC+2i. Data of H3K4me3, H3K27ac and H3K27me3 are from this work. 
H3K36me3, H3K9me3 and H3K4me1 values in ESC+2i were taken from published data sets 
(Joshi et al., 2015; Marks et al., 2012). 
F. Average density profiles of ChIPseq read counts of H3K4me3, H3K27ac and H3K27me3 in 
ESCs at -/+ 5 kb from the TSS of genes bound by TIP5 and random genes.  
G. Average density profiles of H3K4me3, H3K27ac and H3K27me3 at TIP5 bound refseq 
genes in ESCs treated with siRNA-control or siRNA-Tip5. 
 
Figure 5 
TIP5 associates with TOP2A and component of the cohesin complex on chromatin. 
A. Scheme representing the strategy used to identify protein interacting with TIP5 on 
chromatin (Chromatin-IP). 
B. TIP5-interacting proteins on chromatin. Mass spectrometry analysis of FLAG 
immunoprecipitates from wt and F/H-TIP5 ESC+2i. Values of peptide number are shown as 
the difference between peptides obtained in FLAG-IP of F/H-TIP5 and wt ESC chromatin 
extracts. Data are from three independent experiments. The proteins found enriched in 
FLAG-IP of F/H-TIP5 ESCs in all three experiments are shown. Further TIP5-interacting 
proteins identified in only two or one of the immunoprecipitation (IP) experiments are listed in 
Supplementary Table 3. 
C. Anti-FLAG IP of chromatin purified from wt- and F/H-TIP5-ESCs. Western blot shows the 
interaction of TIP5 with SNF2H, TOP2A and SMC1a. After protein transfer, membrane was 
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first incubated with anti-SMC1a antibodies and after signal detection re-incubated with anti-
TOP2A antibodies. 
 
Figure 6 
TOP2A and cohesin interact with TIP5 to regulate gene expression and H3K27me3 
occupancy of ESC+2i 
A. TOP2A and TIP5 regulate gene expression in ESC+2i via a shared pathway. qRT-PCR of 
genes regulated by TIP5 in ESC+2i (left panel) and in ESC+serum (right panel) upon TOP2A 
or TIP5 knockdown by siRNA. Nanog, Rex1 and Actin B (ActB) are shown as genes not 
regulated by TIP5. mRNA levels were normalized to Rps12 mRNA and to ESCs transfected 
with siRNA-Control. Average values of three independent experiments. Error bars represent 
s.d.  
B. Inhibition of type 2 topoisomerase activity phenocopies the alterations in gene expression 
of TIP5-regulated genes in ESC+2i observed upon TOP2A or TIP5 knockdown. ESCs were 
treated with the TOP2 inhibitor ICF-193. mRNA levels were normalized to Rps12 mRNA and 
to ESCs treated with DMSO. Average values of three independent experiments. Error bars 
represent s.d.  
C. SMC3 and TIP5 regulate gene expression in ESC+2i via a shared pathway. qRT-PCR of 
genes regulated by TIP5 in ESC+2i (left panel) and in ESC+serum (right panel) upon SMC3 
or TIP5 knockdown by siRNA. mRNA levels were normalized to Rps12 mRNA and to ESC 
transfected with siRNA-Control. Average values of three independent experiments. Error bars 
represent s.d.  
D,E. ChIP analysis showing that TOP2A regulates H3K27me3 occupancy in ESC+2i (D) but 
not in ESC+serum (E). Data were measured by qPCR and normalized to input and to Tshz1 
value in cells transfected with siRNA-control. Control represents an intergenic region that 
does not contain H3K27me3. Average values of three independent experiments. Error bars 
represent s.d. 
F. Depletion of Smc3 does not affect H3K27me3 occupancy in ESC+2i. H3K27me3 ChIP 
values represent the average values of three independent experiments. Error bars represent 
s.d. 
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G,H. TIP5 binding in ESC+2i depends on TOP2 activity. (G) Anti-FLAG ChIP in F/H-TIP5 
ESCs treated with siRNA-control or siRNA-Top2a. (H) Anti-FLAG ChIP in F/H-TIP5-ESCs 
cultured in 2i treated for 24 hours with DMSO or ICF-193. Values were normalized to input 
and to ATF7IP in control cells and are the average values of three independent experiments. 
Error bars represent s.d. 
I. TIP5 binding in ESC+2i depends on cohesin. Anti-FLAG ChIP in F/H-TIP5-ESCs cultured in 
2i treated with siRNA-control or siRNA-Smc3. Values were normalized to input and to ATF7IP 
in control cells and are the average values of three independent experiments. Error bars 
represent s.d. 
 
Figure 7. TIP5 regulates genome architecture 
A. Number of TIP5-bound regions in A and B compartments, respectively.  
B. Relative contact frequencies over genomic distances in ESCs treated with siRNA-control 
and siRNA-TIP5.  
C.D. Representative images from HoxA (C) and HoxB (D) gene clusters. Blue arrows 
indicated gain or increase of contacts in ESC+siRNA-Tip5 compared to control cells (siRNA-
control). Orange arrows indicate loss or decrease in contacts. HiC contacts were visualized 
using Juicebox (Rao et al., 2014)   
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Supplementary Figure legends 
 
Supplementary Figure 1 
TIP5 knockdown affects proliferation of ESC+2i 
A. Data represent relative cell numbers and were normalized to ESC transfected with siRNA-
Control. TIP5 knockdown was achieved with a different siRNA-Tip5 sequence (siRNA-
Tip5#2). Average values of three independent experiments. Error bars represent s.d. 
B. Data represent relative cell numbers using another ESC line (ESC#2) cultured in 2i 
medium and were normalized to ESC transfected with siRNA-Control. Average values of two 
independent experiments.  
 
Supplementary Figure 2 
TIP5 regulates expression of bivalent genes in ESC+2i 
A. Venn diagrams showing number of differently expressed genes upon TIP5 knockdown 
detected in ESC+2i compared to ESC+serum. 
B. Venn diagrams showing genes differentially expressed in ESC+2i and in ESC+serum 
compared to genes regulated by TIP5 in ESC+2i. 
C. Average density profiles from published ChIPseq data sets at genes upregulated or 
downregulated upon TIP5 depletion and at random genes in ESC+2i. ChIP data for Suz12 
and Ring1b were from (Joshi et al., 2015) whereas EZH2 and Pol II were from (Marks et al., 
2012). 
D. qRT-PCR. Expression analysis of TIP5 regulated genes in ESC+2i upon TIP5 knockdown 
using a different siRNA-Tip5 (siRNA-Tip5#2).  mRNA levels were normalized to Rps12 mRNA 
and to ESC+2i transfected with siRNA-Control. Average values of three independent 
experiments. Error bars represent s.d.  
E. qRT-PCR. Expression analysis of TIP5 regulated genes in another ESC line (ESC#2) 
cultured in 2i medium upon TIP5 knockdown. mRNA levels were normalized to Rps12 mRNA 
and to ESC+2i transfected with siRNA-Control. Average values of two independent 
experiments.  
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Supplementary Figure 3 
A. Western blot showing unchanged levels of total H3K27me3 in ESC+2i upon TIP5 
knockdown. Whole cell lysates from equivalent amounts of cells were analysed. Histone H3 is 
shown as a protein loading control. 
B. Heat map profiles for H3K4me3, H3K27ac and H3K27me3 ChIPseq experiments at all 
gene promoters in ESC+2i (H3K4me3 and H3K27ac) and in both ESC+2i and ESC+serum 
(H3K27me3) treated with siRNA-control or siRNA-Tip5. Heat maps for H3K27me3 were 
further subdivided into H3K27me3-high (Q1) and H3K27me3-low (Q2-4) promoters. Data 
were individually ranked by H3K4me3, H3K27ac and H3K27me3 in the corresponding control 
cells (siRNA-Control). Q1: first quartile corresponding to sequences with high H3K27me3 
content. Q2-4: quartiles 2-4 corresponding to sequences with low H3K27me3 content. 
C. H3K27me3 ChIP in ESC+2i upon TIP5 knockdown using a different siRNA-Tip5 (siRNA-
Tip5#2). Values show H3K27me3 occupancy at promoters of genes regulated by TIP5 and at 
four sequences (#1-#4) with elevated H3K27me3 at CTCF boundaries (H3K27me3hi/CTCF). 
Data were measured by qPCR and normalized to input and Tshz1 value in control cells. 
Average values of three independent experiments. Error bars represent s.d. 
D. TIP5 knockdown does not affect proliferation of TKO-ESCs. Data represent relative cell 
numbers after 3 days of siRNA treatment and were normalized to ESC transfected with 
siRNA-Control. Average values of three independent experiments. Error bars represent s.d. 
E. Knockdown of TIP5 in TKO-ESCs does not affect transcription of genes regulated by TIP5 
in ESC+2i. mRNA levels were normalized to Rps12 mRNA and to ESCs transfected with 
siRNA-Control. Average values of three independent experiments. Error bars represent s.d.  
F. ChIP of H3K27me3 in TKO-ESCs treated with siRNA-control or siRNA-Tip5. Data were 
measured by qPCR and normalized to input and to Tshz1 value in control cells. Control 
represents an intergenic region that does not contain H3K27me3. Average values of three 
independent experiments. Error bars represent s.d. 
G. TIP5 knockdown affect proliferation of Eed-/- and Ring1b-/- ESCs cultured in 2i. Data 
represent relative cell numbers after 3 days of siRNA treatment and were normalized to ESC 
transfected with siRNA-Control. Average values of three independent experiments. Error bars 
represent s.d. 
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H, I. TIP5 depletion also affects gene expression in the absence of PRC-mediated repression. 
RT-qPCR experiments in Eed-/- (H) and Ring1b-/- (I) -ESCs cultured in 2i treated with siRNA-
control or siRNA-Tip5. mRNA levels were normalized to Rps12 mRNA and ESC+2i 
transfected with siRNA-Control. Average values of three independent experiments. Error bars 
represent s.d. 
 
Supplementary Figure 4 
A. Scheme representing the strategy to insert FLAG-HA sequences at the 5' of the 
endogenous TIP5 sequence. 
B, C. PCR genotyping of four clones for insertion of the F/H-TIP5 sequence on the TIP5 
locus. Clones #1 and #3 were homozygous for F/H-TIP5 alleles. Sanger sequencing 
confirmed the integrity of F/H-TIP5. 
D. Venn diagrams showing TIP5 bound regions defined by SICER in ESC+2i compared to 
ESC+serum. 
E. Representative image showing that TIP5 associates with internal chromatin domains (ICD) 
in ESC+2i and ESC+serum. The data refer to TIP5 ChIPseq performed with FLAG-antibodies 
with F/H-Tip5 ESC+2i and ESC+serum. Data for LADs and ICDs refer to ESC+serum and are 
from (Peric-Hupkes et al., 2010). 
F. Venn diagrams showing genes bound by TIP5 compared to TIP5-regulated or random 
genes in ESC+2i. 
 
Supplementary Figure 5 
A. Correlation scores of PCA analysis defining A and B compartments from HiC experiments 
in siRNA-control and siRNA-Tip5 treated ESC+2i. 
B. Chromosome 1 as representative example for the global increase in far-cis contacts upon 
TIP5 depletion in ESC+2i. Differences in HiC contact frequencies (siRNA-Tip5 - siRNA-
Control) were visualized using Juicebox (Rao et al., 2014) 
C, D. Representative images indicating changes in contact frequencies. Blue arrows show 
gain or increase of contacts in ESC+siRNA-Tip5 compared to control cells (siRNA-control). 
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Orange arrows indicate loss or decrease in contacts. HiC contacts were visualized using 
juicebox (Rao et al., 2014) 
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Supplementary Figure 1
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Supplementary Figure 2
Expression of candidate genes upon TIP5 knockdown in ESCs+2i
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Supplementary Figure 3
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Supplementary Figure 4
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4. Discussion 
Ground state ESCs cultured with LIF and 2i have been suggested a good tool for 
studying ground state pluripotency, since ESCs+2i represent a homogenous 
population highly resembling the in vivo pre-implantation epiblast cells of the 
developing embryo (Boroviak et al., 2014; Hackett and Surani, 2014). Here we 
highlight fundamental differences in the chromatin organization and its dependency 
on several chromatin regulators in ground state and primed ESCs. We focused 
particularly on the nucleolar remodeling complex (NoRC) and showed that only 
ground state ESCs are dependent on TIP5, the main component of NoRC. TIP5 is 
highly expressed in ESCs but not bound to rRNA genes, as found in differentiated 
cells. Upon TIP5 depletion, ground state ESCs grow slower and are highly impaired 
in their differentiation potential. Furthermore, we demonstrated that NoRC is required 
for maintaining correct gene expression signatures and epigenetic landscapes in 
ESCs+2i. Importantly, this strong dependency on TIP5 was ground state-specific 
since TIP5 depletion in ESCs+serum did not result in any detectable defects so far. 
Strikingly, we could recapitulate highly similar, ground state-specific phenotypes by 
depleting or inactivating other chromatin regulators such as TOP2A and cohesin, 
which associate with TIP5 on chromatin. HiC analyses revealed an essential role of 
TIP5 in restricting far-cis chromatin contacts in ground state ESCs. Taken together, 
these findings imply that chromatin structures must be held under tight control by 
several chromatin regulators for maintaining ground state pluripotency. ESCs+serum 
by contrast, are developmentally primed and seem to be less dependent on chromatin 
regulators for reinforcing active and repressed genome partitioning. 
 
4.1 Ground state ESC chromatin structures 
Here we described a ground state-specific function of NoRC in regulating the gene 
expression signatures and epigenetic landscapes. TIP5 expression and its global 
genomic binding pattern were very similar in ESCs+2i and ESCs+serum, implying 
that it is most likely not NoRC itself but rather the state of its substrate that 
determines its functional relevance in ESCs. Global genome hypomethylation and low 
H3K27me3 levels at PRC-target sites have been among the most investigated 
chromatin characteristics identified for ESCs+2i (Ficz et al., 2013; Habibi et al., 2013; 
Marks et al., 2012). However, analyses of TIP5 depletion in PRC component (Eed 
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and Ring1b) KOs and DNA methylation triple KOs (TKOs) did not reveal any 
evidences that NoRC function might be linked via these two repressive pathways. 
Recently, ultra-high resolution microscopy by STORM investigating the chromatin 
structures at the nucleosome level revealed that ESCs+2i harbor a more open 
chromatin configuration when compared to ESCs+serum. So-called “nucleosome 
clutches” were significantly smaller in size and contained less nucleosomes per clutch 
in ESCs+2i (Ricci et al., 2015). Here we propose a model in which the open and 
dynamic nature of ground state chromatin might predispose ESCs+2i to a dependency 
on chromatin regulators. ESC+serum, containing a more restricted chromatin state 
including pre-established long-range interactions (Joshi et al., 2015), might be less 
dependent on the contribution of mechanisms monitoring chromatin structures. In line 
with this model, we showed that depletion or chemical inactivation of two additional 
chromatin structure regulators, namely TOP2A and cohesin, could highly recapitulate 
the alterations observed upon TIP5 depletion in ESCs+2i but not in ESCs+serum. 
Alternatively, we cannot exclude that posttranslational modifications restricting 
NoRC activity would be responsible for the functional differences observed in ground 
state and primed ESCs. In fact, a recent study indeed identified S1377 on TIP5 to be 
differentially phosphorylated between ESCs+2i and ESCs+serum (Rafiee et al., 
2016). Whether this phosphorylation site may influence NoRC activity remains to be 
tested experimentally. However, differences in NoRC activity mediated by PTMs 
alone could not explain that chemical inhibition or depletion of TOP2A highly 
recapitulates the ground state-specific defects that were observed in TIP5 depleted 
ESCs+2i. 
 
4.2 Altered chromatin structures caused by TIP5 depletion independently 
affect gene expression and H3K27me3 occupancies in ESCs+2i 
The fact that TIP5 binds to large and active compartments of the genome (type A) and 
that this occupancy does not correlate with sites of TIP5-regulated genes led us 
hypothesize that NoRC might be rather involved in regulating 3D structures in ground 
state ESCs. Indeed, we identified several chromatin regulators directly interacting 
with TIP5 on chromatin in ESCs. Furthermore, HiC analyses revealed a significant 
increase in far-cis contacts upon TIP5 depletion in ESCs+2i. These observations 
suggest that the changes in gene expression and H3K27me3 are both consequences of 
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altered chromatin structures caused by a loss in NoRC function in ESCs+2i. We 
would like to further emphasize that the changes in gene expression and H3K27me3 
do not seem to be directly coupled. Although differently expressed genes were 
enriched in H3K27me3, TIP5 depletion in Eed and Ring1b KO in ESCs+2i revealed 
highly similar gene expression changes as observed in wt ESCs+2i. Thus, PRC-
mediated repression is not implicated in TIP5-mediated regulation of gene expression. 
These results are also in agreement with a recent study demonstrating that global 
expression of bivalent genes is not altered in the absence of H3K27me3 (Galonska et 
al., 2015b). Thus, it rather seems that the gene expression changes and global 
H3K27me3 redistribution display two independent read outs of altered chromatin 
structures triggered by TIP5 depletion. Moreover, we observed that the genes affected 
by TIP5 knockdown are also often differentially expressed in ESCs+2i and 
ESCs+serum, suggesting that these genes – so far for unknown reasons – are in 
general more sensitive to changes in chromatin structures in ESCs.  
 
4.3 3D chromatin architecture and gene regulation 
3D compartmentalization of the genome within the nucleus has been proposed to be 
highly important for gene regulatory circuits (Bonev et al., 2017). CTCF and cohesin 
shape the genome organization into so called topological associated domains (TADs) 
(Nora et al., 2017; Rao et al., 2017; Schwarzer et al., 2017). While CTCF recognizes 
specific DNA sequence motif and functions as an insulating boundary, cohesin is 
thought to be loaded at sites of active transcription and travel along chromosome arms 
by a loop extrusion mechanism until reaching convergently oriented CTCF sites (de 
Wit et al., 2015; Guo et al., 2015; Nora et al., 2017; Sanborn et al., 2015). In 
comparison to ESCs+serum, ESCs+2i contain more CTCF occupied sites and loop 
structures (Jonathan A. Beagan, 2017), further suggesting that the 3D chromatin 
organization might play a particularly important role in ground state ESCs for 
maintaining gene regulatory mechanisms. Indeed, our experiments highlighted that 
cohesin depletion – known to cause a loss in loop structures (Rao et al., 2017) – leads 
to more pronounced gene expression changes in ESCs+2i when compared to 
ESCs+serum.  
Our proteomic interaction studies revealed that the highest interacting partner of TIP5 
is SNF2h, suggesting that the function of TIP5 in ESCs is directed via the NoRC 
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complex. Furthermore, this analysis showed that TIP5 tightly associates with TOP2A 
and cohesin on chromatin. Strikingly, we did not detect CTCF as TIP5-interacting 
partner in any of our mass spectrometric analyses. This implies that cohesin associates 
with NoRC while traveling along the chromosome arms rather than at the stable 
anchor point that are co-occupied by CTCF. Accordingly, we did not detect TIP5 
enrichment at CTCF/cohesin peaks. Our HiC analysis revealed global changes in far-
cis contacts (>10Mb) but does not provide the required resolution for elucidating 
changes in local chromatin structures. However, a recent study highlighted that 
abolishing cohesin loading resulted in a highly similar increase in these long-range 
chromatin contacts (Haarhuis et al., 2017). Since cohesin is known to limit local 
chromatin dynamics (Nozaki et al., 2017), these findings suggested that local 
chromatin compaction might globally limit far-cis chromatin contacts and therefore 
reinforce active and repressed genome partitioning (Haarhuis et al., 2017; Schwarzer 
et al., 2017). Strikingly, the reciprocal experiment of restricting cohesin removal from 
chromatin revealed the inverse outcome resulting in a reduction of far-cis chromatin 
contacts, further supporting this hypothesis (Haarhuis et al., 2017). Taking these 
assumptions into consideration for a putative role of TIP5 in ESCs leads to the 
intriguing model by which NoRC might mediate local chromatin compaction and 
thereby limit far-cis contacts in ground state ESCs. Chromatin of ESCs+serum by 
contrast, generally contains more condensed chromatin structures at the level of 
nucleosomes (Ricci et al., 2015). Thus, primed ESCs might be less dependent on 
factors that additionally limit chromatin dynamics and flexibility, explaining why 
ESCs+serum are less dependent on NoRC than ground state ESCs+2i. How NoRC 
mechanistically controls local chromatin dynamics remains elusive. Our HiC 
experiments did not indicate any global changes in TAD organization, arguing against 
a putative role of NoRC in regulating global cohesin occupancies. Though, it remains 
to be determined whether NoRC might control individual loop structures at a subTAD 
organization level. In fact, one major question in the field of chromatin architecture 
aims to elucidate what controls stable loop formation between two CTCF-bound sites. 
A vast majority of chromosomal contacts between CTCF-bound sites occur at a short 
range (<1Mb) (Handoko et al., 2011; Rao et al., 2014; Tang et al., 2015). Yet, only a 
small subset of all CTCF-bound sites mediate chromosomal contacts, implying that 
cells must have evolved mechanisms that control on and off rates between the 
interaction of CTCF and the extruding cohesin complex (Barbieri et al., 2017; Rao et 
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al., 2014). Interestingly, visual inspection of the HiC contact maps revealed prominent 
changes at many subTAD loop structures in TIP5-depleted ESCs+2i. The spatial 
organization of the HoxA gene cluster for instance, underwent an entire re-
organization in ESCs+2i lacking TIP5. A subTAD demarcating this locus completely 
dissolved and fused with two neighboring subTAD structures creating a new subTAD 
boundary. Strikingly, genes located upstream of this new boundary showed 
transcriptional upregulation, whereas downstream genes were tendentially 
downregulated in response to TIP5 knockdown. Taken together, these observations 
highlight a putative role of NoRC in regulating stable loop associations. In line with 
this hypothesis, SNF2H – the catalytic subunit of NoRC – has been shown to 
specifically regulate nucleosome occupancies at CTCF sites in human cells 
(Wiechens et al., 2016). Future high-resolution chromatin contact maps determined by 
5C experiments might shed further light on the exact mechanistic role of NoRC at 
these loci.  
 
4.4 Topoisomerases and supercoiling in genome architecture 
While cohesin and its contribution to 3D genome organization into TADs has been 
extensively studied in the past years (Rao et al., 2017; Schwarzer et al., 2017), the 
role of topoisomerases in regulating chromatin structures and genome architecture in 
mammalian cells remains under-investigated. Studies in ESCs+serum suggested that 
TOP2A chromatin binding is partially directed via the BAF nucleosome-remodeling 
complex (Dykhuizen et al., 2013). Here, we additionally identified NoRC as an 
interactor of TOP2A in mouse ESCs. Our results suggest that they synergize in order 
to maintain correct gene expression patterns and epigenetic signatures in ground state 
ESCs. Strikingly, TOP2A genomic binding occurs at active sites of the genome that 
poorly correlate with H3K27me3 (Dykhuizen et al., 2013; Thakurela et al., 2013), a 
binding profile that is similar to TIP5 genome occupancy defined by our analyses. 
Unfortunately, due to the discontinuation of validated high-grade ChIP TOP2a 
antibodies (Naughton et al., 2013; Thakurela et al., 2013), we have been unable to 
measure TOP2A genome occupancy in ESCs+2i.  
Computational modeling was used to propose an active role of topoisomerases in 
shaping 3D chromatin structures. In their simulations, loop structures alone could not 
account for contact frequencies that had been experimentally observed within TADs. 
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Only by adding supercoiling as an additional variable, they could recapitulate the 
degree of insulation among different TADs. Specifically long distance enhancer-
promoter contacts were predicted to be stabilized by supercoiling (Benedetti et al., 
2014a; Benedetti et al., 2014b). Furthermore, Stasiak and colleagues have recently 
proposed an additional link between topoisomerases and genome organization (Racko 
et al., 2017). In their mechanistic model, transcription-induced supercoiling catalyzed 
by TOP1 could provide the force for pushing handcuff-shaped cohesin rings along 
chromosome arms. It was further proposed that TOP2B – that has been shown to bind 
CTCF-occupied sites at TAD borders in somatic cells (Uuskula-Reimand et al., 2016) 
– could resolve the torsional stress leading to the stable association of cohesin at TAD 
boundaries (Racko et al., 2017). In summary, topoisomerases have been implicated in 
several processes regulating genome organization in mammalian cells. Thus, it is 
likely that its depletion causes severe effects in chromatin structures. The striking 
similarity in the phenotypes observed in TIP5 and TOP2A depletion experiments 
indicated that both factors are likely involved in similar pathways. This hypothesis is 
further supported by the fact that their co-depletion did not reveal any additive effects 
in gene expression changes. Importantly, knockdown of these two factors did not 
result in any detectable defects in gene expression or H3K27me3 in ESCs+serum, 
further strengthening the idea that ground state ESCs are particularly dependent on 
this set of chromatin regulators. In summary, our data suggests that ground state ESC 
chromatin – more open and dynamic in its nature – strictly requires mechanisms that 
limit local chromatin contacts to maintain proper gene expression patterns and 
epigenetic landscapes.  
 
4.5 Switch of NoRC function according to developmental and pathological 
state 
Previous results from our laboratory determined that the functional role of NoRC 
highly depends on the developmental and pathological state of cells. In somatic and 
healthy cells TIP5 is exclusively localized within the nucleolus, the compartment 
where rRNA genes reside and represses their transcription (Guetg et al., 2012; 
Santoro et al., 2002). By contrast, in both ground state and primed ESCs TIP5 is 
highly expressed but does not associate and hence, does not regulate transcription of 
rRNA genes (this work and (Leone et al., 2017; Savic et al., 2014). Upon early onset 
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of differentiation, NoRC is rapidly recruited to a subset of rRNA genes and 
progressively mediates their epigenetic silencing (Leone et al., 2017; Savic et al., 
2014). Here we describe a further switch in NoRC function from ground state to 
primed pluripotent state, a system that has been used to model very early steps of 
embryonic development (Atlasi and Stunnenberg, 2017; Joshi et al., 2015). While 
NoRC controls expression of many developmental genes and regulates genome-wide 
H3K27me3 occupancy in ground state pluripotency, it remains elusive whether NoRC 
has any functional relevance in primed ESCs. However, the switch to regulating 
rRNA genes occurs only upon exit of pluripotency, since NoRC neither binds nor 
silences rDNA in ESCs+serum yet. Interestingly, NoRC also changes its function 
during the transition from healthy to cancer cells (Gu et al., 2015a). Similarly to 
ESCs, TIP5 is abundantly present in the nucleoplasm in metastatic prostate cancer 
(PCa) cells and regulates genes involved in developmental processes that are 
frequently repressed in metastatic PCa (Gu et al., 2015b). Considering that cancer 
cells often acquire stem cell-like features, it is likely that TIP5 might use similar 
mechanisms to regulate ESCs and cancer cells. Taken together, we demonstrate that 
highly related cell types (ground state and primed ESCs) markedly differ in their 
dependency on various chromatin regulators. This suggests that the global shape of 
chromatin is a fundamental player for gene regulation and chromatin states and 
highlights different degrees of genome plasticity during the early phases of 
development. 
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